Domino Twofold Heck / 6p-Electrocyclization and Regioselective Palladium(0)-Catalyzed Reactions of Brominated Indoles, Furans, Naphthoquinone and 2,4,5,6-Tetrachloropyrimidine by Hussain, Munawar (gnd: 143545175)
  
Domino Twofold Heck / 6π-Electrocyclization and Regioselective 
Palladium(0)-Catalyzed Reactions of Brominated Indoles, Furans, 
Naphthoquinone and 2,4,5,6-Tetrachloropyrimidine 
Dissertation 
zur 
Erlangung des Doktorgrades 
doctor rerum naturalium (Dr. rer. nat.) 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Universität Rostock 
vorgelegt von  
Munawar Hussain geb. am 05. Jan 1977 Khanpur, Rahim Yar Khan, Pakistan. 
Rostock, Juli 2010  
UNIVERSITÄT ROSTOCK
urn:nbn:de:gbv:28-diss2011-0021-7
Die vorliegende Arbeit entstand in der Zeit von April 2008 bis April 2010 am 
Institut für Chemie der Universität Rostock. 
Erinreichung der Dissertation: 
1. Gutachter: Prof. Dr. Peter Langer, Universität Rostock, Germany 
2. Gutachter: Prof. Dr. Scott Taylor, University of Waterloo, Canada 
3. Gutachter: Prof. Dr. Willi Kantlehner, Hochschule Aalen, Germany 
Tag der Abgabe: 17th Juli, 2010 
Rigorosum: 11th Januar, 2011 
  
   
Wissenschaftliches Kolloquium: 
  
“I feel a great pleasure to dedicate all of this work 
to my respected mentor Abu Bilal Mohammad Ilyas Attar 
Qadri then my all teachers from I learned and will 
learn even a single word and my dear parents.
Acknowledgements  
First of AlI I pay my infinite thanks to Almighty Allah Azzawajal who 
blessed me with the chance and courage to complete this memorable 
task. And then Prophet Mohammad (Sallallah ho alai hi wasallam) 
whose personality is like a light through which each and everybody can 
examine his good and bad deeds.    
I wish to present my thanks to all who added to the successful 
completion of my Ph.D. 
I feel it due, to pay my thanks to Prof. Dr. Peter Langer, my Ph.D. 
supervisor, for providing efficient guidance and energetic research 
environment during the whole Ph.D studies . I always found him ready 
to facilitate my research, by effective discussions, reviving 
encouragements, unending trust, providing free hand in research and 
access to every possible facility.  
Particularly, many thanks to my father Hakim Ali Nawaz who is an 
experienced herbal medicine physician in Pakistan. He is the person 
who taught me how to think. Actually my all interest and hence 
achievements in research are due to his inspiration and training  
My special thanks to Dr. Yong Liu due to his exceptional support and 
company during my stay in University of Waterloo Canada, in fact he 
contributed very much in my practical and theoretical understanding.  
I wish to express my special gratitude to Dr. Martin Hein and Dr. Dirk 
Michalik for a number of nice talks about my research, to Dr. Holger 
Feist for his passion to deliver security instructions and making sure the 
security, to Dr. Alexander Villinger for their professional and accurate 
measuring X-ray crytallographic analyses. I would also like to thank 
the members of  NMR, IR, UV, MS, and X-ray laboratories of the 
University of Rostock and the Leibniz Institute for Catalysis Rostock.  
Acknowledgements are made to Dr. Rasheed Ahmad for introducing 
such a nice research group and taking care of my arrival problems.  
I am thankful to all my past and present, foreign and native colleagues 
which I have missed here to mention for their research discussions, nice 
company and time. 
Many thanks to Dr. Tung T. Dang, Rasheed Ahmad Khera, N. T. Hung, 
Dhafer Saber Zinad, Asad Ali, Omer Akravi, Imran Malik, Muhammad 
Nawaz, S. M. T. Toguem, Ghazwan Ali Salman, Dr. Inam Iqbal, Dr. 
Imran Iqbal, Farooq Ibad, Ihsan Ullah Marwat, Olumide Fatunsin, Mr. 
Sharif and all my other colleagues for their contribution and co-
operation. 
I thank to my all countrymen especially Asif Attari, Mohammad 
Nadeem Qadri, Abid Hussain Attari, Aamir Attari, Saeed Ahmad 
Thank you 
  
  Danke  
Thanks a lot
Vielen Dank
Alhamdolillahi 
Rabbil Aalamin 
Wassalatusalam
un Ala Rasool-
e-hilkarim 
  Shukriah 

Attari, javed Iqbal Attari, Ahmad akram Attari and all other Pakistanis 
in all parts of Germany particularly in Hamburg, Frankfurt, Berlin and 
Rostock  as their love, readiness to help and meaningful company gave 
me not only support but also feeling like my own country and city 
which made my stay here enjoyable. 
It is not possible to forget to pay thanks the leaders and staff of Higher 
Education Commission Pakistan particularly Ms. Saima Naurin for her 
dedication to support and facilitate me in all related problems. Financial 
support for my Ph.D. from Higher Education Commission of Pakistan 
and Mecklenburg State, Germany is gratefully acknowledged. 
Special thanks to all of my teachers for their education and training in 
both life and chemistry, especially Dr. Zaheer Ahmad and Dr. Scott D. 
Taylor as I started my research life with them. 
I would like to convey my heartiest thanks to my whole family for their 
love, support and adherence to my achievements and struggle. The 
significance of their support and help in past and present cannot be 
expressed in words.  
I owe all of them in my life! 
Danke schön
Many Thanks
IMAIN CONTENTS 
SUMMARY Page 1
CHAPTER 1 Page 2 - 5
An Overview of Domino Twofold Heck / 6π-Electrocyclization Reactions of 1,2-
Dihalogenated Compounds
Br
X Pd[0]
R R
R
X=Br, OTf
An overview of domino twofold Heck / 6π-
electrocyclization reactions of vicinal 
dihalides is given.  
CHAPTER 2 Page 6 - 17
Synthesis of 1,2-Dihydrocarbazoles and Carbazoles by Domino ′Twofold Heck / 6π-
Electrocyclization′ Reactions of Di- and Tri-N-methylindoles 
N
Br
Br
Me
CO2R
N
Me
CO2R
CO2R
The palladium(0)-catalyzed Heck cross-
coupling reactions of di- and tribromo-N-
methylindoles provided 1,2-
dihydrocarbazoles by a domino ′twofold 
Heck / 6π-electrocyclization process at 120 
°C. The products were transformed by 
Pd/C-catalyzed oxidation to the 
corresponding carbazoles.  
CHAPTER 3 Page 18 - 21
Efficient Synthesis of Functionalized Benzofurans by Domino ′Twofold Heck / 6π-
Electrocyclization′ Reactions   
O
Br
Br O
R
R
R
I have synthesized functionalized 
benzofurans based on domino ′twofold 
Heck / 6π-electrocyclization′ reactions. 
Regioeselectivity issues of Heck cross 
coupling have also been addressed. 
CHAPTER 4 Page 22 - 28
II
Synthesis of Anthraquinones, Fluorenones and Benzocoumarins by Domino ′Twofold 
Heck / 6π-Electrocyclization′ Reactions 
O
Br
X Pd[0]
R
O
R
R
X=Br, OTf
Functionalized anthraquinones, fluorenones 
and benzocoumarins were prepared by 
domino ′twofold Heck / 6π-
electrocyclization′ reactions.   
CHAPTER 5 Page 29 - 38
Synthesis of Aryl-Substituted Pyrimidines by Site-Selective Suzuki-Miyaura Cross-
Coupling Reactions of 2,4,5,6-Tetrachloropyrimidine  
                                                                              
N N
ClCl
Cl
Cl
N N
ArCl
Cl
Cl
ArB(OH)2
[Pd]
N N
ArAr
Cl
Cl
N N
ArAr
Ar
Cl
N N
ArAr
Ar
Ar
(1.0-4.4 equiv.) (1.0 equiv.) (2.0 equiv.)
(3.0 equiv.) (4.4 equiv.)
Suzuki-Miyaura cross coupling reactions of 
2,4,5,6-tetrachloropyrimidine provide an 
expedient synthesis of mono-, di-, tri- and 
tetraarylpyrimidines which are not readily 
available by other methods. All reactions 
proceed with excellent site-selectivity. 
Optimization of reaction conditions for better 
yields and loading of lower percentage of 
catalyst were studied as well. 
CHAPTER 6 Page 39 – 45
Site-Selective Suzuki-Miyaura Cross-Coupling Reactions of 2,3,4,5-Tetrabromofuran 
ArB(OH)2
[Pd]
(1.0-4.4 equiv.)
(2.0 equiv.)
(4.4 equiv.)
O
Br
Br
Br
Br
O
Br
Ar
Br
Ar
O
Ar
Ar
Ar
Ar
Suzuki-Miyaura reactions of 2,3,4,5-
tetrabromofuran allowed a convenient 
synthesis of tetraarylfurans which are 
not readily available by other methods. 
Regioselectivity was achieved by using 
the binary solvent system 
toluene/dioxane (4:1) at C-2, C-5 and 
then C-3, C-4. All reactions proceeded 
with excellent yields and site-
selectivity.
III
EXPERIMENTAL SECTION      Page 49 - 101
APPENDIX Page 102
ERKLÄRUNG Page 109
CURRICULUM VITAE Page 110
REFERENCE Page 116
DETAILED CONTENTS 
1 An Overview of Domino Twofold Heck/ 6π-Electrocyclization Reactions of 1,2-
Dihalogenated Compounds ............................................................................................ 2 
 1.1 Pericyclic  reactions ............................................................................................ 2 
        1.2          My research objectives ........................................................................................ 5 
2          Synthesis of 1,2-Dihydrocarbazoles and Carbazoles by Domino ′Twofold Heck / 6π-
Electrocyclization′ Reactions of Di- and Tri-N-methylindoles. 
2.1 Introduction ......................................................................................................... 6 
2.2 Results and Discussion ........................................................................................ 7 
2.3 Conclusion......................................................................................................... 17
3 Efficient Synthesis of Functionalized Benzofurans by Domino ′Twofold Heck / 6π-
Electrocyclization′ Reactions   ..................................................................................... 18
3.1 Introduction ....................................................................................................... 18 
3.2 Results and Discussion ...................................................................................... 18 
3.3 Conclusion......................................................................................................... 21
4 Synthesis of Anthraquinones, Fluorenones and Benzocoumarins by Domino ′Twofold 
Heck / 6π-Electrocyclization′ Reactions ...................................................................... 22 
4.1 Introduction ....................................................................................................... 22 
4.2 Results and Discussion ...................................................................................... 23 
4.3 Conclusion......................................................................................................... 28
    5          Synthesis of Aryl-Substituted Pyrimidines by Site-Selective Suzuki-Miyaura Cross              
Coupling Reactions of 2,4,5,6-Tetrachloropyrimidine  ............................................... 29 
5.1 Introduction ....................................................................................................... 29 
5.2 Results and Discussion ...................................................................................... 30 
5.3 Conclusion......................................................................................................... 38
6 Site-Selective Suzuki-Miyaura Cross-Coupling Reactions of 2,3,4,5-Tetrabromofuran
 ...................................................................................................................................... 39 
6.1 Introduction ....................................................................................................... 39 
IV
6.2 Results and Discussion ...................................................................................... 40 
6.3 Conclusion......................................................................................................... 45 
7 Abstract.........................................................................................................................46 
Experimental Section ............................................................................................................... 49
8 Material and Methods ................................................................................................... 49 
8.1 General Remarks ............................................................................................... 49 
8.2 Methods for Compound Characterization and Analysis ................................... 49 
8.3 Chromatographic Methods ................................................................................ 51 
9 General Procedures ...................................................................................................... 52 
9.1 Synthesis of 1,2-Dihydrocarbazoles and Carbazoles by Domino ′Twofold Heck 
/ 6π-Electrocyclization′ Reactions of Di- and Tri-N-methylindoles ................. 52 
9.1.1       Synthesis of 2,3-dibromo-N-methylindoles ...................................................... 52 
9.1.2           Synthesis of 2,3,6-tribromo-N-methylindoles .............................................. 52 
9.1.3           Synthesis of 2,3-bis(alkenyl)-N-methylindoles ............................................ 53
         9.1.4      Synthesis of 2,3-dihydrocarbazoles………………………………………..54  
         9.1.5      Synthesis of 3,4-disubstituted carbazoles………………………………… 59                        
         9.1.6      Synthesis of 2-(2-cyanoethyl)-9-methyl-9H-carbazole-3-carbonitriles    ...61  
         9.1.7      Synthesis of 6-bromo-2,3-bis(alkenyl)-N-methylindoles ………………….62  
         9.1.7      Synthesis of 6-alkenyl-2,3-dihydrocarbazoles……………………   …… .66  
          9.1.8      Synthesis of 6-alkenylcarbazoles……………………………………….…70  
         9.1.9      (2E,2'E)-Dibutyl 3,3'-(3-formyl-1-methyl-1H-indole-2,6-diyl)diacrylate... 85  
9.2 Efficient Synthesis of Functionalized Benzofurans by Domino ′Twofold Heck / 
6π-Electrocyclization′ Reactions   .................................................................... 74 
9.2.1 Synthesis of 2,3-bis(alkenyl)furans ............................................................. 74 
9.2.2 Synthesis of 5,6-disubstituted benzofurans ................................................. 77 
 9.3 Synthesis of Anthraquinones, Fluorenones and Benzocoumarines by Domino 
′Twofold Heck / 6π-Electrocyclization′ Reactions ........................................... 79 
9.3.1 Synthesis of mono- and disubstituted anthraquinones ................................ 79 
9.3.2 Synthesis of disubstituted fluorenone .......................................................... 81 
9.3.3 Synthesis of disubstituted benzocoumarins ................................................. 82 
 9.4 Synthesis of Aryl-Substituted Pyrimidines by Site-Selective Suzuki-Miyaura     
Cross-Coupling Reactions of 2,4,5,6-Tetrachloropyrimidine ........................... 82 
9.4.1 Synthesis of tetraaryl-pyrimidines ............................................................... 83 
9.4.2 Synthesis of 2,4,6-triaryl-5-chloropyrimidines ........................................... 87 
9.4.3 Synthesis of 4,6-diaryl-2,5-dichloropyrimidines                                         89 
9.4.4 Synthesis of unsymmetrical 2,4,6-triaryl-5-chloropyrimidines ................... 90 
9.4.5 Synthesis of unsymmetrical 2,4,5,6-tetraaryl-pyrimidines .......................... 91
         9.4.6     Synthesis of 4-aryl-2,5,6-trichloropyrimidines...........................................  92 
          9.4.7            One-pot synthesis of unsymmetrical 2,4,6-triaryl-5-chloropyrimidines    94  
 9.5 Site-Selective Suzuki-Miyaura Cross-Coupling Reactions of 2,3,4,5-
Tetrabromofuran ............................................................................................... 95 
9.5.1             Synthesis of tetraarylfurans ........................................................................ 96 
         9.5.2             Synthesis of 2,5-diaryl-3,4-dibromofurans…………………………......100
Appendix ................................................................................................................................ 102
10 Crystallographic Data ................................................................................................. 102
Abbreviations ......................................................................................................................... 108
Erklärung ................................................................................................................................ 109
VCurriculum Vitae .................................................................................................................... 109
References .............................................................................................................................. 116
11
SUMMARY 
A significant part of this dissertation has been published (see list of publications). Work 
described in this thesis includes domino ′twofold Heck / 6π-electrocyclization′ reactions of 
several carba- and heterocyclic 1,2-dibromoalkenes and regioselective Suzuki-Miyaura cross-
coupling reactions of 2,3,4,5-tetrabromofuran and 2,4,5,6-tetrachloropyrimidine. 
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1 An Overview of Domino Twofold Heck / 6π-Electrocyclization Reactions of 
1,2-Dihalogenated Compounds 
1.1 Pericyclic reactions: These are concerted cyclization reactions wherein the transition 
state of the molecule has a cyclic geometry in which electrons move round a circle without 
positive or negative charges. There are three types of pericyclic reactions. 
1- Cycloaddition reactions 
2- Sigmatropic reactions  
3- Electrocyclic reactions 
1- Cycloaddition reactions: Cycloaddition is a one-step ring-forming reaction between two 
conjugated  systems in which two new  bonds are formed joining the two reagents at each 
end. The mechanism has one step with no intermediates. E.g. Diels-Alder reaction. 
+ [4+2]
2-Sigmatropic reactions: Sigmatropic reaction is a pericyclic reactions wherein the net result 
is one  bond is changed to another -bond in an uncatalyzed intramolecular process. E.g. the 
most famous sigmatropic rearrangement is the [3,3] Claisen rearrangement. 
O O[3,3]
3-Electrocyclic reaction: Electrocyclic reaction is the formation of a new  bond across the 
ends of a conjugated polyene or the reverse.1
The combination of the Heck cross-coupling reaction with electrocyclization reaction 
provides a convenient access to a variety of carbacyclic frameworks. Pioneering work in this 
field was reported by de Meijere and co-workers. In 1987, this research group reported the 
Heck-type vinylation of 1,2,9,10-tetrabromo[2.2]paracyclophanediene (1) to synthesize 
tetravinyl derivative 2 (Scheme 1). Thermal electrocyclization and subsequent aromatization 
of 2 provided benzo-anullated [2.2]paracyclophanediene 3. Interestingly, a prematurely 
interrupted reaction with styrene provided entirely the vicinal dibromide 4 after cyclization 
and aromatization. This research group showed the importance of double Heck-coupling of 
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alkenes with vicinal dibromo-alkenes to synthesize (E,Z,E)-l,3,5-hexatrienes which can 
undergo the annulation of six-membered rings.2
Br
Br
Br
Br
R
Br
Br Ph
Ph Br
Br Ph
Ph
R
R
R
R
R
R
R
R
i
ii
Ph
i
ii
1
2 (32-50%) 3 (12-45%)
4 5 (55%)
R = H, SiMe3, CO2Me, Ph, 4-FPh
Scheme 1. Conditions: i) Pd(OAc)2, Bu4NBr, K2CO3/NaHCO3, DMF, heat (40-100 °C), ii) 
Pd/C (+O2) or S8, xylene, 150 °C. 
The reactions discussed above include the Heck reaction, electrocyclization, double bond 
migration (or isomerisation probably by [1,5]-sigmatropic hydrogen shift)6 and aromatization 
(oxidation).  
In 1990, Armin de Meijere group reported twofold Heck reactions of vicinal 1,2-
dibromocycloalkenes 6 to synthesize (E,Z,E)-l,3,5-hexatrienes 7 in fair to high yields (26-69 
%). Thermal electrocyclization in anaerobic conditions provided the annulated 1,3-
cyclohexadienes 8 (scheme -2). Two-, three- and fourfold Heck type coupling reactions were 
also performed with vicinal di-, tri-, and tetra-bromobenzene, but no subsequent 
electrocyclization was described.3 
(n)
Br
Br
R
(n)
R
R (n)
R
R
n = 1, 2
R = CO2Me, Ph, SiMe3
1
6
6 7 (15-69%) 8 (50-90)
Scheme 2. Conditions: i) Pd(OAc)2, PPh3, NEt3, DMF, heat (90-100 °C), ii) xylene or (n-
Bu2O), 140-150 °C, inert conditions. 
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In 1998, Armin de Meijere research group reported a domino reaction approach based on 
twofold Heck cross-coupling reactions of 1,2-dihalocycloalkenes.4 They prepared (E,Z,E)-
1,3,5-hexatrienes, these provided appropriate systems for a thermal 6-electrocyclization to 
form smoothly functionalized ring-annulated cyclohexa-1,3-dienes. This research group used 
a variety of starting materials and reaction conditions for the synthesis of (E,Z,E)-1,3,5-
hexatrienes, such as the Wittig reaction and Heck-type reactions (Scheme 3). 
(n)
I
I
(n)
Br
Br
OTf
Br
ONf
Br
HC
Br
O
ONf
Br
ONf
Cl
R
R
i
ii ii
i ii
ii i
ii i
n = 1, 5, 6
R = H, SiMe3, SiMe2 Tf = SO2CF3
CO2Me Ph, 4-FPh Nf = SO2(CF2)3CF3
SinBu3 SiEt3
(43
-81
%)
(9-92%)
iv , 80-94%
ii, 62-91%
33-73%
86%
96%
71%
Scheme 3. Conditions: i) alkene, Pd(OAc)2, AgNO3, NEt3, DMSO, heat (20-100 °C), 
Pressure (1-5 bar), time (5 h-48 h); ii), alkene, Pd(OAc)2, PPh3, LiCl, NEt3, DMF, heat (60-90 
°C), iii), alkene,  Pd(OAc)2, PPh3, NEt3, DMF, heat (60-90 °C), iv), (EtO)2POCH2R, NaH, 
THF, 0-25 °C, 12 h.   
Heating of the reaction mixtures at 130-150 °C in oxygen-free xylene or di-n-butyl ether 
resulted in electrocyclization of the (E,Z,E)-1,3,5-hexatrienes. As these electrocyclizations 
were done under thermal conditions, they proceeded by disrotatory ring closure and the two 
substituents at position 1 and 6 had a stereochemical cis relationship (scheme 4).            
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(n)
X
X
R
(n)
R
R (n)
R
R
n = 5, 6
R = CO2Me, Ph, CN, CO2Et
1
6
(n)
R
R
[O]
X = Br
9 10 11 (50-95%) 12 (86%)
Scheme 4. Twofold Heck cross coupling and subsequent electrocyclization, i) Pd(OAc)2, 
PPh3, NEt3 DMF, 90-100 °C, ii) Pd/C (+O2) or S, xylene, 150 °C. 
The 6-electrocyclization of bis-alkenylated Heck products results in a product containing 
two exocyclic double bonds. As stated before probably this isomerization occurred through 
[1,5]-sigmatropic hydrogen shift.6 To refurnish the aromaticity of the adjacent ring, migration 
of the double bonds is necessary. This isomerization must happens in such a way that a more 
stable product can be formed (thermodynamic control).  
  
Although, Kano and co-workers were the first to report the synthesis of carbazoles by 6π-
electrocyclization of 2,3-di(alkenyl)indoles.5 Later, this approach had also been studied by 
Pindur and Adam.6 However, the synthesis of the starting materials was not straightforward 
and needed many steps which is a severe drawback of this method.  Prof. P. Langer and 
coworkers later studied the application of this concept for various 1,2-dihaloaromatic 
compounds which includes both carba- and heterocycles. In general, the electrocyclization 
only works well for substrates in which the central double bond is not involved in a benzene-
type aromatic system. The reaction is possible for weakly aromatic systems and for non-
aromatic double bonds. 
1.2 My Research Objectives: 
Although first domino twofold Heck / 6π-electrocyclization reactions was reported in 
1987, but never reported for the (E,Z,E)-1,3,5-hexatrienes invoving the double bond of 
aromatic system. My goal was to optimize the reaction conditions to apply this strategy 
on 1,2-dihalogenated heteroaromatic compounds like 2,3-dibromo-N-methylindole, 
2,3,6-tribromo-N-methylindole and 2,3-dibromofuran. Later on this strategy was also 
studied for 2,3-dibromonaphthoquinone, 2,3-dibromoindenone and 3-bromo-4-
hydroxy coumarin to synthesize their corresponding benzo-annulated analogs.
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2 Synthesis of 1,2-Dihydrocarbazoles and Carbazoles by Domino Twofold 
Heck / 6π-Electrocyclization Reactions of Di- and Tri-N-methylindoles 
2.1 Introduction 
Carbazole is a natural product isolated first time from coal tar in 1872 by Graebe and Glaser. 
Carbazoles are of significant pharmacological application with antifungal, antibiotic, and 
antitumor activities. Simple carbazole alkaloids were discovered in 1960s as a natural product 
from plant. Murrayafoline A and murrayaquinone-B are examples of naturally occurring  
carbazoles and carbazolequinones isolated from the root bark of Murraya euchrestifolia
Hayata by Japanese researchers (Figure 1).16, 17   
N
H
MeO
MeO
O N
H
Me
OMe
Murrayafoline AMurrayaquinone B
Figure 1. Carbazoles isolated from root bark of Murraya euchrestifolia Hayata 
In the literature, iron-mediated (stoichiometric) cyclizations resulted in ingenious synthesis of 
carbazoles were described by Knölker and coworkers.16d Later on the same group reported 
carbazole syntheses by Buchwald-Hartwig reaction of aryl halides with anilines and following 
oxidative cyclization.18 Recently Ackermann et. al. have reported a proficient synthesis of 
carbazoles and other heterocycles by a new palladium-catalyzed domino N-H / C-H activation 
reaction of anilines with 1,2-dihaloalkenes.19 Diels-Alder reactions of 2- or 3-vinylindoles 
have also been used for the preparation of carbazoles.20 The first report for the synthesis of 
carbazoles by 6π-electrocyclization using 2,3-di(alkenyl)indoles came from Kano and 
coworkers.5 Later, this approach had been also studied further by Pindur and Adam.6
Nevertheless, the synthesis of the precursors were complicated and essentially needed many 
steps which is a real disadvantage of this method. The authors prepared acceptor-substituted 
2,3-di(alkenyl)indoles by Pd(II)-catalyzed reactions of carbon atom C-3 of 2-formylindoles 
with alkenes to form 2-formyl-3-vinylindoles and subsequent Wittig reaction provided the 
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desired product. As this approach did not provide a general method to prepare carbazoles, 
alternatively, double Wittig reaction approach of (unstable) 2,3-diformyl-N-methylindole was 
reported but it resulted in low yields. 
In recent years, it has been revealed that polyhalogenated heterocycles can be functionalized 
regioselectively by palladium(0)-catalyzed cross-coupling reactions and selective activation 
of a single halogen atom. The regioselectivity is controlled by electronic and steric 
parameters.21 Recently, Langer et al. have discovered the synthesis of aryl-substituted 
thiophenes,22 pyrroles,23 and selenophenes,24 by regioselective Suzuki reactions of 
tetrabromothiophene, tetrabromo-N-methylpyrrole, and tetrabromoselenophene, respectively. 
Symmetrical and unsymmetrical 2,3-diarylindoles also have been described by twofold 
Suzuki reactions of 2,3-dihalo-N-(phenylsulfonyl)indoles and N-methylindole.25 Other 
palladium(0)-catalyzed cross-coupling reactions of 2,3-dihaloindoles had never been reported 
before. A detailed literature study of different approaches described earlier suggested that 
domino twofold Heck / 6π-electrocyclization might provide a valuable method for the direct, 
easy and consistent synthesis of substituted dihydrocarbazoles and carbazoles.  
2.2 Results and Discussion 
Even though 2,3-dibromo-N-methylindole (14) has been previously synthesized in 64% yield 
by reaction of N-methylindole (13) and copper(II) bromide,26 I studied this reaction again and 
found that the reaction of N-methylindole (13) with portion-wise addition of NBS (2.1 equiv.) 
in THF (−78 °C, 4 h) can result in regioselective formation of 2,3-dibromo-N-methylindole 
(14) in 90% yield (Scheme 5). Product 14 and 2,3,6-tribromo-N-methylindole (15) have been 
isolated as natural products.27-30 Gribble and Liu have reported the transformation of 14 into 
15 (Br2, CHCl3) in 70-80% yield.30 I found that 2,3,6-tribromo-N-methylindole (15) can be 
prepared in 94% yield by reaction of 13 with NBS (3.1 equiv.) in THF (−78 °C, 4 h). Addition 
of NBS to the reaction mixture at room temperature resulted in a very complex mixture of 
compounds. The same was observed when NBS was added in one portion. In fact, 
bromination of N-methylindole is a highly exothermic reaction. Therefore, to prepare 
regioselectively brominated N-methylindoles, the reaction was performed at -78 °C with 
portion-wise addition of NBS to the reaction mixture. Applying this strategy, I achieved 
consistently the regioselective bromination of N-methylindole. 
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N
Me
N
Br
Br
Me
N
Br
Br
Br
Me
i
i i
13
14 (90%)
15 (94%)
Scheme 5. Bromination of N-methylindole (13); conditions: i, NBS (2.1 equiv.), THF, −78 
°C, 4 h; ii, NBS (3.1 equiv.), THF, −78 °C, 4 h, then 20 °C, 14 h. 
Table 1. Optimization of the reaction conditions for the synthesis of 17b,d 
a Yields of isolated products; all reactions were carried out in DMF using NEt3 as base (36h); b
mixture of 17b,d and 18b,d, respectively (estimated by TLC); c Approx. 50% conversion 
(estimated by tlc) 
The Heck cross coupling reaction of 14 with acrylates 16c-g afforded the 2,3-
di(alkenyl)indoles 17b-e in good yields (Scheme 6, Table 2). The best yields were obtained 
when the reactions were carried out using Pd(OAc)2 (5 mol-%) and the biaryl monophosphine 
Entry Catalyst Temp (°C) % (17b) a % (17d) a
1 Pd(PPh3)4  (5 mol-%) 90 Complex 
mixture 
Complex 
mixture 
2 Pd(OAc)2 (5 mol-%), XPhos (10 mol-%) 90 65 71 
3 Pd(OAc)2 (5 mol-%), SPhos (10 mol-%) 90 72 78 
4 Pd(OAc)2 (5 mol-%), SPhos (10 mol-%) b b
5 Pd(OAc)2 (3 mol-%), SPhos (6 mol-%) 90 Complex 
mixture 
Complex 
mixture 
6 Pd(OAc)2 (2 mol-%), SPhos (4 mol-%) 100 c c
7 Pd(OAc)2 (2 mol-%), SPhos (4 mol-%) 120 18b (77%) 18d (85%)
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ligand L (10 mol-%) which has been recently been developed by Buchwald and coworkers.7
Lower percentage of catalyst resulted in complex mixture (Table 1). The reactions were 
carried out in DMF at 90 °C for 36 h. Recently, Li and Wang reported31 that triethanolamine 
represents an efficient and reusable combined base, ligand, and solvent for palladium(0)-
catalyzed Heck reactions. The application of these conditions to the reaction of 14 with 
acrylate 16g proved to be successful and resulted in the formation of 17e in 63% yield.  
The Pd(OAc)2/L-catalyzed reaction of 14 with acrylates 16b,c,e,f,i carried out at 120 °C 
rather than 90 °C, afforded the 1,2-dihydrocarbazoles 18a-d,f in good yields. The formation 
of these products can be explained by a domino twofold Heck / 6π-electrocyclization
cyclization and following double bond migration. The initially formed 2,3-dihydrocarbazoles 
undergo an isomerization into the more stable 1,2-dihydrocarbazoles. The 6-
electrocyclization of bis-alkenylated Heck products results in a product containing two 
exocyclic double bonds. Possibly this isomerization could occur through 1,5-sigmatropic 
hydrogen shift. To refurnish the aromaticity of the adjacent ring, migration of the double 
bonds is necessary. This isomerization must happen in such a way that a more stable product 
can be formed (thermodynamic control). 
N
Me
i or i i
19
17b-e
N
Br
Br
Me
CO2R
CO2R
CO2R
16b,c,e,f,g,i
N
Me
CO2R
CO2R
18a-d,f
ii i
N
Me
CO2R
CO2R
Scheme 6. Synthesis of 17b-e and 18a-d,f. Conditions: i, for 17b-e: Pd(OAc)2 (5 mol-%), L
(10 mol-%), NEt3, DMF, 90 ˚C, 36 h; ii, for 17e: Pd(OAc)2 (5 mol-%), N(CH2CH2OH)3 (3 
mL), 90 ˚C, 36 h; iii, Pd(OAc)2 (5 mol-%), L (10 mol-%), NEt3 (8.0 equiv.), DMF, 120 ˚C, 48 
h. 
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Table 2. Synthesis of 17b-e and 18a-d,f 
a Yields of isolated products based on 14; b experiment was not carried out 
Figure 2. Ortep plot of 18d
The structures of all products were established by spectroscopic methods. The structure of 
18d was independently confirmed by X-ray crystal structure analysis (Figure 2). 
Heating of a dioxane or benzene solution of 1,2-dihydrocarbazole 18b in the presence of 
DDQ resulted in the formation of carbazole 19, albeit, in only 20% yield. Pindur reported the 
DDQ-mediated formation of 2,3-di(methoxycarbonyl)-N-phenylsulfonylcarbazole from the 
corresponding 1,2-dihydrocarbazole in equally low yield (18%). I found that a dramatic 
increase of the yield (100%) can be achieved when the reaction is carried out using Pd/C (10 
mol-%) in refluxing xylene (Scheme 7). 
17,18 16   R % (17) a % (18) a
a b Et - b 93 
b c nBu 72 77 
c          e nHex 77 81 
d f tBu 78 85 
e g iOct 76 - b
f i (CH2)2NMe2 - b 79 
11
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i
N
Me
CO2R
CO2R
N
Me
CO2R
CO2R
19a-d (100%)18a-d
Scheme 7. Synthesis of carbazole 19a-d; conditions: i, Pd/C (10 mol-%), xylene, reflux, 48 h 
Table 3. Synthesis of 19a-d 
a Yields of isolated products based on 18a-d 
Figure 3. Crystal structure of 19a
The Pd(OAc)2/L-catalyzed reaction of 14 with acrylnitrile (120 °C, 48 h) afforded the 
unexpected carbazole 20 in 49% yield (Scheme 8). The formation of 20 can be explained by 
twofold Heck reaction of 14 to give intermediate A, electrocyclization (intermediate B), base-
mediated conjugate addition to give intermediate C, and subsequent aromatization by 
elimination of HCN. The structure of 20 was independently confirmed by X-ray crystal 
structure analysis (Figure 4). 
18 19   R % (19) a
a a Et 100 
b b nBu 100 
c     c nHex 100 
d d tBu 100 
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N
Me
i
20 (49%)
N
Br
Br
Me
CN
CN
CN
N
Me
CN
CN
N
Me
CN
CN
A
B
C
N
Me
CN
CN
CN
14
CN
NEt3
Scheme 8. Possible mechanism of the formation of 20. Conditions: i, Pd(OAc)2 (5 mol-%), L
(10 mol-%), NEt3, DMF, 120 ˚C, 48 h 
Figure 4. Crystal Structure of 20
The Pd(OAc)2/L-catalyzed reaction of 2,3,6-tribromo-N-methylindole 15 with acrylate 16f
(90 °C, 36 h) afforded the di(alkenyl)indole 22 in 75% yield (Scheme 10). The structure was 
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confirmed by 2D NMR experiments (NOESY, HMBC). The regioselective formation of 22 is 
worth to be noted because Ohta and coworkers reported32 that the regioselectivity of the 
Suzuki reaction of 3,6-dibromo-N-TBDS-indole was in favour of carbon atom C-6. My result 
can be explained by the assumption that the first Heck reaction of 15 occurs at carbon C-2, 
which is most electron-deficient, to give intermediate D (Scheme 20). Due to the electron-
withdrawing character of the 2-(tert-butoxycarbonyl)alkenyl substituent, carbon C-3 becomes 
more electron-deficient and, thus, more reactive than C-6. This might also explain the 
observation that the reaction of 2,3-dibromoindole (14) with only one equivalent of acrylate 
mainly resulted in the formation of 2,3-di[2-(alkoxycarbonyl)ethenyl]indole 17 and starting 
material, except for the case of acrylate 16h where I isolated 21 in 35 % yield along with 17g. 
Product 21 was an unstable compound and at room temperature it underwent decomposition 
within 24 h providing a dark brown colored material, probably due to the loss of Br (Scheme 
9).  
N
Br
Me
14
N
Br
Br
Me
CO2R
21 (R = 2-Et-Hex): 35% + 17g
CO2R
i
16h
Scheme 9. Synthesis of 21. Conditions: i, Pd(OAc)2 (5 mol-%), L (10 mol-%), NEt3, DMF, 90 
°C, 24 h. 
The Pd(OAc)2/L-catalyzed reaction of 15 with acrylate 16d, carried out at 120 rather than 90 
°C, afforded the 1,2-dihydrocarbazole 23 in 73% yield (Scheme 10).  
14
14
N
Me
i
15
22 (R = tBu): 75%
N
Br
Br
Me
CO2R
CO2R
CO2R
16d,f
N
Me
CO2R
CO2R
ii
Br
Br
Br
23 (R = iBu): 73%
Scheme 10. Synthesis of 22 and 23. Conditions: i, Pd(OAc)2 (5 mol-%), L (10 mol-%), NEt3, 
DMF, 90 °C, 24 h; ii, Pd(OAc)2 (5 mol-%), L (10 mol-%), NEt3, DMF, 120 °C, 48 h 
Ohta et al. (ref. 32)
N
Br
TBDS
Br
N
Br
Br
Me
Br
1st attack
N
Br
Me
Br
15 D
CO2tBu
1st attack
1st attack
Scheme 11. Possible explanation for the regioselective formation of 22 and 23 
The Pd(OAc)2/L-catalyzed reaction of 15 with an excess of acrylates 16a,e,f,g (90 °C, 36 h) 
afforded the 2,3,6-tris(alkenyl)indoles 24a,e,f,g in good yields (Scheme 12, Table 4). The 
cross-coupling reactions of 15 with 16a-g, carried out at 120 rather than 90 °C, gave the 7-
alkenyl-1,2-dihydrocarbazoles 25a-g.  
15
15
N
Me
i
15
24a,e,f,g
N
Br
Br
Me
CO2R
CO2R
48a-g
N
Me
CO2R
CO2R
25a-g
i i
Br
RO2C
RO2C
N
Me
CO2R
CO2R
26a-c,eRO2C
ii i
CO2R
Scheme 12. Synthesis of 24a,e,f,g, 25a-g and26a-c,e . Conditions: i, Pd(OAc)2 (5 mol-%), L
(10 mol-%), NEt3, DMF, 90 °C, 36 h; ii, Pd(OAc)2 (5 mol-%), L (10 mol-%), NEt3, DMF, 
120 °C, 48 h; Pd/C (10 mol-%), xylene, reflux, 48 h
Figure 5. Crystal structure of 25e 
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Table 4. Synthesis of 24a,e,f,g , 25a-g and 26a-c,e 
a Yields of isolated products based on 14; b experiment was not carried out; c 27 as a by-
product in 10 % 
Along with 25b, a side product 27 was also isolated which was formed by reduction of carbon 
atom C-2 or C-3 (Figure 15). Oxidation of 25a-c,e was carried out using Pd/C (10 mol-%) in 
refluxing xylene provided corresponding substituted carbazoles 26a-c,e (Scheme 12). 
N
CO2Et
MeEtO2C N
MeEtO2C
CO2Et
OR
Figure 6. Possible structures of side product 27 derived from 25b 
N
Me
ii
29 (55%) 30 (72%)
N
Br
Me
CO2R
Br
RO2C
O
H
O
H
28
N
Me
O
H
i
Scheme 13. Bromination of 1-methyl-1H-indole-3-carbaldehyde (28) and subsequent twofold 
Heck cross coupling reaction; conditions: i, NBS (2.1 equiv.), THF, −78 °C, 8 h; ii, Pd(OAc)2 
(5 mol-%), L (10 mol-%), 16c (2.5 equiv.), NEt3, DMF, 120 °C, 36 h  
24,25   R % (24) a % (25) a % (26) a
a Me 69 79 100 
b Et - b 67+10c 100 
c nBu - b 95 100 
d iBu - b 72 - b
e          nHex 74 74 100 
f tBu 76 79 - b
g iOct 73 74 - b
17
17
1-Methyl-1H-indole-3-carbaldehyde (28) was brominated as well to afford 2,6-dibromo-1-
methyl-1H-indole-3-carbaldehyde (29). Subsequent twofold Heck cross-coupling reaction 
with acrylate 16c provided dialkenylated product (2E,2'E)-dibutyl 3,3'-(3-formyl-1-methyl-
1H-indole-2,6-diyl)diacrylate (30) in 72% yield (Scheme 13). Product 30 can be an important 
precursor for further related studies, e.g. Wittig reactions followed by cyclizations may 
provide a variety of substituted carbazoles. The corresponding Schiff bases can be prepared 
from aniline and their subsequent cyclization may provide a route to synthesize 
dihydrocarbolines.    
2.3 Conclusion 
In conclusion, I have discussed the synthesis of di- and tri-alkenylindoles by palladium(0)-
catalyzed Heck cross-coupling reactions of di- and tri-bromo-N-methylindoles. The reactions 
were carried out at 90 °C using a novel biaryl monophosphine ligand developed by Buchwald 
and co-workers. 1,2-Dihydrocarbazoles were formed by a domino twofold Heck / 6π-
electrocyclization when the reaction was carried out at 120 rather than 90 °C. The 
regioselectivity of the Heck reaction of 2,3,6-tribromo-N-methylindoles was in favour of 
carbon atoms C-2 and C-3. Some of the 1,2-dihydrocarbazoles prepared were transformed, by 
Pd/C-catalyzed dehydrogenation, into the corresponding carbazoles in high yield. 
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3 Efficient Synthesis of Functionalized Benzofurans by Domino ′Twofold 
Heck / 6π-Electrocyclization′ Reactions   
3.1 Introduction 
Natural and non-natural benzofurans and dibenzofurans are of significant pharmacological 
application and found in many natural products.33 Among these, synthetic amiodarone 
represents a potent antiarrythmic and antianginal drug.34 Example of dibenzofurans include 
simple hydroxylated derivatives (such as α- and γ-cotonefuran and γ-pyrufuran).35 They 
possess bioactivities, for example, antimicrobial, antileishmanial, antiprotozoal,36 
antidiabetic,37 cytotoxic,38 and genotoxic activity.39
Presently and during near past years , polyhalogenated heterocycles have been shown to be 
regioselectively functionalized in palladium(0)-catalyzed cross-coupling reactions. To 
determine the regioselectivity in polyhalogenated compounds  electronic and steric 
parameters find key role by activation of single halogen atom.40 Suzuki and Stille reaction for 
substituted dibromofurans also have been reported showing first attack at carbon C-2.41 In my 
thesis, I have studied Heck reactions of 2,3-dibromofuran, and subsequent 6π-
electrocyclizations to give functionalized benzofurans.4   
P
XPhos = SPhos =
P
MeO OMe
Figure 7. Biaryl monophosphine ligands developed by Buchwald and coworkers.7 
3.2 Results and Discussion 
The Heck reaction of 31 with acrylates 16a-f,j-l (2.5 equiv.) afforded the 2,3-
di(alkenyl)furans 32a-i in good yields (Scheme 14, Table 4). The best yields were obtained 
when the reactions were carried out using Pd(OAc)2 (5 mol-%) and the biaryl monophosphine 
ligand XPhos or SPhos (10 mol-%) which were recently developed by Buchwald and 
coworkers (Figure 1, Table 5).7 The reactions were carried out in DMF at 120 °C for 36 h. For 
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Heck cross-coupling with acrylates 16a,d and styrene 16k, XPhos was used. For the rest of 
the acrylates or styrenes, SPhos was used. The employment of Pd(PPh3)4 was less successful 
in terms of yield. 
Table 5. Optimization of the reaction conditions for the synthesis of 20b,d 
a Yields of isolated products; all reactions were carried out in DMF using NEt3 as base (90 °C, 
36h); b Triethanolamine was used as solvent, base and ligand 
Oi
32a-i
O
Br
Br
R
RR
16a-f,j-l
31
Scheme 14. Synthesis of 32a-i and 33a-d. Conditions: i, 16a-f,j-l (2.5 equiv.), Pd(OAc)2 (5 
mol-%), SPhos or XPhos (10 mol-%), NEt3, DMF, 120 °C, 36 h. 
2,3-Di(alkenyl)furans 32a-d were heated in diphenyl ether at 200 °C for 24 h. The addition of  
Pd/C (10 mol-%) and further heating of the reaction mixture at 200 °C for 24 h provided the 
benzofurans 33a-d (Scheme 15, Table 6). Their formation again can be explained by a 
domino twofold Heck / thermal 6π-electrocyclization cyclization and subsequent double bond 
migration. In case of bis-alkenylated indoles, one type of isomerized product was observed. 
Conjugation was further extended with the involvement of the nitrogen lone pair which 
provides extra stability. In case of furans, mixtures of isomeric products were obtained. This 
might be explained by the fact that the +M effect of oxygen and sulfur is much less 
Entry Catalyst % (32b) a % (17f) a
1 Pd(PPh3)4  (5 mol-%) 35 41 
2 Pd(OAc)2 (5 mol-%), XPhos (10 mol-%) 73 72 
3 Pd(OAc)2 (5 mol-%), SPhos (10 mol-%) 78 79 
4 Pd(OAc)2 (3 mol-%), P(Cy)3 (6 mol-%) 65 59 
5 Pd(OAc)2 (2 mol-%), Triethanolamine-b traces traces 
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pronounced than for nitrogen (+M effect order = -NR2 >O>>S). Therefore, the stabilization 
by conjugation is less pronounced. 
When 32f was employed for electrocyclization at 200 °C, it showed decomposition and no 
product was obtained. Below 200 °C, no reaction was observed. This might be due to the 
decomposition of tertiary butyl ester at high temperature (200 °C). 
ii
O
R
R
15a-dO
32a-d
R
R
O
R
R
B
iii
O
R
R
A
+
Scheme 15. Synthesis of 33a-d. Conditions: i, Diphenyl ether, 200 °C, 24h; ii, Pd/C (10 mol-
%),  diphenyl ether, 200 °C, 24 h.  
Table 6. Synthesis of 32a-h and 33a-d.  
a Yields of isolated products; b XPhos was used; c SPhos was used; ddecomposition; e Reaction 
was not carried out. 
32,17 16   R % (32) a % (33) a
a a CO2Me 73b 90
b b CO2Et 78 c 93 
c d CO2iBu  93 b 92
d c CO2nBu 78 c 95
e e CO2nHex 88 c e
f f CO2tBu 79 c d
g j 4-MeOC6H4 90 c e
h k 4-MeC6H4 89 b e
i l 4-tBuOC6H4 87 c e
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3.3 Conclusion 
In conclusion, I have synthesized functionalized benzofurans, based on domino twofold Heck 
/ 6π-electrocyclization reactions of 2,3-dibromofuran. For electrocyclization reactions, a high 
temperature (200 °C) was required. Aromatization proceeded satisfactorily with Pd/C in 
diphenyl ether. 
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4 Synthesis of Anthraquinones, Fluorenones and Benzocoumarins by 
Domino ′Twofold Heck / 6π-Electrocyclization′ Reactions  
4.1 Introduction 
Anthraquinones, also called anthracenediones or dioxoanthracenes, possess significant 
pharmacological applications and occur in various natural products.42 Anthraquinones are 
essential chemical constituents of fungi, lichens, and higher plants. They represent 
components of numerous medicines of plant origin as they acquire a broad spectrum of 
biological activities including antibacterial, purgative, antiinflammatory, astringent, and 
antiviral properties42b,c. The anthracyclines  comprise an important class of antitumor agents 
and antibiotics which include a number of well-known compounds such as daunorubicin, 
adriamycin, and aclarubicin.43 Most of the naturally occurring anthracyclines are separated in 
O-glycosylated form, but some of them, such as saintopin, are found as aglycons.44 Simple 
hydroxylated anthraquinones (such as chrysophanic acid, vismiaquinone, anthragallol, questin 
and several others)  are also widely dispersed in nature.45 Anthraquinones provide the basic 
structure of several natural dyes as well. Anthraquinones are also used as goose repellent.46  
In literature, fluorenones find significant pharmacological applications and are part of many 
natural products. Fluorenones had been synthesized in different ways, for example, by 
Friedel-Crafts acylations of biaryls. Fluorenones had also been prepared based on remote 
aromatic  metalations.47  
Coumarins are also an important class of organic compounds with substantial 
pharmacological relevance. Many polycyclic coumarin derivatives are found as potent 
inhibitors of tumor induction by carcinogenic polycyclic aromatic hydrocarbons. However, 
primarily anti-carcinogenic activity is established in naturally occurring highly oxygenated 
coumarins. Coumarins are also used as food and cosmetic additives, optical brightening 
agents, and dispersed fluorescent and laser dyes. Coumarins had been synthesized by Claisen 
isomerization, Perkin reaction and knovenagel benzo-annelated coumarins.48
In general, in this chapter twofold Heck reaction and subsequent electrocyclization and 
aromatization for the cross conjugated systems (2,3-dibromonaphthoquinones), ,
unsaturated cyclic ketone (2,3-dibromoindenone) and lactone (3-bromo-4-hydroxy-coumarin) 
results are discussed. I have studied for the first time the synthesis of functionalized 
anthraquinones, fluorenones and benzoquinone by domino50 twofold Heck / 6π-
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electrocyclization reactions of 2,3-di-bromonaphthoquinone, 2,3-dibromoindenone and 3-
bromo-2-oxo-2H-chromen-4-yl trifluoromethanesulfonate.4 
4.2 Results and discussion 
The Heck reaction of 2,3-dibromonaphthoquinone (35) with hexyl acrylate (16e) (2.5 equiv.) 
afforded the dihexyl 9,10-dioxo-9,10-dihydroanthracene-2,3-dicarboxylate (36b, 75%)  
successfully (Scheme 16, Table 8). The formation of 36b can be explained by twofold Heck 
reaction, subsequent 6π-electrocyclization and migration of the double bond to give 
intermediate B. Dehydrogenation of the latter afforded 36b. Use of Pd(PPh3)2Cl2 and 
Pd(PCy3)2 did not provide satisfactory results in term of yield. The best yields were obtained 
when the reactions were carried out using Pd(OAc)2 (5 mol-%) and the biaryl monophosphine 
ligand XPhos (10 mol-%).7 The use of Pd(PPh3)4 provided similar results as well (Table 7). 
O
O
R
R
O
O
X
X
H
H
O
O
X
O
O
X
X
H
O
O
X
X
O
O
Br
Br
R
34
16a,d,e,h
i or ii
36b,c35a,c
+
A B C
Scheme 16. Synthesis of 35a,c,d and 36c. Conditions: i, method 1: Pd(OAc)2 (5 mol-%), 
SPhos (10 mol-%), NEt3 (8.0 equiv.), DMF, 90 °C, 8 h; method 2: ii, Pd(OAc)2 (5 mol-%), 
SPhos (10 mol-%), NEt3 (8.0 equiv.), DMF, >110 °C, 8 h. 
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Table 7. Optimization of the reaction conditions for the synthesis of 36b
a Yields of isolated products; all reactions were carried out in DMF using NEt3 as base, 8 h; b 
Isolated as by-product 35b
Table 8. Synthesis of 35a-c and 36b
35,36 16 R Method 1 % (36) a Method 2 % (36)a + % (35)a
a a CO2Me - b Traces + 57
b e CO2nHex 75 35 + 25
c h CO2(2-
Ethylhexyl) 
- b Traces + 62
    a Yields of isolated products; b experiment was not carried out 
The reaction was carried out in DMF at 90 °C for 8 h (method 1). The yields considerably 
decreased when the temperature was increased. While a clean reaction was observed when the 
reaction was carried out at 90 °C, a separable mixture of 36b (35%) and 35b (25%) was 
formed at 110 °C (method 2). Decomposition was observed when the reaction was carried out 
at temperatures higher than 120 °C. The formation of 35b, which contains only one ester 
group, can be explained by the fact that in thermal conditions disrotatory electrocyclization 
provides intermediate B with cis sterechemical relationship of two ester groups. At higher 
temperature, prior to migration of double bond an anti-elimination occurs and provides the 
monsubstituted product 35b. Acrylates, by means of method II, provided mainly 35a and 35b
and only traces of 36a and 36c were observed. 
Entry Catalyst Temp (°C) % (36b) a
1 Pd(PPh3)4  (5 mol-%) 90 73 
2 Pd(PPh3)2Cl2  (5 mol-%) 90 36 
3 Pd(OAc)2 (5 mol-%), P(Cy)3 (10 mol-%) 90 45
4 Pd(OAc)2 (5 mol-%),  XPhos (10 mol-%) 120 35+25b
5 Pd(OAc)2 (5 mol-%),  XPhos (10 mol-%) 90 75 
25
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Disubstituted anthraquinones 36 were generally formed in good yields when the reaction was 
carried out at 90 °C, while monosubstituted anthraquinones 35 were predominantly formed at 
110 °C.  
Indanone was brominated by photobromination to give 2,3-dibromoindenone according to a 
literature protocol.51 The Heck cross-coupling proceeded at 40 °C. I optimized the reaction 
conditions for different temperature and reaction conditions. The best result was obtained 
when PCy3 (10-mol%) and Pd(OAC)2 (5-mol%) were used as catalyst at 40 °C. 2,3-
Dibromoindenone (37) with 4-methylstyrene 16k provided 2,3-di(p-tolyl)-9H-fluoren-9-one 
38 in one step (77 %) (scheme 16). Ligands PCy3, (EtO)2PPh, Pd(PPh3)4 and Pd(Ph3)2Cl2
provided 38 only in low yield (15-20 %) (Table 9). 
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Br
R
37
16k
i or ii
38
A B
C
R= 4-MePh
Scheme 17. Synthesis of 38. Conditions: i: Pd(OAc)2 (5 mol-%), PCy3 (10 mol-%), NEt3 (8.0 
equiv.), DMF, 40 °C, 36 h. 
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Table 9. Optimization of the reaction conditions for the synthesis of 38 
a Yields of isolated products; all reactions were carried out in DMF using NEt3 as base, 36 h; b 
Reaction did not go to completion after 36 h. 
Unlike Heck cross-coupling of 2,3-dibromonaphthoquinone 38, I never observed the 
monosubstituted fluorenone. A possible reason might be that the reaction proceeds at much 
lower temperature which is not sufficient for an anti-elimination. Further synthetic scope of 
the synthesis of functionalized fluorenones is currently being studied by my colleague Omer 
Akravi who has successfully prepared until now four more functionalized fluorenones using 
acrylates and electron donating and withdrawing styrenes.  
Triflation and tosylation of 3-bromo-4-hydroxy-2H-chromen-2-one 40 afforded 39 and 41,
respectively, according to the literature (Figure 16).52
O O
Br
OH
O O
Br
OTf
O O
Br
OTs
4039 41
Figure 8. Coumarins 39, 40, 41
Entry Catalyst Temp.(°C) % (38) a
1 Pd(PPh3)4  (5 mol-%) 40 20 
2 Pd(PPh3)2Cl2  (5 mol-%) 40 18 
3 Pd(OAc)2 (5 mol-%), (EtO)2PPh (10 mol-%) 40 15 
4 Pd(OAc)2 (5 mol-%), P(Cy)3 (10 mol-%) 90 Complex 
mixture
5 Pd(OAc)2 (5 mol-%),  P(Cy)3 (10 mol-%) 60 35 
6 Pd(OAc)2 (5 mol-%),  P(Cy)3 (10 mol-%) 40 60 
7 Pd(OAc)2 (5 mol-%),  P(Cy)3 (10 mol-%) 20 b 
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42 (20%)
O O
CO2iBu
43 (30%)
+
   
Scheme 18. Synthesis of 42. Conditions: i: Pd(PPh3)4 (5-mol%), NEt3 (8.0 equiv.), DMF, 60 
°C, 36 h. 
Structure of 6-oxo-6H-benzo[c]chromene-8-carboxylate 42was also confirmed by X-ray 
crystallography (Figure 9). 
Figure 9. Crystal structure of 42
The Heck cross-coupling of coumarin 39 provided monosubstituted isobutyl 6-oxo-6H-
benzo[c]chromene-8-carboxylate 42 (20%) and by-product 43 (30%) (scheme 18). I also tried 
to reduce the temperature (50 °C), but always found low yield and only monosubstituted 
product 42. Low yields can be explained by decomposition of the starting material, especially 
the reduction at carbon C-4 of triflate 39. Then, I synthesized tosylate 41 which has been 
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successfully employed for Suzuki and Sonogashira cross coupling reactions before.15
Unfortunately, tosylate 41 did not provide the required product as well, because Heck reaction 
did not take place at position C-4 even at increased temperature (110 °C). Reduction of the 
alkene at C-3 provided alkyl-substituted coumarin 44.  
O O
OTs
CO2iBu
44
iO O
Br
OTs
41
CO2iBu
16d
Scheme 19. Synthesis of 44. Conditions: i: Pd(PPh3)4 (5-mol%), NEt3 (8.0 equiv.), DMF, 110 
°C, 36 h. 
Further studies to control the decomposition of 39 are in progress by using an additive  LiCl4 
by one of my colleagues Dhafer Saber Zinad. Alternatively, 3,4-bromo-2H-chromen-2-one 
might be a more suitable starting material for twofold Heck reactions in the future. 
4.3 Conclusion 
In conclusion, I have synthesized and optimized the reaction conditions for the synthesis of 
functionalized anthraquinones by domino ‘twofold Heck– 6-electrocyclization’ reactions of 
2,3-dibromonaphthoquinone. The synthesis of functionalized anthraquinones works under 
mild conditions and the products are not readily available by other methods. The temperature 
performed an important role during the optimization of the reaction conditions. Furthermore, 
the same strategy was used successfully to synthesize functionalized fluorenones from 2,3-
dibromoindenone which also worked at low temperature (40 °C) in one step. 6-Oxo-6H-
benzo[c]chromene-8-carboxylate has also been prepared from 3-bromo-2-oxo-2H-chromen-4-
yl trifluoromethanesulfonate for which further studies are still in progress by my colleagues. 
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5 Synthesis of Aryl-Substituted Pyrimidines by Site-Selective Suzuki-Miyaura     
Cross-Coupling Reactions of 2,4,5,6-Tetrachloropyrimidine  
5.1 Introduction
Pyrimidines thymine (T), cytocine (C) and uracil (U) are the nitrogen bases of DNA and RNA 
They make hydrogen bondings with their complement purines that are adenine (A) and 
guanine (G). In DNA, two combinations A:T and C:G are found whereas in RNA  two 
combinations A:U and  C:G are found.  Pyrimidines are prevalent heterocyclic compounds 
found in several natural products and synthetic pharmacophores with antibacterial, 
antimicrobial, anticancer and antimycotic activities and occur in many synthetic drugs. 
Compounds derived from pyrimidine, for example 1-[(2-hydroxyethoxy)methyl]-6-
(phenylthio)thymine (HEPT) and dihydroalkoxybenzyloxopyrimidines (DABO), show 
significant anti-HIV-1 activity.42a,53,54 Pyrimidines are also part of analgesic, antihypertensive, 
antipyretic, and anti-inflammatory drugs. Pyrimidines and their derivatives are also used as 
pesticides, herbicides, and plant growth regulators.54 L-Lathyrine is one of the example to 
show antitumor and hypoglycemic activity.55  
Reaction conditions and methodology discussed in this chapter provides a straightforward 
way to a variety of aryl-substituted pyrimidines. Generally known syntheses of substituted 
pyrimidines depend on the use of a building block approach or by functionalization of an 
existing pyrimidine nucleus. Pyrimidines are highly electron-deficient ring systems which 
allow nucleophilic aromatic substitutions (SNAr) to be a general strategy for the synthesis of 
large number of pyrimidine derivatives from the corresponding halopyrimidines.54i
Nevertheless in literature, Pinner provided the first synthesis of pyrimidines based on the 
cyclocondensation of amidines with 1,3-diketones56  and numerous other  cyclocondensations 
have also been discovered.57,58 Palladium catalyzed 3-component reactions for the synthesis 
of amidines have been reported by Müller and coworkers.59 A different approach to 
synthesize substituted pyrimidines is based on the functionalization of appropriate pyrimidine 
derivatives. For example, nucleophilic aromatic substitution reactions of Grignard reagents 
with pyrimidines have been reported.60,61 Monohalogenated pyrimidines have been effectively 
used in Negishi62 and Suzuki63 coupling reactions. Other nucleophilic aromatic substitution 
reactions have been reported for 2,4,6-trichloropyrimidine.61,64 Schomaker and Delia reported 
site-selective Suzuki-Miyaura reactions of 2,4,6-trichloropyrimidine.65 2,4,5,6-
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Tetrachloropyrimidine signifies an exciting substrate because all four carbon atoms are 
halogenated. Nucleophilic substitution reactions of the latter are known and allow the 
functionalization of carbon atoms C-2, C-4 and C-6 while carbon atom C-5 remains 
unattacked.66,67 In this chapter, I have discussed my research results related to Suzuki-
Miyaura reactions of 2,4,5,6-tetrachloropyrimidine including optimization of reaction 
conditions. 
5.2 Results and discussion
2,4,5,6-Tetraaryl-pyrimidines had been synthesized by cyclocondensation reactions which 
required several steps.68 The Suzuki-Miyaura cross coupling reaction of commercially 
available 2,4,5,6-tetrachloropyrimidine (45) with arylboronic acids 46a-h (4.4 equiv.) 
afforded the 2,4,5,6-tetraaryl-pyrimidines 47a-h (Scheme 20, Table 10). Both for electron rich 
and poor arylboronic acids the products 47a-g were isolated in good to excellent yields. The 
yield of 47h was rather low and a significant amount of the 2,4,6-triaryl-5-chloropyrimidine 
was isolated (most probably because of steric effects). The reaction conditions were 
systematically optimized for derivatives 47a-d (Table 11). The best yields were obtained 
when Pd(PPh3)2Cl2 (5 mol-%) was used as the catalyst (dioxane, 100 °C, 8 h) (entry 1). 
Excellent yields were obtained when an aqueous solution of K2CO3 (2 M) (entry 1) or when 
K3PO4 were employed as the base (entry 5). The amount of catalyst could be reduced to 2.5 
mol-% without decrease in yield (entry 4).  However, complex product mixtures were formed 
when the amount of the catalyst was reduced further (entries 2 and 3). The yields dropped 
when Pd(PPh3)4 or Pd(OAc)2 (5 mol-%) in the presence of XPhos or SPhos7 were employed 
(entries 8-10). The use of Pd(OAc)2 (5 mol-%) in the presence of P(tBu)3·HBF4 (entry 11) or 
of Pd(OAc)2 (5 mol-%) in the presence of triethanolamine and 2M K2CO3 (entry 12) gave 
unacceptable results. The employment of Pd(OAc)2 (5 mol-%), P(nBu)3 gave good yields for 
47b and 47d (entry 13) but lower than use of Pd(PPh3)2Cl2. The amount of Pd(OAc)2 could be 
reduced to 2.5 mol-% when P(OEt)2Ph was used as the ligand (entry 14). In conclusion, the 
conditions given in entries 4 and 14 of Table 11 allowed to prepare the products in excellent 
yield using only 2.5 mol-% of the palladium catalyst. 
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N N
ClCl
Cl
Cl
N N
ArAr
Ar
Ar
i
ArB(OH)2
46a-h
47a-h45
Scheme 20. Synthesis of 47a-h. Conditions: i, 46a-h (4.4 equiv.), Pd(PPh3)2Cl2 (5 mol-%), 
K2CO3 (H2O, 2 M), dioxane, 100 °C, 8 h; for 47a-g: 79-98% yields 
Table 10. Synthesis of 47a-h 
46,47 Ar % (47) a
a Ph 98 
b 4-MeC6H4 95 
c 4-EtC6H4 93c
d 4-(MeO)C6H4 91 
e 4-FC6H4 89 
f 3-(MeO)C6H4 82 
g 3,5-Me2C6H3 79 
h 3-PhC6H4 25+43b
a Yields of isolated products; b besides 47h, 2,4,6-triaryl-5-chloropyrimidine 48d was isolated 
in 43% yield; c reduced product 2,4,5-tris(4-ethylphenyl)pyrimidine 69 was isolated as by-
product. 
Figure 10. Crystal structure of 47a
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Table 11. Optimization of the reaction conditions for the synthesis of 47a-d 
a Yields of isolated products; all reactions were carried out in dioxane (100 °C, 8 h); b 
formation of a complex mixture of mono-, di-, tri-, and tetraaryl-pyrimidines and of starting 
material; c approximately 80% conversion after 12 h (estimated by tlc); d decomposition; e
experiment was not carried out 
The Suzuki-Miyaura reaction of 45 with arylboronic acids 46b,e,f,h (3.0 equiv.) gave the 
2,4,6-triaryl-5-chloropyrimidines 48a-d (Scheme 21, Table 12). Good yields were obtained 
both for electron rich and poor arylboronic acids. During the optimization, it proved to be 
important to use exactly 3.0 equiv. of the boronic acid and to carry out the reaction at 80 °C (5 
h) instead of 100 °C (8 h) to avoid the formation of tetraaryl-pyrimidines. To a small extent, 
reduction of the unreacted chloride group and formation of tetraaryl-pyrimidines were 
Entry   Conditions % (47a) a % (47b) a % (47c) a % (47d) a
1 Pd(PPh3)2Cl2 (5 mol-%), 2M K2CO3 98 95 93 91 
2 Pd(PPh3)2Cl2 (1 mol-%), 2M K2CO3 -b -b -b -b
3 Pd(PPh3)2Cl2 (2 mol-%), 2M K2CO3 -c -c -c -c
4 Pd(PPh3)2Cl2 (2.5 mol-%), 2M K2CO3 97 94 94 91 
5 Pd(PPh3)2Cl2 (5 mol-%), K3PO4 95 94 93 89 
6 Pd(PPh3)4  (5 mol-%),  aq. K2CO3 (2 M) 81 80 83 77 
7 Pd(PPh3)4  (5 mol-%), K3PO4 83 80 82 75 
8 Pd(OAc)2 (5 mol-%), XPhos (10 mol-
%), 2M K2CO3
71 69 59 58 
9 Pd(OAc)2 (5 mol-%), XPhos (10 mol-
%), K3PO4
71 65 55 59 
10 Pd(OAc)2 (5 mol-%), SPhos (10 mol-
%), 2M K2CO3
48 43 33 50 
11 Pd(OAc)2 (5 mol-%), P(tBu)3·HBF4
(10 mol-%), K3PO4
-e 38 -e 32 
12 Pd(OAc)2(5 mol-%), triethanolamine, 
2M K2CO3
-e -d -e -d
13 Pd(OAc)2 (5 mol-%), P(nBu)3
(10 mol-%), 2M  K2CO3
-e 70 -e 87 
14 Pd(OAc)2 (2.5 mol-%), P(OEt)2Ph 
(5 mol-%), 2M  K2CO3
93 92 90 96 
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observed as side reactions. All products were prepared using Pd(PPh3)2Cl2. Initially, 5.0 mol-
% of the catalyst was used (48b-d). Later, we have found that the use of 2.0 mol-% of catalyst 
is sufficient to achieve equally good yields (products 48a,e,f). 
N N
ClCl
Cl
Cl
N N
ArAr
Ar
Cl
i
ArB(OH)2
46b,e,f,h-j
48a-f45
Scheme 21. Synthesis of 48a-d. Conditions: i, 46b,e,f,h (3.0 equiv.), Pd(PPh3)2Cl2 (2.0 to 5.0 
mol %), K2CO3 (H2O, 2 M), dioxane, 80 °C, 5 h; 80-85% yields 
Table 12. Synthesis of 2,4,6-triaryl-5-chloropyrimidine 48a-d
46 48 Ar % (48) a
b a 4-MeC6H4 83 b
e b 4-FC6H4 83 c
f c 2-(MeO)C6H4 81 c
h d 3-PhC6H4 80 c
i e 3-CF3C6H4 82 b
j f 4-CF3C6H4 85 b
a Yields of isolated products; b 2.0 mol-% of catalyst was used; c 5.0 mol-% of catalyst was 
used 
The Suzuki-Miyaura reaction of 45 with arylboronic acids 46a,b,d (2.0 equiv.) afforded the 
4,6-diaryl-2,5-dichloropyrimidines 49a-c (Scheme 22, Table 13). The stoichiometry 
(employment of exactly 2.0 equiv. of the arylboronic acid), the temperature (not more than 70 
°C), and the reaction time (5 h) again found an important role to avoid multiple-coupling 
reactions. Products 49a-c were prepared using 3 mol-% of Pd(PPh3)2Cl2. The reaction of 49a
with arylboronic acids 46d,k (1.0 equiv.) (80 °C, 5 h) gave the 2,4,6-triaryl-5-
chloropyrimidines 50a,b (Scheme 22, Table 14). The reaction of 49a with 2.0 instead of 1.0 
equiv. of arylboronic acid 46d (100 °C, 5 h) afforded the 2,4,5,6-tetraarylpyrimidines 51a. 
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Reduction of the unreacted chloride group and multiple coupling were again observed as side 
reactions, albeit, to a small extent.  
N N
ClCl
Cl
Cl
N N
Ar1Ar1
Cl
Cl
i
Ar1B(OH)2
46a,b,d
49a-c45
N N
Ar1Ar1
Ar2
Cl
50a,b
i i
Ar2B(OH)2
46d,k
ii i
Ar2B(OH)2
46d
N N
Ar1Ar1
Ar2
Ar2
51a
Scheme 22. Synthesis of 49a-c, 50a,b and 51a. Conditions: i, 46a,b,d (2.0 equiv.), 
Pd(PPh3)2Cl2 (1.25 to 3.0 mol-%), K2CO3 (H2O, 2 M), dioxane, 70 °C, 5 h; ii, 46d (1.0 
equiv.), Pd(PPh3)2Cl2 (3 mol-%), K2CO3 (H2O, 2 M), dioxane, 80 °C, 5 h; iii, 46d (2.0 
equiv.), Pd(PPh3)2Cl2 (1.25 to 3 mol-%), K2CO3 (H2O, 2 M), dioxane, 100 °C, 5 h; for 49a-c, 
50a,b, and 51a,: 79-97% yields 
Table 13. Synthesis of 2,4,6-diyl-5-chloropyrimidine 49a-c
46 49 Ar1 % (49) a
a a Ph 97 b
b b 4-MeC6H4 85 b
d c 4-(MeO)C6H4 93 b
a Yields of isolated products; b 3.0 mol-% of catalyst was used.  
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Table 14. Synthesis of 50a,b and 51a 
46 49 50 51 Ar1 Ar2 % (50,51)a
k a a - 4-Me-C6H4 3-ClC6H4 90 b
d a b - Ph 4-(MeO)C6H4 86 b
d a - a Ph 4-(MeO)C6H4 79 b
a Yields of isolated products; b 3.0 mol-% of catalyst was used. 
The Suzuki-Miyaura reaction of 45 with arylboronic acids 46a,b,d-f,i,k (1.0 equiv.) gave the 
6-aryl-2,4,5-trichloropyrimidines 52a-f (Scheme 23, Table 15). The stoichiometry 
(employment of not more than 1.0 equiv. of the arylboronic acid), the temperature, and the 
reaction time again performed an important role during the optimization. It proved to be 
important to carry out the reaction at 60 °C for only 2 h to avoid multiple-coupling reactions. 
All products were again prepared using Pd(PPh3)2Cl2 as the catalyst. Although 3.0 mol-% of 
the catalyst was used in most cases (products 52b-d,f), the employment of only 1.0 mol-% of 
catalyst proved to be possible to achieve equally good yields (product 52b-d,f). 
N N
ClCl
Cl
Cl
N N
ArCl
Cl
Cl
i
ArB(OH)2
46a,b,d-f,i,k
52a-f45
Scheme 23. Synthesis of 52a-f. Conditions: i, 46a,b,d-f,I,k (1.0 equiv.), Pd(PPh3)2Cl2 (1.0 to 
3.0 mol- %), K2CO3 (H2O, 2 M), dioxane, 60 °C, 2 h; 87-97% yields 
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Table 15. Synthesis of 6-aryl-2,4,5-trichloropyrimidines 52a-f
46 52 Ar % (52) a
b a 4-MeC6H4 87 b
d b 4-(MeO)C6H4 95 c
e c 4-FC6H4 93 c
f d 2-(MeO)C6H4 97 c
i e 3-CF3C6H4 91b
k f 4-ClC6H4 88 c
a Yields of isolated products; b 1.0 mol-% of catalyst was used; c 3.0 mol-% of catalyst was 
used 
One-pot Suzuki-Miyaura reactions to achieve unsymmetrical triarylpyrimidines 50 were also 
studied. To afford 4,6-diaryl-2,5-dichloropyrimidines  (Scheme 24), the Pd-catalyzed reaction 
of 45 with arylboronic acid 46c (2.0 equiv.) was performed at 70 °C. After 5 h heating, 
arylboronic acid 46i (1.0 equiv.) was added  in the same reaction and heated at 80 °C for 
further 5 h to give the unsymmetrical 5-chloro-4,6-bis(4-ethylphenyl)-2-(3-
(trifluoromethyl)phenyl)pyrimidine 50c (overall yield 92% based on 45). Reduction of the 
unreacted chloride group and multiple coupling were again observed as side reactions, albeit, 
to a small extent. The reduced product 53 was isolated in 3% yield.  
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Scheme 24. Synthesis of 50c. Conditions: i, 46c (2.0 equiv.), Pd(PPh3)2Cl2 (1.25), K2CO3
(H2O, 2 M), dioxane, 70 °C, 5 h; ii, 46i (1.0 equiv.), Pd(PPh3)2Cl2 (1 mol-%), 80 °C, 5 h. 
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Figure 11. 2D NMR correlations (HMQCand HMBC) of 50b 
The structure of 50b was confirmed by 2D NMR correlations using HMQC and HMBC. A 
clear correlation was found between the phenyl protons H-2`/6` at  8.43 (d, J = 8.8 Hz) with 
carbon C-2 resonating at 161.9 ppm. This information established unambiguously that the 4-
(MeO)C6H4 moiety is attached at C-2. (Figure 19).  
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5.3 Conclusion
In conclusion, I have optimized the reaction conditions to achieve a convenient synthesis of 
symmetrical and unsymmetrical mono-, di-, tri- and tetraaryl-pyrimidines by Suzuki-Miyaura 
reactions of 2,4,5,6-tetrachloropyrimidine. Pd(PPh3)2Cl2 (2.5 mol-%) and Pd(OAc)2 (2.5 mol-
%), using the ligand P(OEt)2Ph (5 mol-%), were the best catalyst systems observed for these 
reactions. Products prepared and discussed in this chapter are not readily accessible by other 
methods. All reactions proceed with excellent site-selectivity. The selectivity mainly depends 
on the temperature which has been optimized for each type of product. Catalyst loading could 
be reduced to 3-mol% to synthesize tetraaryl-pyrimidines 47 without affecting yields.  
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6 Site-Selective Suzuki-Miyaura Cross-Coupling Reactions of 2,3,4,5-
Tetrabromofuran  
6.1 Introduction 
Substituted furans correspond to one of the most important classes of five-membered 
heterocycles and find great significance in  pharmaceuticals and drugs and are widely found 
in natural and non-natural products.69 These are prominent substructures in numerous natural 
products, for example the cembranolides lophotoxin, kallolides, and pukalide.70,71 Substituted 
furans form an omnipresent structural entity in different classes of biologically active motifs 
and are found in commercially important pharmaceuticals, flavor and fragrance compounds 
(insectlo and fish antifeedants), in addition to anti-leukemic agents.69c,72 Many furan natural 
products exhibit exciting biological activities, for instance, cytotoxic, antitumor, 
antispasmodic, and antifeeding activities. Substituted furans are key synthetic intermediates  
towards the synthesis of a large number of cyclic and acyclic molecules and serve as versatile 
building blocks in synthetic organic chemistry.72 In addition, polysubstituted furans are 
significant precursors for the synthesis of natural and nonnatural products. The synthetic work 
to achieve polysubstituted furans thus fits into an extremely active research doma.73-76
Classically, direct functionalization of existing furans or cyclization of acyclic substrates 
provides substituted furans. An attractive approach to furans is based on transition-metal-
catalyzed cycloisomerization of unsaturated acyclic precursors. This requires rather advanced 
starting materials, for example, allenyl ketones, alkynyl ketones, or epoxides. Recently, a 
synthesis of tetrasubstituted furans from alkynes via palladium catalyzed oxidation and Lewis 
acid catalyzed cyclization has been reported,but the selective substitution depends on the type 
of alkyne used.72,77Recently, Masaya Nakano and co-workers have reported the synthesis of 
tetrasubstituted furans from 3-furancarboxylic acids by cleavage of the three C−H bonds and 
subsequent decarboxylation upon treatment with an excess of aryl bromides in the presence of 
a palladium catalyst.77a But this approach has major draw back of lack of regioselectivity. The 
tendency of furans to undergo lithiation and reactions at C-2 or C-5 makes the synthesis of 
3,4-disubstituted furans a rather demanding task. Although many strategies are existing, they 
are generally not appropriate for complex furans containing a variety of substituents.76 
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6.2 Results and discussion 
The low stability of furans in particular under aerobic and acidic conditions makes cross-
coupling reactions more fragile and the product isolation more difficult than in the thiophene 
series. 2,3-Dibromofuran and substituted dibromofurans have been used in Pd(0) catalyzed 
(Negishi, Stille, Suzuki and Sonogashira coupling reactions) and other nucleophilic aromatic 
substitution reactions.78,79 T. Bach and L. Krüger have reported site-selective Suzuki-Miyaura 
reactions and showed the selectivity in favour of C-2.80 2,3,4,5-Tetrabromofuran signifies an 
exciting substrate because all four carbon atoms are halogenated. In this chapter, I have 
discussed my research work related to Suzuki-Miyaura reactions and the optimization of the 
reaction conditions for arylation of 2,3,4,5-tetrabromofuran. Reaction conditions and 
methodology discussed in this chapter provided a straightforward way to a variety of aryl-
substituted furans which other methods do not provide readily. To my best knowledge, neither 
Suzuki-Miyaura reactions, nor any other Pd(0)-catalysed reactions of 2,3,4,5-tetrabromofuran 
have been reported before.  
Figure 12. Crystal structure of 55a 
O Br
BrBr
Br
ArB(OH)2
i
46a,c-e,g,I,l,m
O Ar
ArAr
Ar
54 55a-h
Scheme 25. Synthesis of 55a-h. Conditions: i, 46a,c-e,g,i,l,m (4.4 equiv.), Pd(PPh3)4 (3 mol 
%), aq. K2CO3 (2 M), dioxane, 80 ˚C, 5 h 
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Table 16. Optimization of the reaction conditions for the synthesis of tetra-arylfurans.
    a Yields of isolated products; all reactions were carried out in dioxane (80 °C, 5 h) 
                                               Figure 13. Crystal structure of 55g
entry   Conditions %(55b) a % (55e) a % (55g) a
1 Pd(PPh3)2Cl2 (3 mol-%), aq. K2CO3 (2 M) 90 82 96 
2 Pd(PPh3)2Cl2 (3 mol-%), K3PO4 85 75 88 
3 Pd(PPh3)4  (3 mol-%),  aq. K2CO3 (2 M) 92 85 98 
4 Pd(PPh3)4  (3 mol-%), K3PO4 88 78 92 
5 Pd(OAc)2 (3 mol-%),  
XPhos (6 mol-%), aq. K2CO3 (2M) 
10 05 15 
6 Pd(OAc)2 (3 mol-%), (Cy)3P (6 mol-%),  aq. 
K2CO3 (2M) 
65 45 69 
7 Pd(OAc)2 (3 mol-%), (Cy)3P (6 mol-%), K3PO4 50 43 55 
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Table 17. Synthesis of tetraarylfurans 55a-h 
55 46 Ar % (55) a
a a C6H5 92 
b c 4-EtC6H4 92 
c l 4-tBuC6H4 92 
d m 3-ClC6H4 80 
e e 4-F C6H4 85 
f i 3-(CF3)C6H4 82 
g d 4-(MeO)C6H4 98 
h g 3,5-Me2C6H3 76 
a Yields of isolated products 
2,3,4,5-Tetrabromofuran (TBF) (54) is not a commercially available substrate and was 
prepared according to a literature procedure.12 The reaction of TBF (54) with arylboronic 
acids 46a,c-e,g,i,l,m (4.4 equiv.) afforded the stable products of 2,3,4,5-tetraaryl-furans 55a-h
(Scheme 25, Table 17). Both for electron rich and poor arylboronic acids, the products 55a-h
were synthesized in good to excellent yields. The reaction conditions were systematically 
optimized for the derivatives 55b,e,g using electron donating and withdrawing boronic acids 
2b,e,g (Table 173). The best yields were obtained when Pd(PPh3)4 (3 mol-%) was used as the 
catalyst (dioxane, 80 °C, 5 h) (entry 1, Table 16). Excellent yields were obtained when an 
aqueous solution of K2CO3 (2 M) (entry 3, Table 16) or K3PO4 were employed as the base 
(entry 2, Table 12).  
The best yields were obtained when Pd(PPh3)4 (3 mol-%) was used as the catalyst (dioxane, 
80 °C, 5 h) (entry 1, Table 16). Excellent yields were obtained when an aqueous solution of 
K2CO3 (2 M) (entry 3, Table 16) or when K3PO4 were employed as the base (entry 2, Table 
16). The yields dropped when Pd(PPh3)2Cl2 or Pd(OAc)2 (3 mol-%) in the presence of XPhos 
or (Cy)3P were employed (entries 1,2 and 5-7, Table 12). The employment of Pd(PPh3)2Cl2 (3 
mol-%) and Pd(OAc)2 (3 mol-%), (Cy)3P (6 mol-%) gave fair to very good yields (entries 
1,2,6,7, Table 16), albeit lower than for Pd(PPh3)4. The use of K3PO4 as the base resulted in 
lower yields compared to the use of a 2M aqueous solution of K2CO3. In conclusion, the 
application of the reaction conditions given in entry 3 of Table 16 allowed to prepare the 
products in excellent yields. It was also noted that electron-poor arylboronic acids provided 
43
43
slightly lower yields than electron-rich arylboronic acids. This can be explained by the lower 
nucleophilicity of electron-poor boronic acids. 
O Br
BrBr
Br
ArB(OH)2
i
46e,j,m,n
O Ar
BrBr
Ar
54 56a-c
Scheme 26. Synthesis of 56a-c. Conditions: i, 46e,j,m,n (2.0 equiv.), Pd(PPh3)4 (2 mol %), 
aq. K2CO3 (2 M), toluene/dioxane (4:1), 80 ˚C, 3 h 
Table 18. Reaction condition optimization for synthesis of 2,5-diaryl-3,4-dibromofurans 
Entry solvent base ligand aTemp. Time 56a 56c
1 dioxane 2M K2CO3 (PPh3)4Pd 60 °C 3h mixture mixture 
2 dioxane 2M K2CO3 Cy3P,  Pd(OAc)2 60 °C 3h mixture mixture 
3 dioxane 2M K2CO3 XPhos, Pd(OAc)2 60 °C 8h traces traces 
4 dioxane 2M K2CO3 (PPh3)2PdCl2 60 °C 3h mixture mixture 
5 dioxane 3 eq. 
Cs2CO3
(PPh3)4Pd 60 °C 3h mixture mixture 
6 dioxane 3 eq. K3PO4 (PPh3)4Pd 60 °C 3h mixture mixture 
7 dioxane 3 eq. K3PO4 Cy3P, Pd(OAc)2 60 °C 3h mixture mixture 
8 toluene 2M K2CO3 (PPh3)4Pd 80 °C 3h No reaction No reaction 
9 toluene 2M K2CO3 (PPh3)4Pd 80 °C 6h No reaction No reaction 
10 toluene 2M K2CO3 (PPh3)4Pd 80 °C 8h No reaction No reaction 
11 THF 2M K2CO3 (PPh3)4Pd 60 °C 3h mixture mixture 
12 DME 2M K2CO3 (PPh3)4Pd 80 °C 3h No reaction No reaction 
13 DME 2M K2CO3 (PPh3)4Pd 80 °C 8h traces traces 
14 dioxane/tolu
ene (4:1) 
2M K2CO3 (PPh3)4Pd 80 °C 3h mixture mixture 
15 dioxane/tolu
ene (3:2) 
2M K2CO3 (PPh3)4Pd 60 °C 8h mixture di major 
16 dioxane/tolu
ene (1:1) 
2M K2CO3 (PPh3)4Pd 80 °C 3h mixture di major 
17 dioxane/tolu
ene (1:4) 
2M K2CO3 (PPh3)4Pd a80 °C 3h 87% 91%  
18 dioxane/tolu
ene (1:4) 
2M K2CO3 (PPh3)4Pd a110 °C 3h Only di Only di  
a Same set of reaction conditions provided the excellent regioselectivity for synthesis of monoaryl tribromofurans , 
-b reaction was not carried out. 
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Table 19. Synthesis of 2,5-biaryl-4,5-dibromofurans 56a-c
46 56 Ar % (56) a
m a 3-ClC6H4 87 
e b 4-FC6H4 88 
j c 3-(CF3)C6H4 91 
n f 2-Naph -b
a Yields of isolated products , –b decomposition was observed 
The Suzuki-Miyaura reaction of 54 with arylboronic acids 46ej,m (2.0 equiv.), in the presence 
of Pd(PPh3)4, gave the 2,5-diaryl-3,4-dibromofurans 56a-c (Scheme 26, Table 19). During the 
synthesis of inhibitors of B-Raf kinase, Andrew and co-workers studied site-selective Suzuki-
Miyaura reactions of 2,3-dibromofuran. These reactions, which were carried out in a 
DME/H2O/K2CO3 system, proceeded in rather low yields.77a The application of these 
conditions to Suzuki reactions of 54 proved to be unsuccessful. Therefore we decided to 
optimize the reaction conditions methodically for different solvent systems, reaction times 
and catalyst systems. Arylboronic acids 46j,m,n were selected for the optimization studies 
based on their electron-withdrawing nature and steric effects. During the optimization, I found 
that the temperature did not have an important influence on the yield of 56 and on the 
regioselectivity provided that exactly 2.0 equiv. of the boronic acids were used. 
Using dioxane as the solvent, Pd(PPh3)4, Pd(PPh3)2Cl2 and Pd(OAc)2, in the presence of Cy3P 
or XPhos, were studied as the catalysts in the reactions of 54 with boronic acids 46j,m,n. All 
these reactions resulted in the formation of complex mixtures of mono-, di-, tri- and 
tetraarylfurans (entries 1-7, Table 18). In case of 46n, a reduced product by loss of a bromine 
atom was formed. The use of different bases (2M aqueous solution of K2CO3 or the use of
K3PO4 or Cs2CO3 in organic solvents) and a decrease of the reaction temperature did not 
allow to solve the problems related to the site-selectivity (entries 1-7, Table 18). The reaction 
suffered from low conversions when the solvents toluene and DME were used. The 
employment of THF as the solvent, using Pd(PPh3)4 and 2M K2CO3, resulted in the formation 
of complex mixtures for different reaction times (3-8 h) and temperatures (60-80 °C) (entries 
8-13). While the use of a single solvent was unsuccessful for the regioselective synthesis of 
2,5-diaryl-3,4-dibromofurans 56a-c, the use of solvent mixtures allowed to address the 
problem. I selected dioxane/toluene as a solvent system to control the solubility of the boronic 
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acids. Pd(PPh3)4 and 2M K2CO3 were again used as the catalyst and base, respectively. While 
the use of a 4:1 dioxane/toluene mixture again provided mixtures of products, the use of a 3:2 
and 1:1 dioxane/toluene mixture showed better results for boronic acids 46j. In fact, the 
desired products 56 were formed as the major products among a complex mixture of other 
products (entries 14-16, Table 18).  Gratifyingly, the employment of a 1:4 dioxane/toluene 
mixture afforded exclusively 2,5-biaryl-3,4-dibromofurans 56a-c which could be isolated in 
excellent yields (85-91%) (entry 17, Table 18). It is  worth to note that the use of a 1:4 
dioxane/toluene mixture of solvents allowed to obtain excellent site-selectivities even when 
the reactions were carried out at reflux (110 °C) (entry 18, Table 18).  
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Figure 14: HMBC Correlations of 56c 
The structure of 56c was established by 2D NMR using HMBC correlations. Phenyl protons 
H- 8.14 and H- 8.21 showed strong correlation with furan carbon C-  147.4. This 
confirmed that two phenyls are attached with C-2 and C-5. 
The structures of all products were established by 2D NMR techniques (NOESY, HMBC) or 
by X-ray crystal structure analyses. 
  
6.3 Conclusion
In conclusion, I have optimized the reaction conditions to achieve a convenient synthesis of 
symmetrical and unsymmetrical di- and tetra-aryl-furans by Suzuki-Miyaura reactions of 
2,3,4,5-tetrabromofuran. Pd(PPh3)4 (3 mol-%) in dioxane solvent was the best catalyst system 
and solvent to achieve tetra-aryl-furans. Due to extensive studies of reaction conditions to 
achieve regioselective arylation of TBF it occurred to me that Pd(PPh3)4, aq. K2CO3 (2 M) in 
1:4 dioxane/toluene were the best conditions to afford 2,5, diaryl-3,4-dibromofurans (56) with 
neat and clean reactions. Products prepared and discussed in this chapter are not readily 
accessible by other available methods. All reactions proceed with excellent site-selectivity 
and selectivity mainly depends on ratio of dioxane in toluene.  
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7 Abstract
An overview of domino twofold Heck / 6π-electrocyclization reactions of vicinal dihalides is 
given. The palladium(0)-catalyzed Heck cross-coupling reactions of di- and tribromo-N-
methylindoles provided 1,2-dihydrocarbazoles are described by a domino ′twofold Heck / 6π-
electrocyclization process at 120 °C. The products were transformed by Pd/C-catalyzed 
oxidation to the corresponding carbazoles. I have synthesized functionalized benzofurans 
based on domino ′twofold Heck / 6π-electrocyclization′ reactions. Functionalized 
anthraquinones, fluorenones and benzocoumarines were also prepared by domino ′twofold 
Heck / 6π-electrocyclization′ reactions   
Suzuki-Miyaura cross-coupling reactions of 2,4,5,6-tetrachloropyrimidine provide an 
expedient synthesis of mono-, di-, tri- and tetraarylpyrimidines which are not readily available 
by other methods. All reactions proceed with excellent site-selectivity. Optimization of 
reaction conditions for better yields and loading of lower percentage of catalyst were studied 
as well. Suzuki-Miyaura reactions of 2,3,4,5-tetrabromofuran allowed a convenient synthesis 
of tetraarylfurans which are not readily available by other methods. Regioselectivity was 
achieved by using the solvent system toluene/dioxane (4:1) at C-2, C-5 and then C-3, C-4. All 
reactions proceeded with excellent yields and site-selectivity. 
  
Zunächst wird ein Überblick über zweifache Heck / 6π-Elektrocyclisierungs-
Dominoreaktionen von vicinalen Dihalogeniden gegeben. 
Br
X Pd[0]
R R
R
X=Br, OTf
47
47
Die Palladium(0)-katalysierte Heck-Kreuzkupplung von Di- und Tribrom-N-methylindolen 
ergab 1,2-Dihydrocarbazole. Der Reaktion liegt eine zweifache Heck / 6π-
Elektrocyclisierungs-Dominoreaktion bei einer Temperatur von 120 °C zugrunde. Die 
Produkte wurden durch eine Palladium/Aktivkohle-katalysierte Oxidation in die 
entsprechenden Carbazole überführt.    
N
Br
Br
Me
CO2R
N
Me
CO2R
CO2R
Zusätzlich habe ich funktionalisierte Benzofurane basierend auf der zweifachen Heck / 6π-
Elektrocyclisierungs-Dominoreaktionen synthetisiert. 
O
Br
Br O
R
R
R
Verschieden funktionalisierte Anthrachinone, Fluorenone und Benzocumarine wurden 
ebenfalls durch die zweifache Heck / 6π-Elektrocyclisierungs-Dominoreaktionen dargestellt.  
O
Br
X Pd[0]
R
O
R
R
X=Br, OTf
Die Suzuki-Miyaura-Kreuzkupplung von 2,4,5,6-Tetrachlorpyrimidinen ergab Mono-, Di-, 
Tri- und Tetraarylpyrimidine, die durch andere Synthesemethoden nur schwer zugänglich 
sind. Alle Reaktionen verlaufen mit exzellenter Regioselektivität. Zusätzlich wurden eine 
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Veränderung der Reaktionsbedingungen zur Ausbeuteverbesserung und eine Minimierung der 
Katalysatormenge untersucht.  
N N
ClCl
Cl
Cl
N N
ArCl
Cl
Cl
ArB(OH)2
[Pd]
N N
ArAr
Cl
Cl
N N
ArAr
Ar
Cl
N N
ArAr
Ar
Ar
(1.0-4.4 equiv.) (1.0 equiv.) (2.0 equiv.)
(3.0 equiv.) (4.4 equiv.)
Die Suzuki-Miyaura-Kreuzkupplung von 2,3,4,5-Tetrabromfuranen ermöglichte die Synthese 
von Tetraarylfuranen, die durch andere Synthesemethoden nur schwer zugänglich sind. Eine 
sehr gute Regioselektivität konnte, zunächst an den Atomen C-2 und C-5, dann an den 
Atomen C-3 und C-4, durch Verwendung des Lösungsmittelgemisches Toluen/Dioxan (4:1) 
erreicht werden. Alle Reaktionen verlaufen mit sehr guter Ausbeute und Regioselektivität. 
ArB(OH)2
[Pd]
(1.0-4.4 equiv.)
(2.0 equiv.)
(4.4 equiv.)
O
Br
Br
Br
Br
O
Br
Ar
Br
Ar
O
Ar
Ar
Ar
Ar
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 Experimental Section 
8 Material and Methods  
      8.1 General Remarks  
Reactions were carried out under inert atmosphere (Argon 4.6) in order to simultaneously 
exclude oxygen and water when appropriate. Pressure tubes were used to avoid condenser. 
Solvents for reactions were dried and distilled by standard methods or purchased from Merck, 
Aldrich, Acros Organics, and others whenever exclusion of water was desired. Solvents for 
liquid chromatography and extraction were always distilled prior to use and partly reused after 
fractional distillation (n-heptane, ethyl acetate).  
8.2 Methods for Compound Characterization and Analysis 
NMR Spectroscopy  
Bruker AC 250, Bruker ARX 300, Bruker ARX 500. For NMR characterization the one-
dimensional 1H NMR, proton-decoupled 13C NMR, and DEPT 135 spectra were collected. If 
necessary, other techniques (NOESY, COSY, HMQC, HMBC) were applied as well. All 
NMR spectra presented in this work were collected in CDCl3 solution. All chemical shifts are 
given in ppm.  
References (1H NMR): TMS ( = 0.00) or residual CHCl3 ( = 7.26) were taken as internal 
standard.  
References (13C NMR): TMS ( = 0.0) or residual CHCl3 ( = 77.0) were taken as internal 
standard.  
Multiplicities are given as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad signal. More complex coupling patterns are represented by combinations 
of the respective symbols. For example, td indicates a triplet of doublets with the larger 
coupling constant associated with the first symbol (here: triplet).  
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Infrared Spectroscopy (IR)  
Nicolet 205 FT-IR, Nicolet Protége 460 FT-IR. Peaks are given the following assignments: w 
= weak, m = medium, s = strong, br = broad.  
Mass Spektrometry (MS)  
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI), Finnigan MAT 95 (CI, 200 eV).  
High Resolution Mass Spectrometry (HRMS)  
Varian MAT 311, Intecta AMD 402.  
Elemental Analysis  
LECO CHNS-932, Thermoquest Flash EA 1112.  
Melting Points  
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected.  
Rotation Angles  
LP (IBZ Meßtechnik, NaD = 589 nm).  
X-ray Structures 
Bruker X8Apex diffractometer with CCD camera (Mo K radiation and graphite 
monochromator, 	 = 0.71073 Å). The space group is determined by the XPREP program and 
the structures were solved via the SHELX-97 program package. Refinements were carried out 
according to the minimum square error method.  
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8.3 Chromatographic Methods  
Thin Layer Chromatography (TLC)  
Merck Kieselgel 60 F254 on aluminium foil from Macherey-Nagel. Detection was carried out 
under UV light at 254 nm and 365 nm. As colourizing reagent the following mixtures were 
used: 1-2/100 p-Anisaldehyde or vanillin, 10/100 glacial acetic acid, 5/100 sulphuric acid, 83-
84/100 methanol.  
Column Chromatography  
Column chromatography was performed with Merck Silica Gel 60 or Macherey-Nagel Silica 
Gel 60 (0.063-0.200 mm, 70-230 mesh). The finer Merck Silica Gel 60 (0.040-0.063 mm, 
230-400 mesh) was chosen when appropriate.  
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9 General Procedures  
9.1 Synthesis of 1,2-Dihydrocarbazoles and Carbazoles by Domino ′Twofold Heck / 
6π-Electrocyclization′ Reactions of Di- and Tri-N-methylindoles 
9.1.1 Synthesis of 2,3-dibromo-N-methylindole (14).  
To a THF solution (20 mL) of N-methylindole (13) (1.0 mL, 8.0 mmol) was portionwise 
added NBS (3.30 g, 18.4 mmol) at – 78 °C and the solution was stirred at this temperature for 
4 h. To the solution was added water (25 mL). The organic and the aqueous layer were 
separated and the latter was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers 
were washed with a saturated aqueous solution of NaHCO3, dried (Na2SO4), filtered and 
concentrated in vacuo. The residue was purified by flash silica column chromatography (pure 
heptanes) to yield 14 as a colourless semisolid (1.83 g, 90%). 
9.1.2 Synthesis of 2,3,6-tribromo-N-methylindole (15). 
 To a THF solution (50 mL) of N-methylindole (13) (2.0 mL, 16.0 mmol) was portionwise 
added NBS (9.40 g, 52.8 mmol) at – 78 °C and the solution was stirred at this temperature for 
4 h and then at 20 °C for 14 h. To the solution was added water (25 mL). The organic and the 
aqueous layer were separated and the latter was extracted with CH2Cl2 (3 x 30 mL). The 
combined organic layers were washed with a saturated aqueous solution of NaHCO3, dried 
(Na2SO4), filtered and concentrated in vacuo. The residue was purified by flash silica column 
chromatography (pure heptanes) to yield 15 (5.50 g, 94%). 
General procedure A for Heck cross-coupling reactions. In a pressure tube (glass bomb) a 
suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 2.5 mol% per Br) and dicyclohexyl (2',6'-
dimethoxybiphenyl-2-yl)phosphine (L) (41 mg, 0.10 mmol) in DMF (5 mL) was purged with 
argon and stirred at 20 °C to get a yellowish or brownish transparent solution. To the stirred 
solution were added the brominated indole 14 or 15(1.0 mmol), NEt3 and  the acrylate. The 
reaction mixture was stirred at 90 °C for 36 h. The solution was cooled to 20 °C, poured into 
H2O and CH2Cl2  (25 mL each), and the organic and the aqueous layer were separated. The 
latter was extracted with CH2Cl2  (3 x 25 mL). The combined organic layers were washed 
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with H2O (3 x 20 mL), dried (Na2SO4), and concentrated in vacuo. The residue was purified 
by chromatography (flash silica gel, heptanes/EtOAc).  
8.1.3 Synthesis of 2,3-bis(alkenyl)-N-methylindoles 17
Dibutyl 3,3'-(1-methyl-1H-indole-2,3-diyl)diacrylate (17b). Product 17b was prepared 
starting with 14 (289 mg, 1.0 mmol), butyl acrylate (16c)
(0.36 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-%), SPhos 
(10 mol-%), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 90 
°C for 24 h following general procedure A, as a brownish 
oil (276 mg, 72%). 1H NMR (250 MHz, CDCl3): δ  =  0.90 (t, 6H, J = 7.1 Hz, 2CH3), 1.30-
1.40 (m, 4H, 2CH2), 1.60-1.70 (m, 4H, 2CH2), 3.70 (s, 3H, NCH3), 4.10 (t, 2H, J = 6.3 Hz, 
CH2O), 4.20 (t, 2H, J = 6.3,  2CH2O), 6.30 (d, 1H, J = 16.1 Hz, CH), 6.50 (d, 1H, , J = 15.8 
Hz, CH), 7.20-7.40 (m, 3H, ArH), 7.80 (d, 1H, J = 16.1 Hz, CH), 7.80 (bd, 1H, J = 8.0 Hz, 
ArH), 7.90 (d, 1H, J = 15.8 Hz, CH). 13C NMR (62 MHz, CDCl3): δ = 13.7, 13.8 (CH3), 19.2, 
19.3 (CH2), 30.8, 30.9 (CH2), 31.2 (NCH3),  64.2, 64.9 (CH2O), 110.0 (CH), 114.1 (C),  
116.6, 121.1, 122.0, 124.7, 124.8 (CH), 125.5 (C), 131.1, 136.5 (CH), 136.8, 139.0 (C), 166.2, 
168.0 (CO). IR (KBr): v = 2957, 2932, 2872 (m), 1706, 1616, 1466 (s), 1364, 1326 (w), 1274, 
1235, 1165 (s), 1132, 1115, 1061, 1046, 1027, 968, 844, 8215 (m), 739 (s), 561 (w) cm. MS 
(EI, 70 eV): m/z (%) = 383 (M+, 3), 381 (62), 325 (13), 308 (06),  269 (09), 252 (100), 225 
(08). HRMS (EI, 70 eV): calcd for C23H29NO4 [M]+: 383.20911; found: 383.208695. 
Dihexyl 3,3'-(1-methyl-1H-indole-2,3-diyl)diacrylate (17c). Product 17c was prepared
starting with 14 (289 mg, 1.0 mmol), hexyl acrylate
(16e) (0.44 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-
%), SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 mmol), 
DMF (5 mL) at 90 °C for 36 h following general 
procedure A, as a deep yellow highly viscous oil (337 mg, 77%). 1H NMR (250 MHz, 
CDCl3): δ  =  0.80 (t, 6H, J = 7.8 Hz, 2CH3), 1.20-1.40 (m, 16H, 8CH2), 3.70 (s, 3H, NCH3), 
4.20 (t, 4H, J = 6.8 Hz, 2CH2O), 6.20 (d, 1H, J = 16.0 Hz, ArH), 6.50 (d, 1H, J = 15.9 Hz, 
ArH), 7.10-7.30 (m, 3H, ArH), 7.70 (d, 1H, J = 15.8 Hz, ArH), 7.80 (d, 2H, J = 8.1 Hz, ArH), 
7.90 (d, 1H, J = 16.0 Hz, ArH). 13C NMR (62 MHz, CDCl3): δ = 13.0 (2CH3), 21.4, 21.5, 
24.4, 24.8, 27.3, 27.7 (CH2), 29.9 (NCH3), 30.3, 30.5 (CH2), 63.5, 64.2 (CH2O), 109.7 (CH), 
113.0 (C), 120.0, 120.2, 121.0, 123.2, 1236 (CH), 124.5 (C), 130.1, 134.2 (CH), 135.5, 138.0 
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(C), 165.2, 166.9 (CO). IR (KBr): v = 2955, 2929, 2857 (m), 1712 (s), 1625, 1529, 1467, 
1360, 1283, 1238 (w), 1170 (s), 1133, 1049, 972, 916 (w), 735 (s) cm. GC-MS (EI, 70 eV): 
m/z (%) = 439 ([M]+, 44), 338 (06), 310 (28), 252 (11), 226 (100), 208 (68), 182 (84). HRMS 
(EI, 70 eV): calcd for C27H37NO4 [M]+: 439.27171; found: 439.270972. 
Di(tert-Butyl) 3,3'-(1-methyl-1H-indole-2,3-diyl)diacrylate (17d). Product 17d was 
synthesized starting with 14 (289 mg, 1.0 mmol), tert-butyl 
acrylate (16f) (0.37 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-%), 
SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 90 
°C for 36 h following general procedure A, as a yellowish highly 
viscous oil (299 mg, 78%, E/Z = 7:3). 1H NMR (250 MHz, CDCl3): δ =  1.50 (s, 18H, 6CH3), 
3.70 (s, 3H, NCH3), 6.20 (d, 1H, J = 16.0 Hz, ArH), 6.40 (d, 1 H, J  = 16.0 Hz, ArH), 7.20–
7.30 (m, 3H, ArH), 7.60 (d, 1H, J = 15.8 Hz, ArH),  7.70 (d, 1H, J = 16.0 Hz, ArH), 8.00 (d, 
1H, J = 7.9 Hz, ArH). 13C NMR (75 MHz, CDCl3): δ = 27.2 , 27.3 (3CH3), 30.1 (NCH3), 
79.0, 80.2 (C-O), 108.6 (CH), 112.8 (C), 117.2, 120.2, 120.6 , 123.8 (CH), 124.5 (C), 125.4, 
129.2, 134.7 (CH), 135.9, 137.2 (C), 164.4, 166.3 (C=O). IR (KBr): v = 2964, 2930 (w), 
1722, 1710, 1693, 1680, 1613 , 1469, 1453, 1391, 1366 (m), 1281, 1258, 1144, 1090, 1017 
(s), 845 (m), 797, 741 (s), 663, 563 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 383 (M+, 39), 271 
(13), 227 (84), 226 (100), 225 (52), 208 (31), 182 (69), 167 (54), 152 (21), 57 (79), 41 (42). 
HRMS (EI, 70 eV): calcd for C23H29NO4 [M]+: 383.20911; found: 383.20905. 
Bis(6-methylheptyl) 3,3'-(1-methyl-1H-indole-2,3-diyl)diacrylate (17e). Product 17e was 
prepared starting with 14 (289 mg, 1.0 mmol), isooctyl 
acrylate (17e) (0.52 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 
5 mol-%), SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 
mmol), DMF (5 mL) at 90 °C for 36 h following 
general procedure A, as a yellow oil (377 mg, 76%).
1H NMR (250 MHz, CDCl3): δ = 0.60-0.90 (m, 12H, 
4CH3), 1.00-1.40 (m, 12H, 6CH2), 1.50-1.60 (m, 6H, aliphatic), 3.80 (s, 3H, NCH3), 4.10 (t, 
2H, J = 6.7 Hz, CH2O), 4.20 (t, 2H, J = 6.8 Hz, CH2O), 6.40 (d, 1H, J = 16.1 Hz, ArH), 6.50 
(d, 1H, J = 16.0 Hz, ArH), 7.10-7.20 (m, 3H, ArH), 7.80 (d, 1H, J = 15.7 Hz, ArH), 7.80 (bd, 
1H, J = 7.6 Hz, ArH), 7.90 (d, 1H, J = 15.7 Hz, ArH). 13C NMR (62 MHz, CDCl3): δ = 13.0, 
14.6 (CH3), 21.5, 24.5, 27.5 (CH2) 29.5 (NCH3), 45.5 (CH2), 63.7, 63.8 (CH2O), 108.1 (C), 
108.7 (CH), 115.7, 120.0, 120.4, 123.2 (CH), 124.5, 125.0 (C), 127.6, 130.1, 134.3 (CH), 
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137.3 (C), 165.3, 167.0 (CO). IR (KBr): v = 2955, 2927, 2871 (m), 1709, 1620, 1465 (s), 
1367, 1280, 1235 (m), 1164 (s), 1132, 1048, 969, 849, 818 (w), 740 (s), 662, 561 (w) cm. GC-
MS (EI, 70 eV): m/z (%) = 495 ([M]+, 32), 337 (16), 281 (14), 253 (10), 252 (22), 226 (100), 
208 (75), 182 (45). HRMS (EI, 70 eV): calcd for C31H45NO4 [M]+: 495.33431; found: 
495.33390. 
(E)-2-ethylhexyl 3-(3-bromo-1-methyl-1H-indol-2-yl)acrylate (21). Product 21 (138 mg, 
35%) was found alongwith 17g (50 mg, 10%) as a light 
brown oil (138 mg, 35%+10% 17g).. 1H NMR (250 MHz, 
CDCl3): δ  =  0.87 (t, J = 7.3, 6H, 2CH3), 1.18-1.45 (m, 8H), 
1.53-1.66 (m, 1H), 3.75 (s, 3H, CH3N), 4.08 (dd, J = 0.8, 6.0 
Hz, 2H, CH2O),  6.80 (d, 1H, J = 16.2 Hz, CH), 7.08-7.15 (m, 1H, ArH), 7.22-7.25 (m, 2H, 
ArH), 7.48-7.52 (m, 1H, ArH), 7.774 (d, 1H, , J = 16.3 Hz, CH). 13C NMR (75.5 MHz, 
CDCl3): δ = 9.8, 13.1 (CH3), 22.0, 22.9, 27.8, 29.5 (CH2), 30.2 (CH),  37.9 (NCH3), 66.2 
(CH2O), 95.0 (C), 108.8, 119.1, 119.4, 120.0, 124.0 (CH), 126.2, 129.8 (C), 130.0 (CH), 
137.0 (C), 166.2 (CO). IR (KBr): v = 2956, 2926, 2871, 2858 (m), 1706 (s), 1625, 1462, 
1372, 1325, 1260, 1233, 1207 (m), 1167 (s), 1014, 930, 767 (w), 738 (m) cm. HRMS (ESI+): 
calcd for C20H26BrNO2 (M+, [79Br]): 391.11469; found: 391.11433, calcd for C20H26BrNO2 
(M+, [81Br]): 393.11263; found: 393.11453.  
Synthesis of bis(2-ethylhexyl) 3,3'-(1-methyl-1H-indole-2,3-diyl)diacrylate (17g). Product 
17g was prepared starting with 14 (289 mg, 1.0 mmol), 
2-Ethylhexyl acrylate (0.27 mL, 1.25 mmol) (0.52 mL, 
2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-%), SPhos (10 mol-
%), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 90 °C 
for 24 h following general procedure A, as a yellow oil 
(50 mg, 10% + 35 % 22). 1H NMR (250 MHz, CDCl3): δ = 0.90 (t, 12H, J = 7.5 Hz, 4CH3), 
1.20-1.40 (m, 16, 8CH2), 1.20-1.60 (m, 2H, CH), 3.80 (s, 3H, NCH3), 4.00-4.10 (m, 4H, 
CH2O), 6.30 (d, 1H, J = 16.0 Hz, ArH), 6.50 (d, 1H, J = 16.0 Hz, ArH), 7.20-7.30 (m, 3H, 
ArH), 7.80 (d, 1H, J = 16.0 Hz, ArH), 7.90 (d, 1H, J = 8.1 Hz, ArH), 8.00 (d, 1H, J = 15.9 Hz, 
ArH). 13C NMR (75 MHz, CDCl3): δ = 11.0, 11.1, 14.0  (CH3), 22.9, 23.0, 23.8, 24.0, 28.9, 
29.0, 30.4, 30.5 (CH2), 31.2 (CH3CN), 38.8, 38.9 (CH aliphatic), 66.8, 67.6 (CH2O), 109.0 
(CH), 113 (C), 115.7, 121.2, 122.0, 123.5, 123.6 (CH), 124.5 (C), 131.1, 135.5 (CH), 135.8, 
138.0 (C), 165.3, 167.0 (CO). IR (KBr): v = 3052 (w), 2957, 2927, 2872, 2858 (m), 1706, 
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1620 (s), 1464 (m), 1411, 1378, 1352, 1339 (w), 1280, 1250, 1235 (m), 1165 (s), 1132, 1031, 
1016, 1016, 968 (m), 850, 818, 766 (w), 740 (s), 655, 561 (w) cm−1. GC-MS (EI, 70 eV): m/z
(%) = 595 ([M]+, 60), 367 (9), 337 (15), 269 (10), 253 (15), 226 (72), 208 (100), 151 (13). 
HRMS (EI, 70 eV): calcd for C31H45NO4 [M]+: 495.33431; found: 495.33712.  
9.1.4 Synthesis of 2,3-dihydrocarbazoles 18
General procedure B for Heck cross-coupling reactions. In a pressure tube (glass bomb) a 
suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 1.25 mol% per Br) and dicyclohexyl (2',6'-
dimethoxybiphenyl-2-yl) phosphine (L) (41 mg, 0.10 mmol) in DMF (5 mL) was purged with 
argon and stirred at 20 °C to get a yellowish or brownish transparent solution. To the stirred 
solution were added the brominated indole 14 or 15 (1.0 mmol), NEt3 (1.1 mL, 8.0 mmol) and  
the acrylate (1.25 equiv. per Br). The reaction mixture was stirred at 120 ˚C for 48 h. The 
solution was cooled to 20 °C, poured into H2O and CH2Cl2  (25 mL each), and the organic 
and the aqueous layer were separated. The latter was extracted with CH2Cl2  (3 x 25 mL). The 
combined organic layers were washed with H2O (3 x 20 mL), dried (Na2SO4), and 
concentrated in vacuo. The residue was purified by chromatography (flash silica gel, 
heptanes/EtOAc). 
Diethyl 9-methyl-2,9-dihydro-1H-carbazole-2,3-dicarboxylate (18a). Product 18a was 
prepared starting with 14 (289 mg, 1.0 mmol), ethyl acrylate (16b)
(0.27 mL, 2.5 mmol),  Pd(OAc)2 (11 mg, 5 mol-%), SPhos (10 
mol-%), NEt3 (1.1o mL, 8.0 mmol), DMF (mL) at 120 °C for 48 h 
according to general procedure B, as a yellow solid (303 mg, 
93%). The synthesis of  18a has been previously reported.81  Mp = 125 °C (lit.81, 125-126 °C).
Mp 100-103 ˚C. 1H NMR (250 MHz, CDCl3): δ = 1.10 (s, 3H, CH3), 1.30 (s, 3H,CH3), 2.90 
(dd, 1H, J = 8.8, 17.1 Hz, H-1),  3.50 (dd, 1 H, J = 2.6, 17.2 Hz, H-1), 3.60 (s, 3H, NCH3), 
3.90-4.10 (m, 3H,  H and CH2O), 4.20 (q, J = 7.1, 13.5 Hz, 2H, CH2O), 7.10-7.20 (m, 3H, 
ArH), 7.50-7.60 (m, 1H, ArH), 7.90 (s, 1H, H-4). 13C NMR (75 MHz, CDCl3): δ = 13.0 
(CH3), 13.5 (CH3), 22.8 (CH2), 28.7 (CH, C-4), 37.7 (NCH3), 59.3 (CH2O), 60.1 (CH2O), 
108.3 (C), 108.6 (CH), 115.4 (C), 116.9, 120.0, 120.8 (CH), 124.1(C), 131.2 (CH), 137.0, 
138.6 (C), 166.3, 172.3 (CO). IR (KBr): v = 2981, 2928, 2854 (w), 1725(s), 1629, 1599 (w), 
1470 1454 (m), 1372, 1261, 1238 (s), 1109, 1079, 147 (m), 787, 747, 723, 608, 561 (w) cm−1. 
GC-MS (EI, 70 eV): m/z (%) = 325 ([M-2]+ (carbazole), 89), 280 (13), 252 (100), 208 (07), 
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179 (13); HRMS (ESI+): calcd for C19H19NO4 [M-2]+ (carbazole): 325.13141; found: 
325.13161. 
Dibutyl 9-methyl-2,9-dihydro-1H-carbazole-2,3-dicarboxylate (18b). Product 18b was 
prepared starting with 14 (289 mg, 1.0 mmol), butyl acrylate
(16c) (0.36 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-%), 
SPhos (10 mol-%), NEt3 (1.1o mL, 8.0 mmol), DMF (mL) at 
120 °C for 48 h according to general procedure B, as a yellow 
highly viscous oil (294 mg, 77%). 1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3H, J = 7.3 Hz, 
CH3), 0.90 (t, 3H, J = 7.4 Hz, CH3), 1.10-1.30 (m, 2H, CH2), 1.30-1.50 (m, 4H, 2CH2), 1.60-
1.70 (m, 2H, CH2), 3.00 (dd, 1H, J = 8.6, 17.0 Hz, H-1),  3.60 (dd, 1H, J = 2.3, 17.0 Hz, H-
1), 3.70 (s, 3H, NCH3), 3.80-4.00 (m, 2H, CH2O),  4.00 (dd, 1H, J = 2.3, 8.3 Hz, H-2), 4.20 
(t, 2H, J = 6.6 Hz, CH2O), 7.00-7.20 (m, 3H, ArH), 7.50- 7.60 (m, 1H, ArH), 7.90 (s, 1H, H-
4). 13C NMR (62 MHz, CDCl3): δ = 13.6 (CH3), 13.8 (CH3), 19.0, 19.3, 23.8 (CH2), 29.8 
(CH3N), 30.5, 31.0 (CH2), 39.0 (CH, C-2), 64.2, 65.0 (CH2O), 109.4 (C), 109.6 (CH), 116.5 
(C), 118.0, 121.0, 121.8 (CH), 125.2 (C), 132.1 (CH), 138.0, 139.7 (C), 167.4, 173.4 (CO). IR 
(KBr): v = 2956, 2932, 2872 (m), 1709 (s), 1629, 1599, 1559, 1562 (w), 1500, 1464, 1387, 
1362, 1340, 1325 (m), 1257, 1222 (s), 1131, 1106, 1077, 1045, 1015 (m), 950, 902, 843, 830, 
783, 765 (w), 742, 720 (m), 632, 608, 561 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 383 ([M]+, 
46), 310 (06), 282 (34), 226 (87), 208 (67), 182 (100), 152 (13); HRMS (EI, 70 eV): m/z calcd 
for C23H29NO4 [M]+: 383.20911; found: 383.20824. 
Dihexyl 9-methyl-2,9-dihydro-1H-carbazole-2,3-dicarboxylate (18c). Compound 18c was 
synthesized starting with 14 (289 mg, 1.0 mmol), hexyl 
acrylate (16e) (0.44 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 
mol-%), SPhos (10 mol-%), NEt3 (1.1o mL, 8.0 mmol), 
DMF (mL) at 120 °C for 48 h following general 
procedure B, as a yellowish solid (357 mg, 81%). Mp 107-109 °C. 1H NMR (250 MHz, 
CDCl3): δ  =  0.70 (t, 3H, J = 7.0 Hz, CH3), 0.80 (t, 3H, J = 7.0 Hz, CH3), 1.10-1.20 (m, 6H, 
3CH2), 1.20-1.50 (m, 8H, 4CH2), 1.60-1.70 (m, 2H, CH2), 3.00 (dd, 1H, J = 8.8, 17.1 Hz, H-
1),  3.50 (dd, 1H, J = 2.3, 17.1 Hz, H-1), 3.60 (s, 3H, NCH3), 3.80-4.00 (m, 2H, CH2O),  4.00 
(dd, 1H, J = 2.4, 8.8 Hz, H-2), 4.10 (t, 2H, J = 6.8 Hz, CH2O), 7.00-7.20 (m, 3H, ArH), 7.50-
7.60 (m, 1H, ArH), 7.90 (s, 1H, H-4). 13C NMR (75 MHz, CDCl3): δ = 12.9, 13.0 (CH3), 21.5, 
21.6, 22.8, 24.4, 24.8, 27.4, 27.9 (CH2), 28.7 (NCH3), 30.3, 30.5 (CH2), 38.0 (CH, C-4), 63.5, 
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64.2 (CH2O), 108.3(C), 108.5 (CH), 115.5 (C), 116.9, 120.0, 121,0 (CH), 124.1 (C), 131.0 
(CH), 137.0, 138.7 (C), 166.4, 172.3 (CO). IR (KBr): v = 2953, 2928, 2857 (m), 1724, 1691 
(s), 1615, 1605, 1526, 1465, 1392, 1311, 1307, 1268 (m), 1223, 1180 (s), 1086, 1046 (m), 
915, 835, 767 (w), 738 (s), 653, 626, 546 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 439 ([M]+, 
41), 310 (30), 226 (100), 208 (68), 182 (84), 152(08). HRMS (EI, 70 eV): calcd for 
C27H37NO4 [M]+: 439.27171; found: 439.27110.
Di-tert-butyl 9-methyl-2,9-dihydro-1H-carbazole-2,3-dicarboxylate (18d). Compound 
18d was prepared starting with 14 (367 mg, 1.0 mmol), tert-butyl 
acrylate (16f) (0.37 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-%), 
SPhos (10 mol-%), NEt3 (1.1o mL, 8.0 mmol), DMF (mL) at 120 
°C  for 48 h according to general procedure B, as a light brown 
solid (325 mg, 85%). Mp 105-107 ˚C. 1H NMR (250 MHz, CDCl3): δ = 1.30 (s, 9H, 3CH3), 
1.50 (s, 9H, 3CH3), 2.90 (dd, 1H, J = 8.9, 17.1 Hz, H-1), 3.50 (dd, 1H, J = 2.5, 17.1 Hz, H-
1), 3.60 (s, 3H, NCH3), 3.90 (dd, 1H, J = 2.1, 8.9 Hz, H-2), 7.00-7.10 (m, 2H, ArH), 7.10-
7.20 (m, 1H, ArH), 7.50-7.60 (m, 1H, ArH), 7.80 (s, 1H, H-4). 13C NMR (75 MHz, CDCl3): δ
= 23.6 (CH2), 27.9 (3CH3), 28.4 (3CH3), 29.7 (CH, C-4), 39.7 (CH3N), 79.7 (C-O), 81.0 (C-
O), 109.2 (C), 109.5 (CH), 118.0 (CH), 118.7 (C), 120.7, 121.5 (CH), 125.2 (C), 130.6 (CH), 
137.9, 139.6 (C), 166.8, 172.5 (CO). IR (KBr): v = 3049, 2973, 2930 (w), 1712 (s), 1614, 
1598, 1470, 1455, 1390 (m), 1365, 1272, 1242, 1152, 1128, 1110 (s), 1046, 1014 (w), 872, 
846, 836 (m), 747, 739 (s), 666, 597, 550 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 383 ([M]+, 
7), 325 (54), 269 (100), 252 (86), 225 (80), 207 (44), 179 (82). HRMS (EI, 70 eV): calcd for 
C23H29NO4 [M]+: 383.20966; found: 383.20855. 
Bis[2-(dimethylamino)ethyl] 9-methyl-2,9-dihydro-1H-carbazole-2,3-dicarboxylate (18f).
Compound 18f was synthesized starting with 14 (289 mg, 1.0 
mmol), 2-(Diethylamino)ethyl acrylate (16i) (0.38 mL, 2.5 
mmol), Pd(OAc)2 (11 mg, 5 mol-%), SPhos (10 mol-%), NEt3
(1.1o mL, 8.0 mmol), DMF (mL) at 120 °C  for 48 h 
following general procedure B, as a yellow highly viscous oil (326 mg, 79%). 1H NMR (250 
MHz, CDCl3): δ =  2.10 (s, 6H, 2CH3), 2.30 (s, 6H, 2CH3), 3.00 (dd, 1H, J = 8.8, 17.1 Hz), 
3.50-3.60 (m, 4H, NCH3 and H-1), 4.00-4.10 (m, 5H, 2NCH2 and H-2),  3.30 (t, 4H, J = 6.3 
Hz, 2CH2O), 7.10-7.20 (m, 3H, ArH), 7.50 (dd, 1H, J = 2.3, 8.5 Hz, ArH), 7.90 (s, 1H, H-4). 
13C NMR (62 MHz, CDCl3): δ = 23.8 (CH2, C-1), 29.8 (NCH3), 38.9 (CH, C-2), 45.5, 45.8 
N
O
O
O
O
N
O
O
O
O
N
N
59
59
(2CH3), 57.3, 57.9 (NCH2), 62.3, 63.2 (CH2O), 109.3 (C), 109.6 (CH), 115.7 (C), 117.9, 
121.1, 122.0 (CH), 125.1 (C), 132.8 (CH), 138.0, 139.8 (C), 167.2, 173.1 (CO). IR (KBr): v = 
2943, 2857, 2820, 2769 (w), 1691, 1614, 1525, 1455 (s), 1394, 1370, 1332, 1286 (m), 1225, 
1166 (s), 1130, 1097 (m), 1031 (s), 954, 919, 835 (w), 739 (s), 627 (w) cm. GC-MS (EI, 70 
eV): m/z (%) = 413 ([M]+, 13), 297 (98), 252 (06), 227 (04), 225 (13), 208 (56), 180 (17), 58 
(100). HRMS (EI, 70 eV): calcd for C23H31N3O4 [M]+: 413.23091; found: 413.230881. 
9.1.5 Synthesis of 3,4-di-substitutedcarbazoles 19
General procedure C for the transformation of 1,2-dihydrocarbazoles to carbazoles. To of 
xylene (5 mL) were added the 1,2 dihydrocarbazole (100 mg) and Pd/C (10 mg, 10 mol-%). 
The solution was stirred under reflux for 48 h under argon atmosphere. The reaction mixture 
was filtered and the filtrate was concentrated in vacuo.
 Diethyl 9-methyl-9H-carbazole-2,3-dicarboxylate (19a). Starting with 18a (100 mg) 
following general procedure C 19a was prepared as a light yellow 
oïl (99 mg, 100%). 1H NMR (300 MHz, CDCl3): δ = 1.31 (t, 3H, 
J = 7.1 Hz , CH3), 1.33 (t, 3H,  J = 7.1 Hz , CH3), 3.81 (s, 3H, 
CH3N),  4.32 (q, 2H, J = 7.2 Hz, CH2O), 4.43 (q, 2H, J = 7.2 Hz, 
CH2O), 7.21-7.31 (m, 1H, ArH), 7.32-7.41 (m, 1H,  ArH),  7.40-
7.51 (m, 1H, ArH), 7.60 (s,1H, ArH),  8.00-8.11 (m, 1H, ArH), 8.51 (s, 1H, ArH);  13C NMR 
(62 MHz, CDCl3): δ = 13.2, 13.3 (CH3), 28.4 (CH3N), 60.3 (CH2O), 60.7 (CH2O) , 108.0, 
108.1, 114.2, 120.0 (CH) 120.6, 121.2 (C), 121.4 (CH), 122.7, (C), 126.1 (CH), 130.1, 140.5, 
141.2 (C), 166.8, 168.2 (CO). IR (KBr): v = 2916 (w), 1713, 1702, 1628, 1599, 1559, 1499, 
1475, 1447, 1427 (m), 1392, 1372, 1339, 1328 (s), 1254, 1240, 1227 (w), 1124, 1106, 1080, 
1047, 1030, 953, 913, 868, 835, 794, 781, 765, 748, 725, 664, 656, 626, 590, 556 (s) cm. GC-
MS (EI, 70 eV): m/z (%) = 325 (M+, 95), 280 (12), 253 (21), 252 (100), 251 (5), 208 (7), 179 
(12), 152 (9); HRMS: m/z calcd for C19H19NO4 [M]+: 325.13141; found: 325.131001. 
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Dibutyl 9-methyl-9H-carbazole-2,3-dicarboxylate (19b). Product 19b was prepared starting 
with 18b (100 mg, 0.26 mmol), following general procedure B, as 
a light yellows semisolid (99 mg, 100%). 1H NMR (250 MHz, 
CDCl3): δ  =  0.90 (t, 3H, J = 7.4 Hz, CH3), 0.90 (t, 3H, J = 7.3 Hz, 
CH3), 1.30-1.50 (m, 4H, 2CH2), 1.60-1.80 (m, 4H, 2CH2), 3.80 (s, 
3H, NCH3), 4.30 (t, 2H, J = 6.8 Hz, CH2O),  4.30 (t, 2H, J = 6.7 
Hz, CH2O), 7.20-7.30 (m, 1H, ArH), 7.30-7.40 (m, 1H, ArH), 
7.40- 7.50 (m, 1H, ArH), 7.60 (s, 1H, H-1), 8.00 -8.10 (m, 1H, ArH), 8.40 (s, 1H, H-4). 13C 
NMR (62 MHz, CDCl3): δ = 13.7, 13.8 (CH3), 19.2, 19.3 (CH2), 29.4 (NCH3), 30.6, 30.8 
(CH2), 65.3, 65.7 (CH2O), 109.0, 109.1, 120.2, 121.0 (CH), 121.7, 122.2 (C), 122.4 (CH), 
123.6 (C), 127.1 (CH), 131.1, 141.5, 142,1 (C), 167.9, 169.4 (CO). IR (KBr): v = 2956, 2931, 
2871 (w), 1709 (s), 1464, 1387, 1362, 1340, 1325 (m) 1255, 1221 (s), 1131, 1106, 1077, 1045 
(m), 950, 902, 843, 829 (w), 784, 743, 721 (m), 632, 608, 561 (w) cm. GC-MS (EI, 70 eV): 
m/z (%) = 381(M+, 56), 308 (15), 280 (100), 224 (87), 212 (27), 206 (77), 180 (10), 152 (11). 
HRMS (EI, 70 eV): calcd for C23H27NO4 [M]+: 381.19401; found: 381.19422. 
Dihexyl 9-methyl-9H-carbazole-2,3-dicarboxylate (19c). Starting with 18c (100 mg)
following general procedure C, as a yellow oil (99 mg, 
100%). 1H NMR (300 MHz, CDCl3): δ  =  0.82 (t, 3H, J = 
7.1 Hz, CH3), 0.83 (t, 3H, J = 7.0 Hz, CH3), 1.24-1.30 (m, 
8H, 4CH2), 1.33-1.40 (m, 4H, 2CH2), 1.66-1.73 (m, 4H, 
2CH2), 3.75 (s, 3H, CH3N),  4.26 (t, 2H, J = 6.7 Hz, CH2O), 
4.28 (t, 2H, J = 6.7 Hz, CH2O), 7.17-7.23 (m, 1H, ArH), 7.32 (d, 1H, J = 8.2 Hz, ArH), 7.42-
7.47 (m, 1H, ArH), 7.53 (s, 1H, ArH), 8.01 (d, 1H, J = 7.8 Hz, ArH), 8.42 (s, 1H, ArH); 13C 
NMR (62.9 MHz, CDCl3): δ = 14.0 (2CH3), 22.6 (2CH2), 25.7, 25.7, 28.6, 28.7 (CH2), 28.7 
(CH3N), 31.5, 30.6 (CH2) 65.6, 66.0 (CH2O), 109.0, 109.1, 120.1, 120.9 (CH), 118.7, 122.2 
(C), 122.3 (CH), 123.6 (C), 127.1 (CH), 131.1, 141.4, 142.1 (C), 167.8, 169.3 (CO). IR 
(KBr): v = 3054, 2953, 2928, 2856 (w), 1712 (s), 1629, 1599, 1561, 1501 (w), 1466 (m), 1387 
(w), 1363, 1340, 1325 (m), 1257, 1222 (s), 1132 (m), 1108 (s) 1079, 1046, 1015, 981, 907 
(m), 867, 883 (w), 785, 766 (m), 729, 722 (s), 646 (m), 633, 609, 561 (w) cm. GC-MS (EI, 70 
eV): m/z (%) = 437 (M+, 41), 353 (10), 252 (100), 225 (10), 182 (84), 152(08); HRMS: m/z 
calcd for C27H35NO4 [M]+: 437.25661; found: 437.25410.
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 Di-tert-butyl 9-methyl-9H-carbazole-2,3-dicarboxylate (19d). Starting with 18d (100 mg) 
following general procedure C, as a light yellow oil (99 mg, 100%). 1H NMR (300 MHz, 
CDCl3): δ = 1.57 (s, 9 H, 3CH3), 1.58 (s, 9 H,3CH3), 3.78 (s, 3H, 
CH3N); 7.17-7.23 (m, 1H, ArH), 7.33 (d, 1H, J = 8.2 Hz,  ArH),  
7.42-7.47 (m, 1H, ArH), 7.50 (s,1H, ArH), 8.03 (d, 1H, J = 7.8 Hz,  
ArH), 8.33 (s,1H, ArH); 13C NMR (75 MHz, CDCl3): δ = 28.1 
(3CH3), 28.3 (3CH3), 29.4 (CH3N); 81.2 (C-O), 81.8 (C-O) , 109.0, 109.1, 119.0, 120.9, 122.0 
(CH), 122.4, 123.2, 123.8 (C), 126.8 (CH),132.8, 141.3, 142.2 (C), 167.0, 168.4 (CO). IR 
(KBr): v = 2975, 2929, 2849 (w), 1713 (s), 1702, 1628, 1596, 1562, 1530, 1503, 1475, 1455, 
1390 (w), 1365, 1337, 1324, 1269, 1251, 1228, 1165, 1129, 1108 (s), 1079, 1046, 1014, 955, 
895, 876, 863, 834, 800, 787, 777, 763, 756, 738, 718 (m), 666, 634, 598, 565, 555 (w) cm. 
EI+ (70 eV): m/z (%) = 381 ([M]+, 27), 325 (5), 270 (13), 269 (100), 251 (48), 252 (33), 225 
(8), 207 (10), 179 (35); HRMS: m/z calcd for C23H28NO4 [M+H]+: 382.20128; found: 
382.20055. 
9.1.6 Synthesis of 2-(2-cyanoethyl)-9-methyl-9H-carbazole-3-carbonitrile 20
Product 7 was prepared, starting with 14 (289 mg, 1.0 mmol), Pd(OAc)2 (11 mg, 5 mol-%), 
acrylonitrile (0.17 mL, 2.5 mmol), SPhos (10 mol-%), NEt3 (1.1o 
mL, 8.0 mmol), DMF (5 mL) at 120 °C  for 48 h according to 
general procedure A, as a light yellow crystals (127 mg, 49%), mp 
185-187 ˚C. 1H NMR (300 MHz, CDCl3): δ  =  2.80 (t, 2H, J = 7.1 Hz, CH2), 3.30 (t, 2H, J = 
7.1 Hz, CH2), 3.80 (s, 3H, NCH3), o7.20-7.30 (m, 1H, ArH), 7.30 (s, 1H, H-1), 7.40 (d, 1H, J
= 8.2 Hz, ArH), 7.40- 7.50 (m, 1H, ArH), 8.00 (d, 1H, J = 7.9 Hz, ArH), 8.30 (s, 1H, H-4). 
13C NMR (75 MHz, CDCl3): δ = 18.0 (CH2), 28.4 (NCH3), 30.0 (CH2), 100.4 (C), 108.2, 
108.9 (CH), 117.6, 118.1 (CN), 119,6, 119.7 (CH), 120.6, 121.2 (C), 125.1, 126.3 (CH), 
137.1, 140.8, 141.9 (C). IR (KBr): v = 2914, 2852 (w), 2206 (s), 1631, 1597, 1557, 1504, 
1464, 1432, 1366, 1330,1320, 1264, 1253 (m), 1112, 1153, 1014, 966, 898 (w), 844, 800, 
767, 754 (s), 725, 666, 652, 550, 530 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 259 ([M]+, 53), 
243 (23), 198 (100), 152 (68), 112 (38). HRMS (EI, 70 eV): calcd for C17H13N3 [M]+: 
259.11095; found: 259.11041. 
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9.1.7        Synthesis of 6-Bromo-2,3-bis(alkenyl)-N-methylindole 22 
General procedure D for Heck cross-coupling reactions. In a pressure tube (glass bomb) a 
suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 2.5 mol% per Br) and dicyclohexyl (2',6'-
dimethoxybiphenyl-2-yl)phosphine (L) (41 mg, 0.10 mmol) in DMF (5 mL) was purged with 
argon and stirred at 20 °C to get a yellowish or brownish transparent solution. To the stirred 
solution were added the 2,3,6-tribromo-N-methylindole (15) (368 mg, 1.0 mmol), NEt3 (0.55 
mL, 4.0 mmol) and  the acrylate (2.5 mmol). The reaction mixture was stirred at 90 °C for 24 
h. The solution was cooled to 20 °C, poured into H2O and CH2Cl2  (25 mL each), and the 
organic and the aqueous layer were separated. The latter was extracted with CH2Cl2  (3 x 25 
mL). The combined organic layers were washed with H2O (3 x 20 mL), dried (Na2SO4), and 
concentrated in vacuo. The residue was purified by chromatography (flash silica gel, 
heptanes/EtOAc). 
Di(tert-butyl) 3,3-(6-bromo-1-methyl-1H-indole-2,3-diyl)diacrylate (22). Product 22 was 
prepared starting with 15 (368 mg, 1.0 mmol) and tert-butyl 
acrylate (16f) (0.37 mL, 2.5 mmol), Pd(OAc)2 (11 mg, 5 mol-
%), SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 mmol), DMF (5 
mL) at 90 °C for 24 h following general procedure D, as a 
yellow solid (276 mg, 75%). Mp 148-152 °C. The structure 
was confirmed by 2D NMR analysis (NOESY, HMBC). 1H NMR (250 MHz, CDCl3): δ = 
1.50 (s, 18 H, 6CH3), 3.70 (s, 3H, NCH3), 6.20 (d, 1 H, J = 16.1 Hz, ArH), 6.30 (d, 1 H, J = 
16.1 Hz, ArH), 7.20 (d, 1H, J = 8.4 Hz, ArH), 7.20 (dd, 1H, J = 1.7, 8.6 Hz, ArH), 7.20 (d, J = 
1.5 Hz, 1H, ArH), 7.80 (d, 1 H, J = 16.1 Hz), 7.70 (d, 1 H, J = 15.9 Hz, ArH). 13C NMR (75 
MHz, CDCl3): δ = 28.0 (2CH3), 28.2 (2CH3), 28.3 (2CH3), 31.3 (NCH3), 81.0, 81.3 (C-O), 
113.0 (CH), 113.8, 118.0 (C), 118.9, 122.3 (CH), 124.3 (C), 124.9, 127.0, 129.8, 135.2 (CH), 
137.0, 139.0 (C), 165.2, 167.0 (C=O). IR (KBr): v = 3090, 2978, 2929 (w), 1709, 1674, 1633, 
1615 (s), 1470 1454 (m), 1365, 1278, 1252, 1147 (s), 1064, 1038 (w), 970, 948 (m), 843, 829, 
805 (s), 772, 757, 737, 640, 589 (w) cm. MS (EI, 70 eV): m/z (%) = 463 ([M+, 81Br], 12),  461 
([M+, 79Br] 13), 349 (16), 331 (17), 305 (46), 259 (35), 225 (100), 181 (97), 57 (38). HRMS 
(EI, 70 eV): calcd for C23H28BrNO4 [M, 79Br]+: 461.11962; found: 461.11828.  
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Di(isobutyl) 7-bromo-9-methyl-2,9-dihydro-1H-carbazole-2,3-dicarboxylate (23). Product
9 was synthesized starting with 47 (367 mg, 1.0 mmol), 
iso-butyl acrylate (16d) (0.36 mL, 2.5 mmol), Pd(OAc)2 
(11 mg, 5 mol-%), SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 
mmol), DMF (5 mL) at 120 °C  for 48 h according to 
general procedure D, as a yellowish highly viscous oil (335 mg, 73%). 1H NMR (250 MHz, 
CDCl3): δ = 0.70 (d, 6H, J = 6.7 Hz, 2CH3), 0.80 (d, 6H, J = 6.7 Hz, 2CH3), 1.60-1.80 (m, 
1H, CH), 1.90-2.00 (m, 1H, CH), 3.50 (dd, 1H, J = 2.1, 17.2 Hz, H-1),  3.60 (s, 3H, NCH3), 
3.70 (dd, 2H, J = 3.6, 6.6 Hz, CH2O), 3.90 (dd, 2H, J = 0.7, 6.5 Hz, CH2O), 3.90 (dd, 1H, J = 
0.7, 6.5 Hz, H-1), 4.00 (dd, 1H, J = 2.0, 8.6 Hz, H-2), 7.20 (dd, 1H, J = 1.6, 8.4 Hz, 
ArH), 7.30 (d, 1H,  J = 1.4 Hz, ArH), 7.40 (d, 1H, J = 8.4 Hz, ArH), 7.80 (s, 1H, H-4). 13C 
NMR (75 MHz, CDCl3): δ = 18.8, 18.9 (CH3), 19.3 (2CH3), 23.7 (CH2), 27.6, 28.0 (CH), 29.9 
(NCH3), 38.8 (CH, C-2), 70.6, 71.2 (CH2O), 109.4 (C), 112.7 (CH), 115.2, 117.5 (C), 119.1 
(CH), 123.9 (C), 124.1, 131.3 (CH), 138.8, 140.2 (C), 167.2, 173.1 (CO). IR (KBr): v = 3052, 
2948, 2867 (w), 1728, 1703, 1664, 1588, 1573, 1473, 1435 (s), 1392, 1379, 1325 (m), 1269, 
1244, 1189, 1140, 1079, 1040 (s), 998, 975, 934, 904, 872, 853, 813 (w), 776, 736, 691 (s), 
660, 646, 608, 576, 562 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 463 ([M+, 81Br], 4),  461 ([M, 
79Br]+, 5), 436 (54), 389(10), 299 (100), 267 (70), 225 (12), 178 (17). HRMS (EI, 70 eV): 
calcd for C23H28BrNO4 [M, 79Br]+: 461.12017; found: 461.12020. 
9.1.8        Synthesis of 2,3,6-tris(alkenyl)-N-methylindoles 24 
Trimethyl 3,3',3''-(1-methyl-1H-indole-2,3,6-triyl)triacrylate (24a). Product 24a was 
prepared starting with 15 (368 mg, 1.0 mmol), methyl 
acrylate (16a) (0.34 mL, 3.75 mmol), Pd(OAc)2 (11 
mg, 5 mol-%), SPhos (10 mol-%), DMF (5 mL), NEt3
(1.10 mL, 8.0 mmol) and tert-butyl acrylate (0.3 mL, 
3.3 mmol), at 90 °C for 36 h following general 
procedure D, as a yellowish highly viscous oil (264 mg, 69%). 1H NMR (250 MHz, CDCl3):
δ = 3.60 (s, 3H, CH3O), 3.70 (s, 3H, OCH3), 3.70 (s, 3H, NCH3), 3.80 (s, 3H, OCH3),  6.20 (d, 
1 H, J = 16.1 Hz, ArH), 6.40 (d, 1 H, J = 15.9 Hz, ArH), 6.40 (d, 1 H, J = 15.9 Hz, ArH), 
7.20-7.40 (m, 2H, ArH), 7.70 (d, 1H, J = 15.9 Hz, ArH), 7.80 (d, 1H, J = 16.2 Hz, ArH), 7.80 
(dd, 1H, J = 1.3, 7.5 Hz, ArH), 7.90 (d, 1H, J = 15.9 Hz, ArH). 13C NMR (75 MHz, CDCl3): δ
= 29.4 (CH3CN),  51.0, 52.1, 52.2 (OCH3), 108.7 (C), 110.6, 115.0, 115.3, 119.3, 119.4, 123.0 
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(CH), 125 (C), 128.9 (CH), 129.0 (C), 134.2 (CH), 136.3, 137.1 (C), 143.2 (CH), 164.4, 
165.6, 166.1 (CO). IR (KBr): v = 3028, 2950, 2848 (w), 1710, 1615, 1606 (s), 1298, 1283 
(m), 1163, 1138 (s), 1037, 973 (m), 842, 781, 767, 746, 628, 606, 585 (w) cm. GC-MS (EI, 70 
eV): m/z (%) = 383 (M+, 60), 352 (07), 324 (64), 292 (100), 265 (32), 234 (19), 204 (19). 
HRMS (EI, 70 eV): calcd for C21H21NO6 [M]+: 383.13634; found: 383.136074. 
Trihexyl 3,3',3''-(1-methyl-1H-indole-2,3,6-triyl)triacrylate (24e). Product 24e was 
prepared starting with 15 (367 
mg, 1.0 mmol), n-hexyl acrylate 
(16e) (0.66 mL, 3.75 mmol), 
Pd(OAc)2 (11 mg, 5 mol-%), 
SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 90 °C for 36 h following 
general procedure D, as a yellow highly viscous oil (437 mg, 74%). 1H NMR (250 MHz, 
CDCl3): δ  =  0.80 (t, 9 H, J = 6.6 Hz, 3CH3), 1.10-1.30 (m, 16H, 8CH2), 1.60-1.70 (m, 8H, 
4CH2), 3.80 (s, 3H, NCH3), 3.90 (t, J = 6.7 Hz, 2H, CH2), 4.10-4.30 (m, 4H, 2CH2), 6.20 (d, 
1H, J = 16.0 Hz, ArH), 6.40 (d, 1H, J = 15.9 Hz, ArH), 6.50 (d, 1H, J = 16.0 Hz, ArH), 7.20-
7.40 (m, 2H, ArH), 7.70 (d, 1H, J = 15.9 Hz, ArH), 7.70 (d, 1H, J = 16.1 Hz, ArH), 7.80 (d, 
1H, J = 8.9 Hz, ArH), 7.90 (d, 1H, J = 16.0 Hz, ArH). 13C NMR (62 MHz, CDCl3): δ = 14.0 
(3CH3), 22.6, 25.7, 28.7 (3CH2), 31.3 (CH3N), 31.5 (3CH2), 64.0, 64.7, 65.3 (CH2O), 109.5 
(C), 110.5, 117.3, 117.6 (CH), 117.6(C), 120.3, 120.4, 125.3 (CH), 126.9, 129.6 (C), 130.6, 
136.0 (CH), 137.3, 138.0 (C) 143.9 (CH), 165.0, 166.1, 167.7 (CO). IR (KBr):  v = 2953, 
2927, 2857 (m), 1703, 1610 (s), 1560, 1530 (w), 1465, 1269, 1241, 1204 (m), 1160 (s), 1037, 
979, 906, 845, 808, 764, 724, 609, 583 (w) cm−1. MS (EI, 70 eV): m/z (%) = 593 (M+, 90), 
492 (12), 463 (69), 406 (29), 380 (100), 362 (74), 336 (14), 278 (25), 234 (69). HRMS (EI, 70 
eV): calcd for C36H51NO6 [M]+: 593.37109; found: 593.36965. 
Tris(tert-butyl) 3,3',3''-(1-methyl-1H-indole-2,3,6-triyl)triacrylate (24f). Product 24f was 
synthesized starting with 15 (367 mg, 1.0 mmol), 
tert-butyl acrylate (16f) (0.55 mL, 3.75 mmol), 
Pd(OAc)2 (11 mg, 5 mol-%), SPhos (10 mol-%), 
NEt3 (1.10 mL, 8.0 mmol), DMF (5 mL) at 90 °C 
for 36 h following general procedure D, as a yellow oil (387 mg, 76 %). 1H NMR (250 MHz, 
CDCl3): δ = 1.50  (s, 9H, 3CH3), 1.50 (s, 18H, 6CH3), 3.80 (s, 3H, NCH3), 6.20 (d, 1 H, J = 
16.1 Hz, ArH), 6.40 (d, 1 H, J = 15.8 Hz, ArH), 6.40 (d, 1 H, J = 16.1 Hz, ArH), 7.30 (dd, 1H, 
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J = 1.0, 8.4 Hz, ArH), 7.40 (s, 1H, ArH), 7.70 (d, 1H, J = 16.1 Hz, ArH), 7.80 (d, 1H, J = 16.1 
Hz, ArH), 7.80 (d, 1H, J = 16.1 Hz, ArH), 7.90 (d, 1H, J = 8.5 Hz, ArH). 13C NMR (75 MHz, 
CDCl3): δ = 28.1 (3CH3), 28.2 (3CH3), 28.3 (3CH3), 31.2 (NCH3),  80.1, 80.4, 81.4 (C-O), 
110.6 (CH), 114.0 (C), 118.9, 119.5, 121.2, 121.4 (CH), 127.0 (C), 127.2, 129.9 (CH), 130.9 
(C), 135.3 (CH), 138.3, 139.0 (C), 144.0 (CH), 165.2, 166.4, 167.0 (CO). IR (KBr): v = 2976, 
2931 (w), 1699, 1621, 1614 (s), 1455, 1391, 1366 (m), 1306, 1280, 1252, 1140 (s), 1038, 975, 
844, 809, 763, 729, 609 (m), 584 (w) cm. MS (EI, 70 eV): m/z (%) = 509 (M+, 10), 453 (04),  
395 (06), 352 (13), 339 (100), 321 (53), 311 (06), 295 (38), 265 (32), 234 (29), 204 (12). 
HRMS (EI, 70 eV): calcd for C30H39NO6 [M]+: 509.27719; found: 509.27692. 
Tris(6-methylheptyl) 3,3',3''-(1-methyl-1H-indole-2,3,6-triyl)triacrylate (24g). Product
24g was synthesized 
starting with 15 (367 mg, 
1.0 mmol), Pd(OAc)2 (11 
mg, 5 mol-%), isooctyl 
acrylate (16g) (0.79 mL, 
3.75 mmol), SPhos (10 mol-
%), NEt3 (1.10 mL, 8.0 
mmol), DMF (5 mL) at 90 
°C for 36 h following general procedure D, as a yellow oil (493 mg, 73%). 1H NMR (250 
MHz, CDCl3): δ  = 0.60-1.80 (m, 45H, aliphatic protons), 3.80 (s, 3H, NCH3), 4.00-4.30 (m, 
6H, 3CH2O), 6.30 (d, 1H, J = 15.7 Hz, ArH), 6.40 (d, 1H, J = 16.4 Hz, ArH), 6.50 (d, 1H, J = 
16.1 Hz, ArH), 7.30-7.40 (m, 2H, ArH), 7.70 (d, 1H, J = 16.1 Hz, ArH), 7.80 (bd, 1H, J = 8.7 
Hz, ArH), 7.80 (d, 1H, J = 16.8 Hz, ArH), 7.80 (d, 1H, J = 15.9 Hz, ArH). 13C NMR (62 
MHz, CDCl3): δ = 13.0, 14.6, 15.2 (CH3), 20.1, 22.9, 24.5, 25.9, 26.7, 27.5 (CH2), 31.2 
(NCH3), 45.6 (CH2), 63.0, 63.8, 65.6 (CH2O), 110.6 (CH), 114 (C), 117.0, 117.9, 121.3, 
121.4, 125.3 (CH), 126.9, 130.7 (C), 130.9, 136.0 (CH), 138.3, 139.0 (C), 145 (CH), 165.9, 
167.3, 167.7 (CO). IR (KBr): v = 2955, 2927, 2870 (m), 1705, 1623 (s), 1561, 1533 (w), 1463 
(s) 1380 (w), 1267, 1234, 1161 (s), 1036, 977, 845, 808, 768, 740, 609 (w) cm−1. MS (EI, 70 
eV): m/z (%) = 677 (M+, 90), 563 (16), 519 (60), 436 (38), 408 (69), 390 (59), 295 (30), 278 
(34), 252 (22), 226 (06), 208 (10), 194 (11). HRMS (EI, 70 eV): calcd for C42H63NO6 [M]+: 
677.46499; found: 677.463279. 
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9.1.9 Synthesis of 6-alkenyl-2,3-dihydrocarbazoles 25
Dimethyl 7-(3-methoxy-3-oxoprop-1-enyl)-9-methyl-2,9-dihydro-1H-carbazole-2,3-
dicarboxylate (25a). Compound 25a was prepared 
starting with 15 (367 mg, 1.0 mmol), methyl acrylate 
(16a) (0.34 mL, 3.75 mmol), Pd(OAc)2 (11 mg, 5 
mol-%), SPhos (10 mol-%), NEt3 (1.1o mL, 8.0 
mmol), DMF (5 mL) at 120 °C  for 48 h according to general procedure B, as a brownish 
highly viscous oil (302 mg, 79%). 1H NMR (250 MHz, CDCl3): δ = 3.00 (dd, 1H, J = 8.5, 
17.3 Hz, H-1), 3.50 (s, 3H, NCH3), 3.60 (dd, 1H, J = 2.4, 17.3 Hz, H-1), 3.60 (s, 3H, OCH3), 
3.70 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 4.00 (dd, 1H, J = 2.4, 8.8 Hz, H-2), 6.40 (d, 1H, J = 
15.9 Hz, ArH), 7.30-7.40 (m, 2H, ArH), 7.50 (d, 1H, J = 8.6 Hz, ArH), 7.70 (d, 1H, J = 15.9 
Hz, ArH), 7.90 (s, 1 H, H-4). 13C NMR (75 MHz, CDCl3): δ = 23.0 (CH2), 29.7 (CH, C-4), 
38.7 (NCH3), 51.6 (OCH3), 51.8 (OCH3), 52.6 (OCH3), 108.7, 110.4 (CH), 114.6, 115.9 
(CH), 117.3, 120.0 (CH), 125.8, 127.4, 131.0 (CH), 137.2, 141.0, 145.0 (CH), 166.5, 166.8, 
172.5 (C). IR (KBr): v = 2999, 2950, 2846 (w), 1709 (s), 1628, 1605, 1270, 1231, 1188, 1166, 
1110, 1040, 1060 (m), 973, 803 (s), 778 (s), 727 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 383 
[M]+, 353 (69), 323 (61), 293 (40), 284 (51), 189 (31), 102 (100), 77 (22). HRMS (EI, 70 eV): 
calcd for C21H21NO6 [M]+: 383.13689; found: 383.13632.
Diethyl 7-(3-ethoxy-3-oxoprop-1-enyl)-9-methyl-2,9-dihydro-1H-carbazole-2,3 
dicarboxylate (25b). Product 25b was synthesized 
starting with 15 (367 mg, 1.0 mmol), ethyl acrylate (16b) 
(0.41 mL, 3.75 mmol), Pd(OAc)2 (11 mg, 5 mol-%), 
SPhos (10 mol-%), NEt3 (1.1o mL, 8.0 mmol), DMF (5 
mL) at 120 °C  for 48 h following general procedure B, 
as yellowish highly viscous oil (410 mg, 78%). 1H NMR (250 MHz, CDCl3): δ  =  1.10 (t, 3H,
J = 7.3 Hz, CH3), 1.20 (t, 3H, J = 7.1 Hz, CH3), 1.30 (t, 3H, J = 7.0 Hz, CH3), 3.00 (dd, 1H, J
= 8.8, 17.2 Hz, H-1),  3.50 (dd, 1H, J = 2.4, 17.2 Hz, H-1), 3.60 (s, 3H, NCH3), 3.80-4.10 (m, 
3H and 1H, H-2 and CH2O), 4.10-4.30 (m, 4H, 2CH2O), 6.40 (d, 1H, J = 15.9 Hz), 7.30 (m, 
2H,  ArH), 7.50 (d, 1H, J = 8.5 Hz, ArH), 7.70 (d, 1H, J = 15.8 Hz), 7.80 (s, 1H, H-4). 13C 
NMR (62 MHz, CDCl3): δ = 14.0 (CH3), 14.4 (CH3), 14.5 (CH3), 23.8 (CH2),  29.8 (NCH3), 
38.8 (CH, C-2), 60.3 (CH2O), 60.4 (CH2O), 61.2 (CH2O), 109.6 (C), 110.2, 115.9 (CH), 117.4 
(C), 118.2, 120.8 (CH), 126.7, 128.3 (C), 131.5 (CH), 138.1, 141.8 (C), 145.7 (CH), 167.1, 
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167.3, 173.0 (CO). IR (KBr): v = 2979, 2931 (m), 1731, 1697, 1606 (s), 1475, 1274 (m), 
1227, 1168 (s), 1034, 982, 962, 852, 811, 771, 710 (s), 605, 582 (w) cm. MS (EI, 70 eV): m/z
(%) = 425 (M+, 76), 380 (12), 352 (100), 324 (23), 306 (98), 279 (77), 262 (30), 251 (16), 234 
(92), 206 (22). HRMS (EI, 70 eV): calcd for C24H27NO6 [M]+: 425.18329; found: 425.18236. 
Dibutyl 7-(3-butoxy-3-oxoprop-1-enyl)-9-methyl-2,9-dihydro-1H-carbazole-2,3-
dicarboxylate (25c). Product 25c was 
prepared, following general procedure B, 
starting with 15 (367 mg, 1.0 mmol), 
Pd(OAc)2 (11 mg, 5 mol-%), n-butyl 
acrylate (16c) (0.53 mL, 3.75 mmol), 
SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 
mmol), DMF (5 mL) at 120 °C  for 48 h 
as a yellow solid (483 mg, 95%). Mp 112-114 °C. 1H NMR (250 MHz, CDCl3): δ  =  0.80 (t, 
3H, J = 7.3 Hz, CH3), 0.90 (t, 3H, J = 7.3 Hz, CH3), 0.90 (t, 3H, J = 7.3 Hz, CH3), 1.10-1.30 
(m, 2H, CH2), 1.30-1.50 (m, 6H, 3CH2), 1.60-1.70 (m, 4H, 2CH2), 3.00 (dd, 1H, J = 8.6, 17.2 
Hz, H-1),  3.60 (dd, 1H, J = 2.2, 17.2 Hz, H-1), 3.70 (s, 3H, NCH3), 3.80-4.00 (m, 2H, 
CH2O), 4.00 (dd, 1H, J = 1.9, 8.6 Hz, H-2), 4.10-4.20 (m, 4H, 2CH2O), 6.40 (d, 1H, J = 15.8 
Hz, CH), 7.20-7.30 (m, 2H, ArH), 7.50 (d, 1H, J = 8.3 Hz, ArH), 7.70 (d, 1H, J = 16.1 Hz, 
ArH), 7.80 (s, 1H, H-4). 13C NMR (75 MHz, CDCl3): δ = 13.6 (CH3), 13.7 (CH3), 13.8 (CH3), 
19.0 (CH2), 19.2 (CH2), 19.3 (CH2), 24.0 (CH2), 29.9 (CH3), 30.4 (CH2), 30.8 (CH2), 31.0 
(CH2), 38.8 (NCH3), 64.3 (CH2O), 64.4 (CH2O), 65.1 (CH2O), 109.7 (C), 110.2, 116.0 (CH), 
117.6 (C), 118.2, 120.8 (CH), 126.7, 128.4 (C), 131.4 (CH), 138.2, 141.8 (C), 145 (CH), 
167.2, 167.5, 173.1 (CO). IR (KBr): v = 2954, 2931 (m), 1721, 1703, 1676 (s), 1469, 1277 
(m), 1219, 1167 (s), 1042, 998, 960, 854 (w), 821, 770, 735 (m), 605, 582, 553 (w) cm. MS 
(EI, 70 eV): m/z (%) = 509 ([M]+, 78), 436 (14), 408 (72), 378 (20), 352 (100), 334 (94), 308 
(18), 278 (31), 234 (94). HRMS (EI, 70 eV): calcd for C30H39NO6 [M]+: 509.27719; found: 
509.276955.  
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 Di(isobutyl) 7-(3-isobutoxy-3-oxoprop-1-enyl)-9-methyl-2,9-dihydro-1H-carbazole-2,3-
dicarboxylate (25d). Product 25d was prepared 
starting with 15 (367 mg, 1.0 mmol), iso-butyl 
acrylate (16d) (0.54 mL, 3.75 mmol), Pd(OAc)2 
(11 mg, 5 mol-%), SPhos (10 mol-%), NEt3
(1.10 mL, 8.0 mmol), DMF (5 mL) at 120 °C  
for 48 h following general procedure B, as a 
yellow semisolid (363 mg, 72%). 1H NMR (250 
MHz, CDCl3): δ = 0.70 (d, 6H, J = 6.7 Hz, 2CH3), 0.90 (dd, 12H, J = 3.4, 6.7 Hz, 4CH3), 
1.70-1.80 (m, 1H, CH), 1.90-2.00 (m, 2H, CH), 3.00 (dd, 1H, J = 8.7, 17.2 Hz, H-1),  3.60 
(dd, 1H, J = 2.0, 17.2 Hz, H-1), 3.60-3.70 (m, 5H, NCH3 and CH2O), 3.90-4.00 (m, 4H, 
2CH2O), 4.10 (dd, 1H, J = 2.0, 8.5 Hz, H-2), 6.20 (d, 1H, J = 15.8 Hz, ArH),  7.30 (d, 1H, J
= 8.4 Hz, ArH), 7.40 (s, 1H, ArH), 7.60 (d, 1H, J = 8.2 Hz, ArH), 7.80 (d, 1H, J = 15.9 Hz, 
ArH), 7.90 (s, 1H, H-4). 13C NMR (75 MHz, CDCl3):  δ = 18.8 (CH3), 18.9 (CH3), 19.2 
(2CH3), 19.3 (2CH3), 23.9 (CH2), 27.6, 27.9, 28.0 (CH), 29.9 (NCH3), 38.8 (CH, C-2), 70.5, 
70.6, 71.2 (CH2O), 109.7 (C), 110.3, 116.3 (CH), 117.6 (C), 118.2, 120.9 (CH), 126.7, 128.4 
(C), 131.3 (CH), 138.2, 141.9 (C), 145.7(CH), 167.1, 167.5, 173.0 (CO). IR (KBr): v = 2956, 
2872 (w), 1715, 1693 (s), 1633, 1608, 1529, 1494, 1468, 1454, 1392, 1375, 1355, 1309, 1278 
(m), 1228, 1205, 1166 (s), 1110, 1086, 1038, 1017, 989 (m), 942, 930, 852, 832, 799, 779, 
756, 731, 705, 650, 615, 600, 550 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 507 ([M-2]+ 
(carbazole), 100), 451 (36), 407 (22), 378 (78), 352 (29), 278 (18), 251 (11), 234 (25), 204 
(12). HRMS (EI, 70 eV): calcd for C30H37NO6 [M-2]+ (carbazole): 507.26154; found: 
507.26138. 
Dihexyl 7-(3-(hexyloxy)-3-oxoprop-1-enyl)-9-methyl-2,9-dihydro-1H-carbazole-2,3- 
dicarboxylate (25e). Product
25e was prepared, starting with 
15 (367 mg, 1.0 mmol), n-hexyl 
acrylate (16e) (0.66 mL, 3.75 
mmol), Pd(OAc)2 (11 mg, 5 mol-
%), SPhos (10 mol-%), NEt3
(1.10 mL, 8.0 mmol), DMF (5 
mL) at 120 °C  for 48 h following general procedure B, as a yellowish highly viscous oil (435 
mg, 74%). 1H NMR (300 MHz, CDCl3): δ  =  0.70 (t, 3H, J = 6.9 Hz, CH3), 0.80 (t, 3H, J = 
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6.3 Hz, CH3), 0.80 (t, 3H, J = 6.9 Hz, CH3), 1.00-1.20 (m, 6H, 3CH2), 1.20-1.40 (m, 14H, 
7CH2), 1.60-1.70 (m, 4H, 2CH2), 3.00 (dd, 1H, J = 8.6, 17.1 Hz, H-1),  3.60 (dd, 1H, J = 
2.1, 17.1 Hz, H-1), 3.70 (s, 3H, NCH3), 3.80-4.00 (m, 2H, CH2O),  4.00 (dd, 1H, J = 2.1, 8.7 
Hz, H-2), 4.10 (t, 2H, J = 6.8 Hz, CH2O), 4.20 (t, 2H, J = 6.8 Hz, CH2O), 6.40 (d, 1H, J = 
15.8 Hz, ArH), 7.30 (d, 1H, J = 8.4 Hz, ArH), 7.30 (s, 1H, ArH), 7.50 (d, 1H, J = 8.1 Hz, 
ArH), 7.70 (d, 1H, J = 16.0 Hz, CH), 7.80 (s, 1H, H-4). 13C NMR (62 MHz, CDCl3): δ = 13.9 
(CH3), 14.0 (2CH3), 22.4 (CH2), 22.5 (2CH2), 23.9, 25.4, 25.6, 25.7, 28.4, 28.7, 28.8 (CH2), 
29.9 (NCH3), 31.3, 31.4, 31.5 (CH2), 38.8, C(2)H), 64.5, 64.7, 65.3 (CH2O), 109.7 (C), 110.2, 
116.0 (CH), 117.6 (C), 118.2, 120.8 (CH), 126.7, 128.4 (C), 131.4 (CH), 138.1, 141.8 (C), 
145,7 (CH), 167.1, 167.4, 173.1 (CO). IR (KBr):  v
 = 2954, 2928, 2857 (m), 1715, 1695, 
1629, 1605 (s), 1558, 1527, 1488 (w), 1471(w), 1395, 1303, 1278 (m), 1245, 1228 (w), 1162 
(s), 974, 908, 848, 821, 754, 730, 700, 607, 592 (w) cm−1. MS (EI, 70 eV): m/z (%) = 593 
([M]+, 62), 492 (09), 464 (41), 406 (07), 380 (100), 362 (72), 336 (08), 278 (20), 251 (9), 234 
(53). HRMS (EI, 70 eV): calcd for C36H51NO6 [M]+: 593.37109; found: 593.37046. 
Di(tert-butyl) 7-(3-tert-butoxy-3-oxoprop-1-enyl)-9-methyl-2,9-dihydro-1H-carbazole-
2,3-dicarboxylate (25f). Product 25f was synthesized 
starting with 15 (367 mg, 1.0 mmol), Pd(OAc)2 (11 
mg, 5 mol-%), tert-butyl acrylate (16f) (0.55 mL, 3.75 
mmol), SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 
mmol), DMF (5 mL) at 120 °C  for 48 h  following 
general procedure B, as a yellow oil (401 mg, 79%).
1H NMR (250 MHz, CDCl3): δ = 1.30 (s, 9H, 3CH3), 1.40 (s, 9H, 3CH3), 1.50 (s, 9H, 3CH3), 
3.00 (dd, 1H, J = 8.7, 17.1 Hz, H-1),  3.60 (dd, 1H, J = 2.2, 17.1 Hz, H-1), 3.70 (s, 3H, 
NCH3), 3.90 (dd, 1H, J = 2.2, 8.7 Hz, H-2), 6.30 (d, 1H, J = 16.0 Hz, ArH), 7.30 (dd, 1H, J = 
1.2, 8.2 Hz, ArH),  7.30 (s, 1H, ArH), 7.50 (d, 1H, J = 8.2 Hz, ArH),  7.60 (d, 1H, J = 15.9 
Hz, ArH), 7.70 (s, 1H, H-4). 13C NMR (75 MHz, CDCl3): δ = 23.6 (CH2), 27.9, 28.2, 28.3 
(3CH3), 29.8 (NCH3), 39.6 (CH, C-2), 78.9, 79.2, 80.1 (C-O), 108.5 (C), 109.9, 116.7, 117.2 
(CH), 118.6, (C), 119.6 (CH), 125.6, 127.3 (C), 130 (CH), 137.1, 140.7 (C), 143.8 (CH), 
165.5, 165.7, 171.2 (C=O). IR (KBr): v = 2976, 2931 (w), 1705 (s), 1631, 1612, 1469, 1461, 
1454, 1391 (w), 1366, 1277, 1255 (m), 1147 (s), 1113, 1080, 1041, 980, 846, 812, 791, 765, 
608 (w) cm. MS (EI, 70 eV): m/z (%) = 509 ([M]+, 02), 507 (33), 451 (51), 395 (39), 378 
(15), 339 (95), 321 (100), 295 (17), 277 (34), 249 (80), 204 (12), 176 (5). HRMS (EI, 70 eV): 
calcd for C30H37NO6 ([M-2H]+ (carbazole): 507.26154; found: 507.26178.
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Bis(6-methylheptyl) 9-methyl-7-(3-(6-methylheptyloxy)-3-oxoprop-1-enyl)-2,9-dihydro-
1H-carbazole-2,3-
dicarboxylate (25g). 
Compound 25g was 
synthesized starting with 15
(367 mg, 1.0 mmol), isooctyl 
acrylate (16g) (0.79 mL, 3.75 
mmol), Pd(OAc)2 (11 mg, 5 mol-%), SPhos (10 mol-%), NEt3 (1.10 mL, 8.0 mmol), DMF (5 
mL) at 120 °C  for 48 h following general procedure B, as a yellow oil (501 mg, 74%). 1H 
NMR (250 MHz, CDCl3): δ = 0.60-1.80 (m, 45H, aliphatic), 3.00 (dd, 1H, J = 8.9, 17.2 Hz, 
H-1),  3.60-3.70 (m, 4H, 1 x H-1 and NCH3), 3.90-4.30 (m, 7H, 3CH2O and H-2),  6.40 (d, 
1H, J = 15.9 Hz, ArH),  7.30-7.40 (m, 2H, ArH), 7.50 (d, 1H, J = 8.8 Hz, ArH), 7.80 (d, 1H, J
= 16.4 Hz), 7.90 (s, 1H, H-4). 13C NMR (75 MHz, CDCl3): δ  = 12.2 (2CH3), 14.1 (2CH3), 
14.4 (2CH3), 19.6, 23.4, 29.1 (CH2), 25.0, 27.0 (CH),  29.9 (CH3N), 31.9 (CH), 38.8 (CH, C-
2), 46.5, 46.6, 46.7 (CH2), 64.9, 65.0, 65.3 (CH2O), 108.7 (C), 109.2, 115.0 (CH), 116.6 (C), 
117.2, 119.9 (CH), 125.7, 127.6 (C), 130.4 (CH), 137.2, 140.9 (C), 145.7 (CH), 166.1, 166.5, 
172.1 (CO). IR (KBr): v = 2955, 2927 (w), 1704, 1631, 1608 (s), 1562, 1527 (w), 1462, 1382, 
1366, 1305 (m), 1267, 1228, 1206, 1161 (s), 1112, 1084, 1039, 847, 809, 780 (m), 609, 581 
(w) cm. MS (EI, 70 eV): m/z (%) = 677 ([M]+, 100), 563 (21), 548 (14), 519 (44), 434 (60), 
408 (99), 390 (81), 234 (44). HRMS (EI, 70 eV): calcd for C42H63NO6 [M]+: 677.46499; 
found: 677.46337. 
9.1.10       Synthesis of 6-alkenylcarbazoles 26 
(E)-Dimethyl 7-(3-methoxy-3-oxoprop-1-enyl)-9-methyl-9H-carbazole-2,3-dicarboxylate 
(26a). Starting with 25a (100 mg) following general 
procedure C, 26a was isolated as a yellow oil (98 mg, 
100%). 1H NMR (300 MHz, CDCl3): δ = 3.77 (s, 3H, 
CH3N),  3.83 (s, 3H, CH3O),  3.89 (s, 3H, CH3O), 3.91 
(s, 3H, CH3O),  6.51 (d, 1H J = 16.0 Hz), 7.44 (d, 1H,  
J = 8.2 Hz,  ArH), 7.49 (s, 1H, ArH), 7.59 (s, 1H,  ArH), 7.82 (d, 1 H,  J = 16.0 Hz, ArH), 
8.03 (d, 1H, J = 8.1 Hz, ArH), 8.48 (s, 1 H, ArH); 13C NMR (62.9 MHz, CDCl3): δ = 29.5 
(CH3N), 51.8, 52.5, 52.8 (CH3O), 109.2, 109.3, 118.0, 120.1, 121.3 (CH) 121.7 (C), 122.9 
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(CH), 123.3, 123.9, 131.4, 133.5, 142.3, 142.4 (C), 145.3 (CH), 167.4, 168.0, 169.4 (CO);  IR 
(KBr): v = 3047, 3004, 2917, 2848 (w), 1708 (s), 1627 (m), 1563, 1498 (w), 1431 (m), 1376 
(w), 1351, 1314 (m), 1272, 1259, 1245, 1232, 1173, 1110 (s), 1080, 1039, 974, 964 (m), 930, 
900, 881 (w), 839, 826,803, 777, 760 (m), 747, 729 (w), 711, 653, 603, 584 (m), 551(w) cm. 
GC-MS (EI, 70 eV): m/z (%) = 381 ([M]+, 100), 351 (16), 350 (80), 204 (11), 159 (42), 145 
(22); HRMS: m/z calcd for C21H19NO6 [M]+: 381.12069; found: 381.120947.
(E)-Diethyl 7-(3-ethoxy-3-oxoprop-1-enyl)-9-methyl-9H-carbazole-2,3-dicarboxylate
(26b). Starting with 25b (100 mg) following 
general procedure C, 26b was prepared as a yellow 
oil (98 mg, 100%). 1H NMR (300 MHz, CDCl3): δ  
=  1.23 (t, 3H, J = 7.1 Hz, CH3), 1.31 (t, 3H, J = 7.1 
Hz, CH3), 1.32 (t, 3H, J = 7.1 Hz, CH3), 3.81 (s, 3H, 
CH3N), 4.20 (q, 2H, J = 7.0 Hz, CH2O), 4.31 (q, 2H, J = 7.0 Hz, CH2O), 4.31 (q, 2H, J = 7.0 
Hz, CH2O), 6.51 (d, 1H, J = 15.7 Hz), 7.40 (d, 1H, J = 7.9 Hz, ArH), 7.41 (s, 1H, ArH), 7.51 
(s, 1H, ArH), 7.80 (d, 1H, J = 15.7 Hz), 8.02 (d, 1H, J = 7.9 Hz, ArH), 8.41 (s,1H, ArH); 13C 
NMR (62 MHz, CDCl3): δ = 14.1 (CH3), 14.3 (CH3), 14.4 (CH3),  29.4 (CH3N), 60.5, 61.4, 
61.8 (CH2O), 109.0, 109.2, 118.4, 120.0, 121.3 (CH) 122.1 (C) 122.7 (CH), 123.1, 123.8, 
131.7, 133.4, 142.2, 142.3 (C), 145.0 (CH), 167.0, 167.5, 169.0 (CO). IR (KBr): v = 2979, 
2849 (m), 1703 (s), 1628, 1604, 1560, 1498, 1473, 1391, 1373, 1343, 130 (m), 1258, 1240, 
1227 (s), 1173, 1108, 1078, 1039, 975 (m), 908, 874, 842, 804 (w), 779, 730, 664, 606, 585 
(s) cm. GC-MS (EI, 70 eV): m/z (%) = 423 ([M]+, 99), 378 (6), 349 (41), 322 (6), 162 (7), 153 
(100), 139 (58) ; HRMS: m/z calcd for C24H25NO6 [M]+: 423.16764; found: 423.16659.
(E)-Dibutyl 7-(3-butoxy-3-oxoprop-1-enyl)-9-methyl-9H-carbazole-2,3-dicarboxylate
(26c). Starting with 25c (100 mg) following 
general procedure C, 26c was prepared as a 
yellow oil (99 mg, 100%). 1H NMR (300 
MHz, CDCl3): δ  =  0.81 (t, 3H, J = 7.4 Hz, 
CH3), 0.91 (t, 3H,  J = 7.4 Hz, CH3), 0.93 (t, 
3H, J = 7.4 Hz, CH3), 1.10-1.31 (m, 2H, CH2), 1.31-1.52 (m, 6H, 3CH2), 1.57-1.71 (m, 4H, 
2CH2), 3.71 (s, 3H, CH3N), 4.22 (t, 2H, J = 6.9 Hz, CH2O),  4.31 (t, 2H,  J = 6.6 Hz, CH2O), 
4.34 (t, 2H,  J = 6.6 Hz, CH2O), 6.52 (d, 1H, J = 16.1 Hz, CH), 7.42 (d, 1H,  J = 8.5 Hz,  
ArH), 7.51 (s, 1H, ArH), 7.62  (s, 1H, ArH), 7.80 (d, 1H, J = 15.3 Hz, CH), 8.01  (d, 1H,  J = 
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7.6 Hz, ArH), 8.51 (s, 1H, ArH); 13C NMR (62.9 MHz, CDCl3): δ = 13.8 (3CH3), 19.3 
(3CH2), 29.5 (CH3N),   30.6, 30.7, 30.8 (CH2), 64.5, 65.4, 65.8 (CH2O), 109.1, 109.2, 118.4, 
120.1, 121.3 (CH), 122.3 (C), 122.7 (CH), 123.2, 123.9, 131.8, 133.5, 142.3, 142.4 (C), 145.0 
(CH), 167.1, 167.6, 169.1 (CO). IR (KBr): v = 2931 (w), 1706, 1627, 1602, 1563, 1500, 1455, 
1387, 1343 (w), 1258 (m), 1223, 1163, 1106, 1077, 1038, 977, 901, 843, 810, 779, 738, 715, 
663, 609, 583 (s) cm. (EI, 70 eV): m/z (%) = 507 ([M]+, 100), 434 (6), 378 (33), 332 (7), 278 
(4); HRMS: m/z calcd for C30H37NO6 [M]+: 507.26154; found: 507.26156. 
(E)-Dihexyl 7-(3-(hexyloxy)-3-oxoprop-1-enyl)-9-methyl-9H-carbazole-2,3-dicarboxylate
(26e). Starting with 25e (100 mg)
following general procedure C, 26e
was isolated as yellow oil (98 mg, 
100%).   1H NMR (300 MHz, 
CDCl3): δ  =  0.81 (t, 3H, J = 6.9 Hz, 
CH3), 0.82 (t, 6H, J = 7.0 Hz, 2CH3),  1.21-1.33 (m, 12H, 6CH2), 1.30-1.41 (m, 6H, 3CH2), 
1.61-1.70 (m, 6H, 3CH2), 3.81 (s, 3H, CH3N), 4.10 (t, 2H, J = 6.7 Hz, CH2O), 4.21 (t, 2H, J = 
7.0 Hz, CH2O), 4.32 (t, 2H, J = 7.0 Hz, CH2O), 6.52 (d, 1H, J = 16.2 Hz), 7.41 (d, 1H, J = 8.1 
Hz, ArH),  7.51 (s, 1H, ArH), 7.63 (s, 1H, ArH), 7.81 (d, 1H, J = 16.2 Hz), 8.01 (d, 1H, J = 
8.1 Hz, ArH), 8.41 (s, 1H, ArH); 13C NMR (75 MHz, CDCl3): δ  = 13.0 (3CH3), 22.6 (4CH2), 
24.5 (3CH2), 27.5, 27.6, 27.7 (CH2), 28.4 (CH3N ), 30.5 (2CH2),  63.8, 64.7, 65.1 (CH2O), 
108,0, 108.2, 117.4, 119.0 , 120.3 (CH), 121.2 (C), 121.7 (CH), 122.1, 122.9, 130.8, 132.4, 
141.2 ,141.3 (C), 144.0 (CH), 166.1, 166.6, 168.1 (CO). IR (KBr): v = 2927 (w), 1708 (s), 
1627, 1602, 1563, 1500, 1455, 1388, 1369, 1343, 1305 (m), 1259, 1224, 1163, 1108 (s), 1078, 
1038, 979, 905, 845, 810, 781, 725, 663, 642, 609, 583,543 (w) cm. (EI+, 70 eV): m/z (%) = 
591 ([M]+, 100), 406 (26), 322 (05), 43 (08); HRMS: m/z calcd for C36H49NO6 [M]+: 
591.35544; found: 591.35593. 
(2E,2'E)-Diethyl 3,3'-(1-methyl-1H-indole-2,6-diyl)diacrylate OR (2E,2'E)-diethyl 3,3'-
(1-methyl-1H-indole-3,6-diyl)diacrylate (27). Product 27 was found as byproduct of 25b as 
a light brown oil. 1H NMR 
(250 MHz, CDCl3): δ  = 
 1.19-1.31 (m, 6H, 2CH3), 
3.78 (s, 3H, NCH3), 4.16-
4.26 (m, 4H, 2CH2O), 6.41 
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(d, 1H, J = 15.9 Hz, CH), 6.44 (d, 1H, , J = 15.7 Hz, CH), 6.87 (s, 1H, ArH), 7.27 (dd, J = 1.2, 
8.5, ArH), 7.3 (s, 1H, ArH), 7.50 (d, 1H, J = 8.5 Hz, ArH), 7.70 (d, 1H, J = 15.4 Hz, ArH), 
7.73 (d, 1H, J = 15.4 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 14.4, 30.1 (NCH3), 60.4, 
60.7 (CH2O), 102.7, 110.5, 116.6, 119.4, 119.9, 121.6 (CH), 128.1, 128.9 (C), 131.0 (CH), 
136.0, 138.0 (C), 144.7 (CH), 165.8, 166.3 (CO). IR (KBr): v = 2978, 2929, 2852 (w), 1705, 
1699, 1628, 1604 (s), 1464, 1362, 1302, 1284, 1261, 1242 (m), 1157, 1137, 1090, 1032, 975, 
964 (s), 867 (m), 805 (s), 744, 700, 646, 600, 582 cm−1. MS (EI, 70 eV): m/z (%) = 327 (M+, 
100), 282 (15), 255 (04), 180 (05). HRMS (EI, 70 eV): calcd for C23H29NO4 [M]+: 327.14706; 
found: 327.14715. 
9.1.10 (2E,2'E)-Dibutyl 3,3'-(3-formyl-1-methyl-1H-indole-2,6-diyl)diacrylate 30  
Product 30 was prepared starting with 29 (158 mg, 0.5 mmol), butyl acrylate (16c) (0.18 mL, 
1.25 mmol), Pd(OAc)2 (11 mg, 5 mol-%), SPhos 
(10 mol-%), NEt3 (0.50 mL, 4.0 mmol), DMF (5 
mL) at 120 °C for 36 h following general 
procedure D, as a brownish oil (147 mg, 72%). 1H 
NMR (300 MHz, CDCl3): δ  =  0.89 (t, 3H, J = 
7.4 Hz, CH3), 0.90 (t, 3H, J = 7.3 Hz, CH3), 1.42-
1.61 (m, 4H, 2CH2), 1.63-1.71 (m, 4H, 2CH2), 3.71 (s, 3H, NCH3), 4.18 (t, 2H, J = 6.9 Hz, 
CH2O), 4.19 (t, 2H, J = 6.6,  CH2O), 6.46 (d, 1H, J = 15.9 Hz, CH), 6.51 (d, 1H, , J = 16.1 
Hz, CH), 7.42-7.50 (m, 2H, ArH), 7.73 (d, 1H, J = 16.2 Hz, CH), 8.30 (d, 1H, J = 7.4 Hz, 
ArH), 10.13 (s, 1H, CHO). 13C NMR (75.5 MHz, CDCl3): δ = 13.7, 13.8 (CH3), 19.1, 19.2, 
30.6, 30.8 (CH2), 31.3 (NCH3),  64.5, 65.3 (CH2O), 110.2 (CH), 117.1 (C),  118.1, 122.6, 
123.1 (CH), 127.2 (C), 128.6, 129.6 (CH), 131.6, 138.1, 143.1 (C), 144.7 (CH), 165.4, 167.1 
(CO), 184.7 (CH). IR (KBr): v = 2958, 2932, 2873 (m), 1706, 1617, 1476 (s), 1364, 1327 (w), 
1274, 1235, 1166 (s), 1132, 1115, 1061, 1046, 1027, 968, 844, 8215 (m), 740 (s), 561 (w) 
cm−1. MS (EI, 70 eV): m/z (%) = 411 (M+, 02), 384 (02), 379 (12), 310 (100), 254 (09). 
HRMS (ESI+): calcd for C24H30NO5 [M+H]: 412.21185; found: 412.21191. 
N
O
O
O
H
O
O
74
74
9.2 Efficient Synthesis of Functionalized Benzofurans by Domino ′Twofold Heck / 6π-
Electrocyclization′ Reactions   
9.2.1    Synthesis of 2,3-bis(alkenyl)furans 32  
General procedure A for the synthesis of 32a-h:. In a pressure tube (glass bomb) a suspension 
of Pd(OAc)2 (12 mg, 5 mol %) and XPhos or SPhos (10 mol %) in DMF (5 mL) was purged 
with Ar and stirred at 20 °C to give a yellowish or brownish clear solution. To the stirred 
solution were added 2, 3-dibromofuran (31) (0.12 ml, 1.0 mmol), NEt3 (1.1 mL, 8.0 mmol) 
and the acrylate (2.5 mmol). The reaction mixture was stirred at 120 ˚C (or mentioned) for 
36h. The solution was cooled to 20 °C, poured into H2O and CH2Cl2  (25 mL each), and the 
organic and the aqueous layer were separated. The latter was extracted with CH2Cl2 (3 x 25 
mL). The combined organic layers were dried (Na2SO4), and concentrated in vacuo. The 
residue was purified by chromatography (flash silica gel, heptanes/EtOAc).  
(2E,2'E)-Dimethyl 3,3'-(furan-2,3-diyl)diacrylate (32a). Following the general procedure A
32a was isolated as light yellow oil (172 mg, 73%). 1H NMR (300 MHz, 
CDCl3):  δ = 3.72 (s, 3H, CH3O), 3.74 (s, 3H, CH3O), 6.16 (d, 1H, J = 
15.8 Hz, CH), 6.34 (d, 1H, J = 15.8 Hz, CH), 6.57 (d, 1H, J = 2.2 Hz, 
ArH), 7.38 (d, 1H, J = 1.7 Hz, ArH), 7.55 (d, 1H, J = 15.8 Hz, CH), 7.62 
(d, 1H, J = 15.8 Hz, CH). 13C NMR (75.5 MHz, CDCl3): δ = 51.79, 51.85 (CH3O), 109.4, 
117.8, 119.8 (CH), 124.8 (C), 127.4, 132.7, 145.2 (CH), 150.5 (C), 166.9, 167.0 (CO). IR 
(KBr): v
 = 3100, 3108 (w), 2850 (m), 1711 (s), 1676 (w), 1631 (m), 1510 (w), 1445, 1292 
(m), 1275, 1245, 1178 (s), 1035, 1970, 872, 749 (m), 861, 756 (w), 721 (m), 530 (m), cm. 
GC-MS (EI, 70 eV): m/z (%) = 236 ([M]+, 11), 230 (14), 213 (29), 187 (100), 173 (05), 151 
(06), 111 (04). HRMS (EI, 70 eV): calcd for C12H12O5 [M]+: 236.06847; found: 236.06801. 
(2E,2'E)-Isobutyl 3,3'-(furan-2,3-diyl)diacrylate (32c). Following the general procedure A
32c was isolated as light yellow oil (297 mg, 93%). 1H NMR (300 
MHz, CDCl3):  δ = 0.89 (d, 12H, J = 6.8 Hz, 4CH3), 1.86-1.97 (m, 
2H, 2CH), 3.90 (d, 2H, J = 6.7 Hz, CH2O), 3.91 (d, 2H, J = 6.7 Hz, 
CH2O), 6.17 (d, 1H, J = 15.6 Hz, CH), 6.35 (d, 1H, J = 15.6 Hz, CH), 
6.58 (d, 1H, J =1.8 Hz, ArH), 7.37 (d, 1H, J = 2.0 Hz, ArH), 7.55 (d, 
1H, J = 15.6 Hz, CH), 7.59 (d, 1H, J = 15.6 Hz, CH). 13C NMR (62.9 MHz, CDCl3): δ = 19.1 
(4CH3), 27.8 (2CH), 70.7, 70.8 (CH2O), 109.3, 118.2, 120.3 (CH), 124.7 (C), 127.2, 132.4, 
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145.1 (CH), 150.5 (C), 166.4, 166.5 (CO). IR (KBr): v = 3000, 3119 (w), 2935 (s), 2852 (m), 
1711 (s), 1631 (m), 1579, 1509 (w), 1290 (m), 1272, 1257 (s),  1045, 1968, 832, 740 (m), 
8761, 746 (w), 658,  606 (w), 530 (m), cm. GC-MS (EI, 70 eV): m/z (%) = 320 ([M]+, 71), 
305 (18), 290 (11), 262 (11), 249 (20), 189 (17), 153 (19). HRMS (EI, 70 eV): calcd for 
C18H24O5 [M]+: 320.16237; found: 320.16360. 
(2E, 2'E)-Dibutyl 3,3'-(furan-2, 3-diyl) Diacrylate (32d). Following the general procedure 
32d  was isolated as light yellow oil (249 mg, 78%). 1H NMR (300 
MHz, CDCl3): δ = 0.86 (t, 6H, J = 7.3 Hz, 2CH3), 1.28-1.40 (m, 4H, 
2CH2), 1.56-1.65(m, 4H, 2CH2), 4.10-4.15 (m, 4H, 2CH2O), 6.14 (d, 1H, 
J = 15.6 Hz, CH), 6.32 (d, 1H, J = 15.6 Hz, CH), 6.56 (d, 1H, J =1.9 Hz, 
ArH), 7.36 (d, 1H, J = 2.0 Hz, ArH), 7.52 (d, 1H, J = 15.6 Hz, CH), 7.57 (d, 1H, J = 15.5 Hz, 
CH). 13C NMR (75.5 MHz, CDCl3): δ = 13.6 (2CH3), 19.1 (2CH2), 30.7 (2CH2), 64.4, 64.5 
(CH2O), 109.3, 118.2, 120.3 (CH), 124.7 (C), 127.2, 132.3, 145.1 (CH), 150.5 (C), 166.5, 
166.6 (CO). IR (KBr): v = 3133, 3118 (w), 2925 (s), 2850 (m), 1711 (s), 1676 (w), 1631 (m), 
1549, 1500 (w), 1445 (m), 1290 (m), 1275, 1255, 1168 (s),  1035,  1969, 862, 749 (m), 8761, 
746 (w), 720 (m), 648,  606 (w), 539 (m), cm. GC-MS (EI, 70 eV): m/z (%) = 320 ([M]+, 71), 
264 (08), 247 (23), 190 (17), 163 (86), 147 (100), 134 (11), 119 (53). HRMS (EI, 70 eV):
calcd for C18H24O5 [M]+: 320.16238; found: 320.16236. 
(2E,2'E)-Dihexyl 3,3'-(furan-2,3-diyl)diacrylate (32e). Following the general procedure A
32e was isolated as light yellow oil (331 mg, 88%). 1H NMR (300 
MHz, CDCl3):  δ = 0.83-0.86 (m, 6H, 2CH3), 1.16-1.34 (m, 12H, 
6CH2), 1.58-1.68 (m, 4H, 2CH2), 4.13 (t, 2H, J = 6.8 Hz, CH2O), 
4.14 (t, 2H, J = 6.7 Hz, CH2O), 6.16 (d, 1H, J = 15.5 Hz, CH), 6.35 
(d, 1H, J = 15.5 Hz, CH), 6.57 (d, J = 2.4 Hz, 1H, ArH), 7.37 (d, 1H, 
J = 1.9 Hz, ArH), 7.55 (d, 1 H, J = 15.5 Hz, CH), 7.60 (d, 1H, J = 15.6 Hz, CH). 13C NMR 
(75.5 MHz, CDCl3): δ = 14.0 (2CH3), 22.5, 22.6, 28.7, 31.4 (2CH2), 64.9, 65.0 (OCH2), 
109.4, 118.3, 120.3 (CH), 124.7 (C), 127.2, 1324, 145.1 (CH), 150.5 (C), 166.5, 166.6 (CO). 
IR (KBr): v = 3122, 3108 (w), 2921, 1711 (s), 1631 (m), 1549, 1500 (w), 1445 (m), 1377 (w), 
1292 (m), 1275, 1255, 1167 (s),  1069 (w), 1035 (m),  1018 (w), 1959 (m), 933 (w), 862 (m), 
825 (w), 749 (m), 8761, 746 (w), 721 (m), 648, 607 (w), 538 (m), cm. GC-MS (EI, 70 eV): 
m/z (%) = 376 ([M]+, 01), 345 (08), 291 (03), 206 (10), 189 (100), 162 (08). HRMS (EI, 70 
eV): calcd for C22H32O5 [M]+: 376.22497; found: 376.22397. 
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(2E,2'E)-Tert-butyl 3,3'-(furan-2,3-diyl)diacrylate (32f). Following the general procedure 
32f was isolated as light yellow oil (252 mg, 79%). 1H NMR (300 
MHz, CDCl3):  δ = 1.46 (s, 18H, 6CH3), 6.03 (d, 1H, J = 16.1 Hz, 
CH), 6.27 (d, 1H, J = 15.5 Hz, CH), 6.54 (d, 1H, J = 2.3 Hz, 
ArH), 7.34 (d, 1H, J = 2.3 Hz, ArH), 7.44 (d, 1H, J = 15.5 Hz, CH), 
7.45 (d, 1H, J = 15.7 Hz, CH). 13C NMR (75.5 MHz, CDCl3): δ = 28.2 (6CH3), 80.7, 80.8 (C), 
109.4, 120.1, 122.1 (CH), 124.4 (C), 126.5, 131.6, 144.8  (CH), 150.5 (C), 165.8, 165.9 (CO). 
IR (KBr): v = 2976, 2931 (m), 1705 (s), 1636, 1454, 1392, 1367, 1313, 1283, 1253 (m), 1146 
(s), 1018, 977, 844, 767, (m), 711, 685, 594, 574 (w), cm. GC-MS (EI, 70 eV): m/z (%) = 320 
([M]+, 15), 247 (11), 208 (100), 163 (31), 147 (21), 119 (26). HRMS (EI, 70 eV): calcd for 
C18H24O5 [M]+: 320.16183; found: 320.16232. 
2,3-Bis(4-methoxystyryl)furan (32g). Following the general procedure 32g was isolated as 
light yellow oil (299 mg, 90%). 1H NMR (300 MHz, CDCl3):  δ = 
3.74 (s, 6H, 2OCH3), 6.56 (d, J = 2.1 Hz, 1H, ArH), 6.71 (d, 1H, 
J = 16.2 Hz, CH), 6.82 (d, J = 8.8 Hz, 4H, ArH), 6.87-6.92 (m, 
3H),  7.25 (d, J = 2.0 Hz, 1H, ArH), 7.34 (d, 2H, J = 8.6 Hz, 
ArH), 7.38 (d, 2H, J = 8.7 Hz, ArH). 13C NMR (62.9 MHz, 
CDCl3): δ = 55.3 (OCH3), 108.7, 112.1, 114.1, 114.2, 116.0 (CH), 121.6 (C), 126.8, 127.4, 
127.7, 128.1 (CH), 130.0, 130.3 (C), 142.1(CH), 150.0, 159.2, 159.4 (C). IR (KBr): v = 3030, 
2996, 2992, 2930, 2963, 2833 (w), 1599, 1571, 1508, 1497, 1456, 1436, 1417, 1298, 1290, 
1267 (m), 1246 (s), 1174, 1145, 1109, 1061, 958, 934, 895, 852, 845 (m), 815 (s), 740, 720 
(m), 696, 659, 679, 637, 610, 561, 547 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 332 ([M]+, 
100), 207 (20), 166 (10), 121 (17). HRMS (EI, 70 eV): calcd for C22H20O3 [M]+: 332.14070; 
found: 332.140727. 
2,3-Bis(4-methylstyryl)furan (32h). Following the general procedure A 32h was isolated as 
light yellow oil (270 mg, 89%). 1H NMR (300 MHz, CDCl3):  δ = 
2.24 (s, 6H, 2CH3), 6.54 (d, J = 2.0 Hz, 1H, ArH), 6.68 (d, 1H, J = 
16.2 Hz, CH), 6.97 (m, 3H), 7.05 (d, J = 7.9 Hz, 4H, ArH), 7.22 
(d, 1H, J = 2.0 Hz, ArH), 7.28 (d, 2H, J = 7.9 Hz, ArH), 7.29 (d, J
= 8.2 Hz, 2H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 21.3, 21.4 
(CH3), 108.8, 113.1, 117.1 (CH), 122.0 (C), 126.2, 126.5, 127.4, 128.7, 129.4, 129.5 (CH), 
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134.4, 134.8, 137.3, 137.7 (C), 142.3 (CH), 150.1 (C). IR (KBr): v = 3020, 2992, 2963, 2833 
(w), 1599, 1571, 1508, 1498, 1456, 1436, 1418, 1298, 1290 (m), 1246, 1174 (s),  1029, 959, 
815, 740, 720 (m), 659, 679, 638, 610, 562, 548 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 300 
([M]+, 100), 245 (08), 281 (33), 216 (10), 198 (10), 204 (08). HRMS (EI, 70 eV): calcd for 
C22H20O [M]+: 300.15142; found: 300.15133. 
2,3-Bis(4-tert-butoxystyryl)furan (32i). Following the general procedure A 32i was isolated 
as light yellow oil (361 mg, 87%). 1H NMR (300 MHz, CDCl3):  
δ = 1.37 (s, 18H, 6CH3), 6.54 (d, J = 2.0 Hz, 1H, ArH), 6.67 (d, 
1H, J = 16.1 Hz, CH), 6.8-6.94 (m, 7H), 7.23 (d, J = 2.0 Hz, 1H, 
ArH), 7.30 (d, 2H, J = 8.5 Hz, ArH), 7.31 (d, 2H, J = 8.6 Hz, 
ArH). 13C NMR (62.9 MHz, CDCl3): δ = 28.9 (6CH3), 78.7, 78.8 
(O-C), 108.8, 112.9, 116.9 (CH), 121.8 (C), 124.2, 124.3, 126.7, 
126.9, 127.0, 128.3 (CH), 132.4, 132.7 (C), 142.3 (CH), 150.1, 155.0, 155.3 (C). IR (KBr):
v = 3033, 2972, 2929, 2872, 1623 (w), 1503, 1362, 1271 (m), 1159 (s), 1102, 1060, 1029, 
968, 959, 947 (w), 891, 864, 832, 743, 690, 677, 591 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 
416 ([M]+, 14), 360 (07), 304 (100), 210 (07). HRMS (EI, 70 eV): calcd for C28H32O3 [M]+: 
416.23460; found: 416.235161. 
9.2.2    Synthesis of 5,6-disubstitutedbenzofuranfurans 33  
General procedure B for the synthesis of benzofurans 33a-d. A diphenyl ether solution (3 
mL) of 32a-d (0.5 mmol) was stirred at 200 °C for 24 h (or 12h) in a pressure tube. The 
solution was allowed to cool to 20 °C and Pd/C (30 mg, 10 mol %) was added. The solution 
was stirred at 200 °C (or mentioned) for 24 h under argon atmosphere. The reaction mixture 
was filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (flash silica gel, heptanes/EtOAc). 
Dibutyl benzofuran-5,6-dicarboxylate (33d). 33d was prepared starting with 32d (160 mg, 
0.5 mmol), following the general procedures A and B, as a light yellow 
highly viscous oil (151 mg, 95%). 1H NMR (300 MHz, CDCl3): δ = 0.86 
(t, 6H, J = 7.3 Hz, 2CH3), 1.30-1.43 (m, 4H, 2CH2), 1.60-1.69 (m, 4H, 
2CH2), 4.24 (t, 2H, J = 6.7 Hz, CH2O), 4.25 (t, 2H, J = 6.7 Hz, CH2O),  
6.74 (d, 1H, J = 2.2 Hz, ArH), 6.67 (d, 1H, J = 2.2 Hz, ArH), 7.78 (s, 1H, ArH), 7.88 (s, 1H, 
ArH). 13C NMR (75.5 MHz, CDCl3): δ = 13.7 (2CH3), 19.2 (2CH2), 30.6 (2CH2), 65.5, 65.6 
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(CH2O), 107.0, 112.5, 122.5 (CH), 127.8, 128.7, 129.4 (C), 148.1 (CH), 155.1 (C), 167.5, 
168.0 (CO). IR (KBr): v = 3144, 3117 (w), 2959, 2921, 2852 (m), 1711 (s), 1631, 1462, 1446, 
1377, 1292 (w), 1275, 1255, 1223, 1169 (m), 1036, 969, 862, 794, 721, 539 (w) cm. GC-MS 
(EI, 70 eV): m/z (%) = 318 ([M]+, 05), 245 (05), 189 (100), 16 (10). HRMS (ESI+): calcd for 
C18H22O5 [M]+: 318.14623; found: 318.14626. 
Diethyl benzofurane-5,6-dicarboxylate (33b). Following the general procedure 33b was 
isolated as light yellow oil (122 mg, 93%). 1H NMR (300 MHz, CDCl3):  
δ = 0.86 (t, 6H, J = 7.5 Hz, 2CH3),  4.30-4.35 (m, 4H, 2CH2O), 6.77 (d, 
1H, J = 2.2 Hz, ArH),  7.69 (d, 1H,  J =2.2 Hz, ArH), 7.81 (s, 1H, ArH), 
7.91 (s, 1H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 14.1 (2CH3), 61.6, 
61.7 (CH2O), 107.3, 112.4, 122.5 (CH), 127.8, 128.8, 129.5 (C), 148.2 (CH),  155.2 (C), 
167.6, 168.0 (CO). IR (KBr): v = 3411, 3120, 2931, 2872 (w), 1715 (s), 1619, 1586, 1529 
(w), 1488, 1465 (m), 1391 (w), 1367 (m), 1300, 1219, 1149, 1125, 1102, 1039 (s), 896, 859, 
772, 691, 588 (m), cm. GC-MS (EI, 70 eV): m/z (%) = 262 ([M]+, 18), 234 (04), 217 (19), 189 
(100), 175 (05), 145 (06), 133 (04), 116 (07). HRMS (EI, 70 eV): calcd for C14H14O5 [M]+: 
262.08458; found: 262.084126. 
Dimethyl benzofurane-5,6-dicarboxylate (33a). Following the general procedure 33a was 
isolated as light yellow oil (105 mg, 90%). 1H NMR (300 MHz, CDCl3):  δ
= 3.81 (s, 3H, CH3O), 3.82 (s, 3H, CH3O), 6.75 (d, 1H, J = 2.1 Hz, ArH),  
7.63 (d, 1H, J =2.2 Hz, ArH), 7.80 (s, 1H, ArH), 7.90 (s, 1H, ArH). 13C 
NMR (75.5 MHz, CDCl3): δ = 52.6, 52.7 (2CH3O), 107.0, 112.6, 122.6 
(CH), 127.4, 128.2, 129.6 (C), 148.3 (CH), 155.2 (C), 167.9, 168.4 (CO). IR (KBr): v = 3010, 
3121, 2850 (w), 1723, 1716 (s), 1583, 1486, 1435, 1529 (w), 1229, 1202, 1165, 1071, 1021, 
981, 865, 797, 750, 692, 666 (s) cm. GC-MS (EI, 70 eV): m/z (%) = 234 ([M]+, 10), 204 (04), 
215 (19), 187 (100), 171 (05), 149 (06), 111 (04). HRMS (EI, 70 eV): calcd for C12H10O5 
[M]+: 234.05282; found: 234.05277. 
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Diisobutyl benzofuran-5,6-dicarboxylate (33c). Following the general procedure 33c was 
isolated as light yellow oil (146 mg, 92%). 1H NMR (300 MHz, 
CDCl3): δ = 0.92 (d, 6H, J = 6.7 Hz, 2CH3), 0.93 (d, 1 H, J = 6.8 
Hz, 2CH3), 1.96-2.01 (m, 2H, 2CH), 4.02 (d, J = 6.7 Hz, 4H, 
CH2O), 4.03 (d, 2H, J = 6.7 Hz, CH2O),  6.76 (d, 1H, J = 2.2 Hz, 
ArH),  7.71(d, 1H, J =2.1 Hz, ArH), 7.81 (s, 1H, ArH), 7.91 (s, 1H, 
ArH). 13C NMR (75.5 MHz, CDCl3): δ = 19.1  (4CH3), 27.5 (2CH), 71.8, 71.9 (CH2O), 107.0, 
112.6, 122.6 (CH), 127.9, 128.8, 129.5 (C), 148.2 (CH),  155.2 (C), 167.6, 168.0 (CO). IR 
(KBr): v = 3434 (w), 2959, 2874 (m), 1769 (w), 1716 (s), 1614, 1585, 1529 (w), 1468, 1377 
(m), 1305, 1218 (s), 1125 (m), 1103, 1035, 938 (s), 893, 773 (m), 691, 632 (w), cm. GC-MS 
(EI, 70 eV): m/z (%) = 318 ([M]+, 01), 263 (03), 189 (100), 162 (09), 144 (04), 133 (02), 116 
(06). HRMS (ESI+): calcd for C18H22O5 [M]+: 318.14674;found: 318.14664. 
9.3 Synthesis of Anthraquinones, Fluorenone and Benzocoumarine by Domino 
′Twofold Heck / 6π-Electrocyclization′ Reactions 
9.3.1  Synthesis of mono- and disubstituted anthraquinones 
General procedure for the synthesis of 35a-c and 36bc.  
In a pressure tube (glass bomb) a suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 5 mol%) and 
XPhos (48 mg, 0.10 mmol) in DMF (5 mL) was purged with argon and stirred at 20 °C to 
give a yellowish or brownish clear solution. To the stirred solution were added 34 (316 mg, 
1.0 mmol), NEt3 (1.1 mL, 8.0 mmol) and the alkene 16a,e,h (2.5 equiv.). The reaction mixture 
was stirred at 90 °C (for 36b) or 110 °C (for 35a-c) for 8 h. The solution was cooled to 20 °C, 
poured into H2O and CH2Cl2  (25 mL each), and the organic and the aqueous layer were 
separated. The latter was extracted with CH2Cl2  (3 x 25 mL). The combined organic layers 
were washed with H2O (3 x 20 mL), dried (Na2SO4), concentrated in vacuo and the residue 
was purified by chromatography (flash silica gel, heptanes/EtOAc) to give 36b or 35a-c.  
Dihexyl 9,10-dioxo-9,10-dihydroanthracene-2,3-dicarboxylate (36e). Starting with 34
(316 mg, 1.0 mmol), 36b was isolated as a violet 
highly viscous oil (348 mg, 75%). 1H NMR (300 MHz, 
CDCl3):  = 0.83 (t, 6H, J = 7.2 Hz, 2CH3), 1.25-1.38 
(m, 12H, 6CH2), 1.66-1.76 (m, 4H, 2CH2), 4.31 (t, 4H, 
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J = 6.9 Hz, 2CH2O), 7.77-7.81 (m, 2H, ArH), 8.26-8.30 (m, 2H, ArH), 8.55 (s, 2H, ArH). 13C 
NMR (75.5 MHz, CDCl3):  = 14.0 (2CH3), 27.5, 25.6, 28.5, 31.4 (2CH2), 66.6 (2CH2O), 
127.6, 128.1 (2CH), 133.3, 134.6 (2C), 134.7 (2CH), 137.0 (2C), 166.2 (2CO), 181.7 (2CO). 
IR (KBr): v = 3061, 2957, 2930, 2875 (m), 1728, 1680 (s), 1647, 1615 (w) 1590, 1520 (m), 
1411, 1393, 1370, 1343 (w), 1250 (s), 1170, 1120, 1040, 957, 800, 783  (m), 711 (s), 575 (w) 
cm. GC-MS (EI, 70 eV): m/z (%) = 464 ([M]+, 02), 381 (17), 279 (100), 207 (04%). HRMS 
(ESI+): calcd for C28H32O6 (M)+: 464.21934; found: 464.220607. 
Methyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (35a). Starting with 34 (316 mg, 
1.0 mmol), 35a was isolated as a violet highly viscous oil (152 mg, 
57%). The synthesis of 36a has been previously reported.82 1H 
NMR (300 MHz, CDCl3):  = 3.93 (s, 3H, CH3O), 7.71-7.77 (m, 
2H, ArH), 8.20-8.35 (m, 4H, ArH), 8.83 (dd, 1H, J = 0.5, 1.2 Hz, 
ArH). 13C NMR (62.9 MHz, CDCl3):   = 52.7 (CH3O), 127.3, 127.4, 127.5, 128.6 (CH), 
133.3, 133.4, 133.5(C), 134.3, 134.4, 135.5 (CH), 135.1, 136.0 (C), 165.5 (CO), 182.2, 182.5 
(CO). IR (KBr): v = 2957, 2828, 2870 (m), 1720, 1680 (s), 1640, 1615 (w) 1580, 1519, 1470 
(m), 1411, 1389, 1386, 1370 (w), 1253 (s), 1171, 1144, 1100, 1034, 956, 947, 792, 782  (m), 
711 (s), 655, 576 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 266 ([M]+, 57), 235 (100), 207 (21), 
151 (34%). HRMS (ESI+): calcd for C6H10O4 (M)+: 266.05791; found: 266.05666. 
Hexyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (35b). Starting with 34 (316 mg, 
1.0 mmol), 35b was isolated as a violet highly viscous 
oil (84 mg, 25% + 36b). 1H NMR (300 MHz, CDCl3): 
 = 0.84 (t, 3H, J = 7.1 Hz, CH3), 1.28-1.31 (m, 6H, 
3CH2), 1.69-1.79 (m, 2H, CH2), 4.32 (t, 2H, J = 6.7 
Hz, CH2O), 7.71-7.77 (m, 2H, ArH), 8.21-8.35 (m, 4H, ArH), 8.83 (dd, 1H, J = 0.4, 1.6 Hz, 
ArH). 13C NMR (75.5 MHz, CDCl3):   = 13.0 (CH3), 21.5, 24.6, 27.6, 30.4 (CH2), 65.1 
(CH2O), 127.3, 127.4, 127.5, 128.5 (CH), 132.3, 132.4, 132.5(C), 134.3, 134.4, 135.5 (CH), 
136.5, 136.0 (C), 164.0 (CO), 181.2, 181.5 (CO). IR (KBr): v = 2999, 2957, 2930 (m), 1730 
(s), 1650 (w) 1590, 1520 (m), 1400, 1390, 1369, 1333 (w), 1249 (s), 1171, 1122, 1044, 967, 
811, 785  (m), 710 (s), 565 (w) cm. cm. GC-MS (EI, 70 eV): m/z (%) = 336 ([M]+, 05), 253 
(100), 235 (38), 151 (32%). HRMS (ESI+): calcd for C21H20O4 (M)+: 336.13616; found: 
336.13611. 
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2-Ethylhexyl 9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (35c). Starting with 34
(316 mg, 1.0 mmol), 35c was isolated as a violet 
highly viscous oil (225 mg, 62%). 1H NMR (250 MHz, 
CDCl3):  = 0.85-0.98 (m, 6H, 2CH3), 1.29-1.33 (m, 
8H, 4CH2), 1.70-1.78 (m, 1H, CH), 4.21 (d, 2H, J = 6.8 
Hz, CH2O), 7.70-7.76 (m, 2H, ArH), 8.19-8.33 (m, 4H, ArH), 8.83 (brs, 1H, Hz, ArH). 13C 
NMR (62.9 MHz, CDCl3):  = 11.0, 14.0 (CH3), 22.1, 23.9, 29.0, 30.5 (CH2), 38.9 (CH), 68.3 
(CH2O), 127.3, 127.4, 127.5, 128.5 (CH), 132.3, 132.4, 132.5(C), 134.3, 134.4, 135.5 (CH), 
135.6, 136.0 (C), 165.0 (CO), 182.2, 182.5 (CO). IR (KBr): v = 3000, 2928, 2935 (m), 1733 
(s), 1655 (w) 1588, 1519 (m), 1399, 1391, 1358, 1344 (w), 1250 (s), 1169, 1111, 1035, 966, 
809, 783 (m), 709 (s) cm. GC-MS (EI, 70 eV): m/z (%) = 364 ([M]+, 01), 253 (86), 235 (100), 
207 (31), 151 (67). HRMS (ESI+): calcd for C21H20O4 (M)+: 364.16746; found: 364.16681. 
9.3.2    Synthesis of disubstituted Fluorenone 38
Synthesis of 2,3-dip-tolyl-9H-fluoren-9-one (38). In a pressure tube (glass bomb) a 
suspension of Pd(OAc)2 (12 mg, 0.05 mmol, 5 mol%) and 
Cy3P (28 mg, 0.10 mmol) in DMF (5 mL) was purged with 
argon and stirred at 20 °C to give a yellowish solution. To the 
stirred solution were added 2,3-dibromo-1H-inden-1-one (37) 
(288 mg, 1.0 mmol), NEt3 (1.1 mL, 8.0 mmol) and the 4-
Methylstyrene (0.33 mL, 2.5 mmol). The reaction mixture was 
stirred at 60 °C 36 h. The solution was cooled to 20 °C, poured into H2O and CH2Cl2  (25 mL 
each), and the organic and the aqueous layer were separated. The latter was extracted with 
CH2Cl2  (3 x 25 mL). The combined organic layers were washed with H2O (3 x 20 mL), dried 
(Na2SO4), concentrated in vacuo and the residue was purified by chromatography (flash silica 
gel, heptanes/EtOAc) to give 38 as a light brown highly viscous oil (276 mg, 77%). 1H NMR 
(300 MHz, CDCl3):  = 2.24 (s, 3H, CH3), 2.27 (s, 3H, CH3), 6.96 (brs, 4H, ArH), 7.01 (brs, 
4H, ArH), 7.21-7.26 (m, 1H, ArH), 7.39-7.48 (m, 3H, ArH), 7.60-7.63 (m, 1H, ArH), 7.64 (s, 
1H, ArH). 13C NMR (62.9 MHz, CDCl3):   = 21.1, 21.2 (CH3), 120.3, 122.7, 124.3, 126.7, 
128.7, 128.9, 129.0, 129.4, 129.5 (CH), 133.1 (C), 134.7 (CH), 136.6, 137.1, 137.6, 138.1, 
141.5, 144.2, 146.9 (C), 193.7 (CO). IR (KBr): v = 3072, 2960, 2931, 2863 (m), 1727, 1680 
(s), 1640, 1617 (w) 1590, 1522, 1470 (m), 1411, 1390, 1378, 1370, 1344 (w), 1248 (s), 1172, 
1134, 1119, 1035, 955, 946, 795, 780 (m), 710 (s), 654, 575 (w) cm. GC-MS (EI, 70 eV): m/z
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(%) = 360 ([M]+, 100), 345 (29), 332 (10), 302 (18), 207 (09), 151 (17). HRMS (ESI+): calcd 
for C27H20O (M)+: 360.15087; found: 360.149855.  
9.3.3    Synthesis of Benzocoumarin 42
Synthesis of isobutyl 6-oxo-6H-benzo[c]chromene-8-carboxylate (42). In a pressure tube 
(glass bomb) a suspension of Pd(PPh3)4 (58 mg,                     
0.05 mmol, 5 mol%), 3-bromo-2-oxo-2H-chromen-4-yl 
trifluoromethanesulfonate (39) (373 mg, 1.0 mmol), NEt3 (1.1 
mL, 8.0 mmol) and the isobutyl acrylate (0.36 mL, 2.5 mmol) in 
DMF (5 mL) was purged with argon and stirred at 20 °C. The reaction mixture was stirred at 
60 °C 36 h. The solution was cooled to 20 °C, poured into H2O and CH2Cl2  (25 mL each), 
and the organic and the aqueous layer were separated. The latter was extracted with CH2Cl2  
(3 x 25 mL). The combined organic layers were washed with H2O (3 x 20 mL), dried 
(Na2SO4), concentrated in vacuo and the residue was purified by chromatography (flash silica 
gel, heptanes/EtOAc) to give 42 as a highly viscous light brown oil (60 mg, 20%). 1H NMR 
(300 MHz, CDCl3):  = 0.98 (d, 6H, J = 6.7 Hz, 2CH3), 1.94-2.16 (m, 1H, CH), 4.10 (d, 2H, J
= 6.7 Hz, CH2O),  7.28-7.35 (m, 2H, ArH), 7.45-7.52 (m, 1H, ArH), 8.05 (dd, 1H, J = 1.4, 7.9 
Hz, ArH), 8.13 (d, 1H, J = 8.2 Hz, ArH), 8.40 (dd, 1H, J = 1.9, 8.5 Hz, ArH),  8.99 (d, 1H, J = 
1.6 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  = 19.1 (CH3), 27.9 (CH), 71.7 (CH2O), 117.3 
(C), 118.0 (CH), 121.3 (C), 123.4, 124.9 (CH), 130.98 (C), 131.7, 132.2, 135.3 (CH), 138.3, 
151.9 (C), 160.5, 165.1 (CO). IR (KBr): v = 3071, 2959, 2929 (m), 1726, 1679 (s), 1637, 
1616 (w) 1592, 1522, 1470 (m), 1407, 1390, 1378, 1369, 1334 (w), 1249 (s), 1173, 1135, 
1119, 1035, 956, 946, 796, 781 (m), 710 (s), 654, 574 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 
296 ([M]+, 18), 240 (100), 195 (13), 139 (27). HRMS (ESI+): calcd for C18H16NaO4 (M+Na)+: 
319.0941; found: 319.094. 
9.4 Synthesis of Aryl-Substituted Pyrimidines by Site-Selective Suzuki-Miyaura 
Cross-Coupling Reactions of 2,4,5,6-Tetrachloropyrimidine  
General procedure for Suzuki Cross Coupling: The reaction was carried out in a pressure 
tube. To a dioxane suspension (3-5 mL) of the chlorinated pyrimidine, Pd(PPh3)2Cl2 (3-5 
mol%) and of the arylboronic acid was added an aqueous solution of K2CO3 (2 M, 1-2 mL). 
The mixture was heated at the indicated temperature (60-100 °C) under Argon atmosphere for 
the indicated period of time (2-8 h). The reaction mixture was diluted with water and 
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extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried (Na2SO4), 
filtered and the filtrate was concentrated in vacuo. The residue was purified by flash 
chromatography (silica gel, EtOAc / heptanes). 
9.4.1  Synthesis of tetra-aryl-pyrimidines 47 
2,4,5,6-Tetraphenylpyrimidine (47a). Starting with 45 (87 mg, 0.40 mmol), Pd(PPh3)2Cl2
(15 mg, 5 mol%), dioxane (3 mL), K2CO3 (H2O, 2 M, 1 mL) and 
phenylboronic acid (215 mg, 1.76 mmol), 47a was isolated as a  white 
solid (150 mg, 98%). Reaction temperature: 100 °C for 8 h. The 
synthesis of 47a has been previously reported.83  Mp = 129 °C (lit.83, 
129 °C). 1H NMR (250 MHz, CDCl3):  = 6.88-6.92 (m, 2H, ArH), 
7.06-7.20 (m, 8H, ArH), 7.31-7.44 (m, 8H, ArH), 8.55-8.59 (m, 2H, 
ArH). 13C NMR (62.9 MHz, CDCl3):   = 127.2 (C), 127.3, 127.8, 
128.3, 128.4, 128.5, 128.6, 130.0, 130.6, 131.1 (CH), 136.6, 137.8, 138.8, 162.9, 165.4 (C). 
IR (KBr): v = 3059, 2916, 2852 (w), 1536, 1488 (s), 1442, 1370, 1298 (m), 1246 (s), 1194, 
1179, 1090, 1079, 1024, 1000 (m), 965, 929, 912 (w), 866, 800, 750, 729, (m), 688 (s), 620, 
614, 605, 592 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 383 ([M-1]+, 30), 383 ([M-1]+, 100), 
331 (01), 305 (04), 280 (05), 178 (09). HRMS (EI, 70 eV): calcd for C22H20N2 [M]+: 
384.16265; found: 384.162991. 
2,4,5,6-Tetrap-tolylpyrimidine (47b). Starting with 45 (87 mg, 0.40 mmol), Pd(PPh3)2Cl2
(15 mg, 5 mol%), dioxane (3 mL), K2CO3 (H2O, 2 M, 1 mL) 
and p-tolylboronic acid (240 mg, 1.76 mmol), 47b was 
isolated as a  white solid (167 mg, 95%). Reaction 
temperature: 100 °C for 8 h. Mp = 105-107 °C. 1H NMR 
(300 MHz, CDCl3):  = 2.22 (s, 3H, CH3), 2.23 (s, 6H, 
2CH3), 2.34 (s, 3H, CH3),  6.79 (d, J = 8.3, 2H, ArH), 6.89 
(d, J = 7.7, 2H, ArH), 6.96 (d, J = 7.7, 4H, ArH), 7.16-7.25 
(m, 6H, ArH), 8.44 (d, J = 8.3, 2H, ArH). 13C NMR (62.9 
MHz, CDCl3):  = 21.3, 21.5 (CH3), 128.3, 128.4, 129.0, 129.1, 129.9, 130.9 (CH), 133.9, 
135.3, 136.3, 136.7, 138.4, 140.5, 162.6, 165.1 (C). IR (KBr): v = 3060, 3029, 2947, 2863, 
2258 (w), 1606 (m), 1521, 1504 (s), 1409, 1391, 1354, 1186, 1175, 1020, 901, 825, 813 (m), 
798, 728 (s), 650, 627, 570 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 440 ([M]+, 66), 439 ([M-
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1]+, 100), 347 (02), 205 (09). HRMS (EI, 70 eV): calcd for C32H28N2 [M-1]+: 439.21688; 
found: 439.217130. 
2,4,5,6-Tetrakis(4-ethylphenyl)pyrimidine (47c). Starting with 45 (87 mg, 0.40 mmol), 
Pd(PPh3)2Cl2 (15 mg, 5 mol%), dioxane (3 mL), K2CO3
(H2O, 2 M, 1 mL) and 4-ethylphenylboronic acid (264 mg, 
1.76 mmol), 47c was isolated as a  white solid (184 mg, 
93%). Reaction temperature: 100 °C for 8 h. Mp = 129-131 
°C. 1H NMR (300 MHz, CDCl3):  = 1.08-1.14 (m, 9H, 
3CH3), 1.90 (t, J = 7.6 Hz, 3H, CH3),  2.47-2.53 (m, 6H, 
3CH2), 2.67 (q, J = 7.7 Hz, 2H, CH2), 6.82 (d, J = 8.3 Hz, 
2H, ArH), 6.90 (d, J = 8.3 Hz, 2H, ArH), 6.96 (d, J = 8.6 
Hz, 4H, ArH), 7.20-7.26 (m, 6H, ArH), 8.47 (d, J = 8.3 Hz, 
2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 15.2, 15.4, 15.5 (CH3), 28.6, 28.7, 28.9 (CH2), 
127.8, 127.8, 127.9, (CH), 128.4 (C), 128.5, 130.0, 131.0 (CH), 134.2, 135.6, 136.6, 143.2, 
144.7, 146.8, 162.7, 165.1 (C). IR (KBr): v = 3059, 3030, 2964, 2929, 2868, 1609, 1574, 
1567, 1556 (w), 1522, 1413, 1392, 1185, 1177, 1062, 1047, 1020, 946, 855, 844, 826 (m), 
810 (s), 741, 692, 652, 628, 572, 548 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 496 ([M]+, 69), 
495 ([M-1]+, 100), 467 (06), 204 (05). HRMS (ESI+): calcd for C36H36N2 [M]+: 496.28785; 
found: 496.28780. 
2,4,5,6-Tetrakis(4-methoxyphenyl)pyrimidine (47d). Starting with 45 (87 mg, 0.40 mmol), 
Pd(PPh3)2Cl2 (15 mg, 5 mol%), dioxane (3 mL), K2CO3
(H2O, 2 M, 1 mL) and 4-methoxyphenylboronic acid (268 
mg, 1.76 mmol), 47d was isolated as a  white solid (183 
mg, 91%). Reaction temperature: 100 °C for 8 h. Mp = 
134-136 °C. 1H NMR (300 MHz, CDCl3):  = 3.67 (s, 3H, 
OCH3), 3.68 (s, 6H, 2OCH3), 3.77 (s, 3H, OCH3), 6.67 (d, 
J = 8.9, 6H, ArH), 6.80 (d, J = 8.7, 2H, ArH), 6.90 (d, J = 
8.9, 2H, ArH), 7.28 (d, J = 8.9 4H, ArH), 8.49 (d, J = 8.6, 
2H, ArH). 13C NMR (75.5 MHz, CDCl3):  = 55.1, 55.2, 55.4 (OCH3), 113.2, 113.7, 114.0 
(CH), 127.2, 129.5 (C), 130.0 (CH), 130.8 (C), 131.5 (CH), 131.6 (C), 132.2 (CH), 158.7, 
159.8, 161.7, 162.2, 164.7 (C). IR (KBr): v = 3075, 3002, 2955, 2934, 2912, 2837 (w), 1601, 
1574, 1526, 1515, 1501, 1463, 1453, 1415, 1391, 1361, 1299, 1283 (m), 1247, 1167 (s) 1025, 
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907, 850, 834, 818, 805, 728, 667, 648, 636, 621, 578 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 
504 ([M]+, 90), 503 ([M-1]+, 100), 489 (04), 459 (05), 223 (09). HRMS (ESI+): calcd for 
C32H28N2O4 [M]+: 504.20491; found: 504.20491. 
2,4,5,6-Tetrakis(4-fluorophenyl)pyrimidine (47e). Starting with 45 (87 mg, 0.40 mmol), 
Pd(PPh3)2Cl2 (15 mg, 5 mol%), dioxane (3 mL), K2CO3 (H2O, 2 
M, 1 mL) and 4-fluorophenylboronic acid (247 mg, 1.76 mmol), 
47e was isolated as a white solid (162 mg, 89%). Reaction 
temperature: 100 °C for 8 h. Mp = 228-229 °C. 1H NMR (250 
MHz, CDCl3):  = 6.81-6.90 (m, 8H, ArH), 7.03-7.11 (m, 2H, 
ArH), 7.25-7.31 (m, 4H, ArH), 8.49-8.56 (m, 2H, ArH). 19F 
NMR (282.4 MHz, CDCl3)  = -113.3, -111.7, -110.0 .13C NMR 
(62.9 MHz, CDCl3):   = 114.9 (d, JF,C = 21.7, CH), 115.5 (d, 
JF,C = 21.6, CH), 115.9 (d, JF,C = 21.6, CH), 127.6 (C), 130.5 (d, JF,C = 8.7, CH), 131.8 (d, JF,C
= 8.4, CH), 132.2 (d, JF,C = 3.7, C), 132.6 (d, JF,C = 8.1, CH), 133.5 (d, JF,C = 2.8, C), 1134.4 
(d, JF,C = 3.3, C), 162.1, (C), 162.2 (d, JF,C = 250.0, CF), 163.2 (d, JF,C = 273.3, CF), 164.6 
(C), 164.9 (d, JF,C = 250.7, CF). IR (KBr): v = 3071, 3063, 1912 (w), 1598, 1529, 1512 (m), 
1500 (s), 1413, 1390, 1364, 1355 (m), 1297, 1289, 1267 (w), 1225 (s), 1193, 1158, 1148, 
1100, 1088, 1013 (m), 1002, 962, 954, 940, 872 (w), 856, 894, 827, 809, 736, 669, 646, 634, 
620, 570, 527 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 456 ([M]+, 67), 455 ([M-1]+, 100), 359 
(05), 214 (15). HRMS (ESI+): calcd for C28H16F4N2 [M]+: 456.12496; found: 456.12500. 
2,4,5,6-Tetrakis(3-methoxyphenyl)pyrimidine (47f). Starting with 45 (87 mg, 0.40 mmol), 
Pd(PPh3)2Cl2 (15 mg, 5 mol%), dioxane (3 mL), K2CO3
(H2O, 2 M, 1 mL) and 3-methoxyphenylboronic acid (268 
mg, 1.76 mmol), 47f was isolated as a  white solid (165 
mg, 82%). Reaction temperature: 100 °C for 8 h. Mp = 
100-102 °C. 1H NMR (250 MHz, CDCl3):  = 3.45 (s, 3H, 
OCH3), 3.51 (s, 6H, 2OCH3), 3.79 (s, 3H, OCH3), 6.45-
6.47 (m, 1H, ArH),6.50- 6.55 (m, 1H, ArH), 6.62-6.67 (m, 
1H, ArH), 6.72-6.77 (m, 2H, ArH), 6.87 (t, J = 1.5, 2H, ArH), 6.95-6.99 (m, 4H, ArH), 7.04 
(s, 1H, ArH), 7.07 (s, 1H, ArH), 7.31 (t, J = 8.0, 1H, ArH), 8.11-8.18 (m, 2H, ArH). 13C NMR 
(62.9 MHz, CDCl3):  = 55.1, 55.3, 55.4 (OCH3), 113.4, 113.5, 114.8, 115.2, 116.3, 116.8, 
121.1, 122.4, 123.6128.8 (CH), 128.9 (C), 129.4, 129.5 (CH), 138.1, 139.2, 140.0, 159.0, 
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159.6, 159.9, 162.6, 165.1 (C). IR (KBr): v = 3078, 2997, 2931, 2832 (w), 1595, 1584, 1522 
(s), 1487, 1462, 1449, 1420, 1384, 1350, 1316, 1275 (m), 1233 (s), 1210, 1176, 1157, 1149, 
1124, 1080 (m),  1034 (s), 994, 918, 907, 878 (w), 865, 860, 802, 786, 775, 751, 731, 711, 
692, 670, 634 (m), 605, 581, 549, 533 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 504 ([M]+, 65), 
503 ([M-1]+, 100), 489 (21), 397 (13), 236 (13). HRMS (ESI+): calcd for C32H28N2O4 [M]+: 
504.20491; found: 504.20480. 
2,4,5,6-Tetrakis(3,5-dimethylphenyl)pyrimidine (47g). Starting with 45 (87 mg, 0.40 
mmol), Pd(PPh3)2Cl2 (15 mg, 5 mol%), dioxane (3 mL), K2CO3
(H2O, 2 M, 1 mL) and 3,5-dimethylphenylboronic acid (264 mg, 
1.76 mmol), 47g was isolated as a  white solid (157 mg, 79%). 
Reaction temperature: 100 °C for 8 h. Mp = 190-192 °C. 1H 
NMR (300 MHz, CDCl3):  = 2.04 (s, 6H, 2CH3), 2.13 (s, 12H, 
4CH3), 2.34 (s, 6H, 2CH3),  6.50 (s, 2H, ArH), 6.72 (s, 1H, ArH), 
6.83 (s, 2H, ArH), 6.96 (s, 4H, ArH), 7.04 (s, 1H, ArH), 8.17 (s, 
2H, ArH). 13C NMR (75.5 MHz, CDCl3):  = 21.1, 21.3, 21.4 (CH3), 126.3, 127.8, 128.4, 
128.8, 130.1, 132.2 (CH), 136.5, 136.9, 137.2, 137.8, 137.9, 138.4, 138.7, 162.7, 165.3 (C). 
IR (KBr): v = 3009, 2912, 2858, 2727, 1598, 1573, 1567 (w), 1515 (s), 1433, 1386, 1371 (m), 
1252, 1191, 1177, 1036, 914, 908 (w), 861, 845, 724, 717, 696, 684, 669, 654, 541 (m) cm. 
GC-MS (EI, 70 eV): m/z (%) = 496 ([M]+, 65), 481 (100), 331 (08), 233 (08). HRMS (EI, 70 
eV): calcd for C36H36N2 [M-1]+: 496.28730; found: 496.285615. 
2,4,5,6-Tetra(biphenyl-3-yl)pyrimidine (47h). Starting with 45 (87 mg, 0.40 mmol), 
Pd(PPh3)2Cl2 (15 mg, 5 mol%), dioxane (3 mL), 
K2CO3 (H2O, 2 M, 1 mL) and biphenyl-3-ylboronic 
acid (349 mg, 1.76 mmol), 47h was isolated as a  
white solid (69 mg, 25%). Mp = 185-186 °C. Reaction 
temperature: 100 °C for 8 h. 1H NMR (250 MHz, 
CDCl3):  = 6.99-7.3 (m, 1H, ArH), 7.21-7.60 (m, 
30H, ArH), 7.65-7.69 (m, 3H, ArH), 8.51-8.64 (m, 
1H, ArH), 8.86 (t, J = 1.7, 1H, ArH). 13C NMR (75.5 
MHz, CDCl3):  = 126.3, 127.1, 127.2, 127.2, 127.3, 
127.4, 127.5, 127.6, 128.6, 128.7, 128.8, 128.9, 129.0, 129.1 (CH), 129.2 (C),129.3, 129.5, 
130.1, 130.5 (CH), 137.5, 138.2, 139.0, 140.6, 140.7, 141.2, 141.5, 141.9, 163.0, 163.4 (C). 
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IR (KBr): v = 3058, 3030, 2928, 1712, 1598 (w), 1525 (s), 1498, 1478, 1451, 1418, 1383, 
1356 (m), 1260, 1220, 1183, 1169, 1090, 1076, 901, 804 (w), 756, 698 (s), 637, 615 (m) cm -1. 
GC-MS (EI, 70 eV): m/z (%) = 688 ([M]+, 85), 687 ([M-1]+, 100), 611 (07), 508 (08), 326 
(08), 252 (06). HRMS (EI, 70 eV): calcd for C52H36N2 [M]+: 688.28785; found: 688.28777. 
9.4.2  Synthesis of 2,4,6-triaryl-5-chloropyrimidines 48 
5-Chloro-2,4,6-trip-tolylpyrimidine (48a). Starting with 45 (217 mg, 1.00 mmol), 
Pd(PPh3)2Cl2 ( 14 mg, 2 mol%), dioxane (5 mL), 2M K2CO3
(1 mL) and p-tolylboronic acid (408 mg, 3.00 mmol), 48a
was isolated as a white solid (318 mg, 83%). Reaction 
temperature: 80 °C for 5 h. Mp = 113-114 °C. 1H NMR (300 
MHz, CDCl3):  = 2.33 (s, 3H, CH3), 2.38 (s, 6H,  CH3), 7.18 
(d, J = 8.0 Hz, 2H, ArH), 7.25 (d, J = 7.9 Hz, 4H, ArH), 7.77 
(d, J = 8.1 Hz, 4H, ArH), 7.36 (d, J = 8.2 Hz, 2H, ArH). 13C 
NMR (62.9 MHz, CDCl3):  = 21.4, 21.5 (CH3), 124.1 (C), 128.4, 128.8, 129.2, 129.7 (CH), 
134.3, 134.5, 140.4, 141.0, 161.5, 164.4 (C). IR (KBr): v = 3061, 3033, 2916, 2855, 2720, 
1614, 1584 (w), 1539, 1530, 1520 (m), 1503 (s), 1456, 1406 (w), 1358 (s), 1308, 1298, 1263, 
1210 (w), 1181 (s), 1110, 1070, 1053 (w), 1033, 1021 (m), 967, 955, 939, 907, 867 (w), 833, 
817 (m), 785 (s), 768, 754, 728, 721, 709, 677, 643, 630, 619, 567 (m)  cm. GC-MS (EI, 70 
eV): m/z (%) =386 ([M, 37Cl]+, 32), 384 ([M, 35Cl]+, 100), 357 (03), 337 (04), 204 (12), 136 
(22). HRMS (EI, 70 eV): calcd for C25H21ClN2 [M, 35Cl]+: 384.13933; found: 384.13991. 
5-Chloro-2,4,6-tris(4-fluorophenyl)pyrimidine (48b). Starting with 45 (217 mg, 1.00 
mmol), Pd(PPh3)2Cl2 ( 35 mg, 5 mol%), dioxane (5 mL), 2M 
K2CO3 (1 mL) and 4-fluorophenylboronic acid (420 mg, 3.00 
mmol), 48b was isolated as a white solid (329 mg, 83%). 
Reaction temperature: 80 °C for 5 h. Mp = 236-238 °C. 1H 
NMR (300 MHz, CDCl3):  = 7.05- 7.18 (m, 6H, ArH), 7.85-
7.90 (m, 4H, ArH), 8.44-8.49 (m, 2H, ArH). 13C NMR (62.9 
MHz, CDCl3):   = 115.3 (d, JF,C = 22.6 Hz, ArH), 115.5 (d, 
JF,C = 22.5 Hz, ArH), 124.3 (C), 130.5 (d, JF,C = 8.6 Hz, ArH), 131.9 (d, JF,C = 8.6 Hz, ArH), 
132.7 (d, JF,C = 3.4 Hz, C), 132.9 (d, JF,C = 3.3 Hz, C), 162.7 (C), 163.6 (d, JF,C = 251.7 Hz, 
CF), 163.6 (d, JF,C = 251.7 Hz, CF), 163.7 (C). IR (KBr): v = 3067, 2959, 2914, 2855 (w), 
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1600, 1537 (m), 1501 (s), 1411, 1380, 1359, 1231, 1149, 1099, 1029, 1013, 990, 956, 871 
(m), 834, 795 (s), 741, 731, 675, 637, 625, 613 (w), 565, 530 (w) cm. GC-MS (EI, 70 eV): 
m/z (%) = 398 ([M, 37Cl]+, 35), 396 ([M, 35Cl]+, 100), 361 (17), 275 (07), 240 (51), 154 (72). 
HRMS (ESI+): calcd for C22H13ClF3N2 [M+1, 35Cl]+: 397.0714; found: 397.0711, calcd for 
C22H13ClF3N2 [M+1, 37Cl]+: 399.0692; found: 399.0689. 
5-Chloro-2,4,6-tris(2-methoxyphenyl)pyrimidine (48c). Starting with 45 (217 mg, 1.00 
mmol), Pd(PPh3)2Cl2 (35 mg, 5 mol%), dioxane (5 mL), 2M 
K2CO3 (1 mL) and 2-methoxyphenylboronic acid (456 mg, 3.00 
mmol), 48c was isolated as a brownish semisolid (350 mg, 81%). 
Reaction temperature: 80 °C for 5 h. Mp = 149-150 °C. 1H NMR 
(250 MHz, CDCl3):  = 3.76 (s, 6H, 2OCH3), 3.78 (s, 3H,  OCH3), 
6.87-7.03 (m, 6H, ArH), 7.24-7.42 (m, 5H, ArH), 7.69 (dd, J = 1.8, 
7.6 Hz, 1H, ArH). 13C NMR (62.9 MHz, CDCl3):   = 55.6, 56.1 (OCH3), 111.1, 112.1, 120.6, 
120.8 (CH), 126.9, 128.2, 129.0 (C), 130.6, 130.8, 130.9, 131.9 (CH), 156.9, 157.7, 162.8, 
163.0 (C). IR (KBr): v = 3061, 2970, 2927 (w), 1602, 1531, 1510 (m), 1483 (s), 1458, 1446, 
1372, 1317, 1309, 1284 (m), 1253 (s), 1177, 1097, 1038, 1025 (m), 867, 832, 820, 807, 773, 
766 (s), 729, 691, 668, 660 (w), 634, 615, 578, 586 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 
434 ([M, 37Cl]+, 34), 432 ([M, 35Cl]+, 100), 417 (51), 397 (59), 367 (17), 266 (29). HRMS (EI, 
70 eV): calcd for C25H21ClN2 [M, 35Cl]+: 432.12407; found: 432.12401. 
2,4,6-Tri(biphenyl-3-yl)-5-chloropyrimidine (48d). Starting with 45 (217 mg, 0.50 mmol), 
Pd(PPh3)2Cl2 (18 mg, 2.5 mol%), dioxane (5 mL), 
2M K2CO3 (1 mL) and biphenyl-3-ylboronic acid 
(298 mg, 1.50 mmol), 48d was isolated as a white 
solid (228 mg, 80%). Reaction temperature: 80 °C 
for 5 h. Mp = 189-191 °C. 1H NMR (250 MHz, 
CDCl3):  = 7.27-7.48 (m, 10H, ArH), 7.51-7.71 (m, 
11H, ArH), 7.85 (dt, J = 1.4, 7.7 Hz, 2H, ArH), 8.10 
(t, J = 1.5 Hz, 2H, ArH), 8.50 (dt, J = 1.4, 7.9 Hz, 1H, ArH), 8.74 (t, J = 1.7 Hz, 1H, ArH). 
13C NMR (75.5 MHz, CDCl3):   = 123.9 (C), 126.2, 126.3, 126.4, 126.5, 126.6, 127.5, 127.6, 
127.7, 127.8, 128.0, 128.7 (CH), 136.3, 136.6, 139.6, 139.9, 140.2, 140.6, 160.6, 163.7 (C). 
IR (KBr): v = 3059, 3028, 2962, 2918, 2849 (w), 1531, 1510, 1496, 1478, 1362, 1347 (m), 
1262, 1254, 1186, 1166, 1088, 1071, 1050, 1035, 1019, 918, 909, 888, 798, 788 (w), 744, 689 
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(s), 632, 601 (m) cm. MS (EI, 70 eV): m/z (%) = 572 ([M, 37Cl]+, 34), 570 ([M, 35Cl]+, 100), 
536 (17), 391 (05), 356 (34), 285 (14). HRMS (ESI+) calcd for C40H28ClN2 [M+1, 35Cl]+: 
571.19360; found: 571.19333. 
9.4.3 Synthesis of 4,6-diaryl-2,5-dichloropyrimidines 49 
2,5-Dichloro-4,6-diphenylpyrimidine (49a). Starting with 45 (217 mg, 1.0 mmol), 
Pd(PPh3)2Cl2 (21 mg, 3 mol%), dioxane (5 mL), 2M K2CO3 (2 mL) 
and phenylboronic acid (244 mg, 2.0 mmol), 49a was isolated as a  
white solid (291 mg, 97%). Reaction temperature: 70 °C for 5 h. Mp 
= 135-136 °C. 1H NMR (300 MHz, CDCl3):  = 7.21-7.42 (m, 6H, 
ArH), 7.62-7.81 (m, 4H, ArH). 13C NMR (75.5 MHz, CDCl3):  = 
125.7 (C), 128.4, 129.6, 130.7 (CH), 135.5, 158.3, 167.4 (C). IR (KBr): v = 3059, 2916, 2852 
(w), 1535, 1487 (s), 1442, 1370, 1297 (m), 1245 (s), 1179, 1090, 1024, 865, 750 (m), 750, 
688, 606, 592 (s) cm. GC-MS (EI, 70 eV): m/z (%) = 302 ([M, 35Cl, 37Cl]+, 65), 300 ([M, 35Cl,
35Cl]+, 100), 255 (33), 225 (18). HRMS (EI, 70 eV): calcd for C16H10Cl2N2[M, 35Cl, 35Cl]+: 
300.0221; found: 300.02211. 
2,5-Dichloro-4,6-dip-tolylpyrimidine (49b). Starting with 45 (217 mg, 1.0 mmol), 
Pd(PPh3)2Cl2 (21 mg, 3 mol%), dioxane (5 mL), 2M 
K2CO3 (2 mL) and p-tolylboronic acid (270 mg, 2.0 
mmol), 49b was isolated as a  white solid (279 mg, 85%). 
Reaction temperature: 70 °C for 5 h. Mp = 109-110 °C.  
1H NMR (300 MHz, CDCl3):  = 2.35 (s, 6H, 2CH3), 7.20 
(d, J = 7.9 Hz, 4H, ArH),  7.79 (d, J = 8.2 Hz, 4H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 
129.0 (C, CH), 129.6 (C, CH), 132.7, 141.0, 167.2 (C). IR (KBr): v = 3062, 3028, 2919, 2859 
(w), 1609 (m), 1532, 1484 (s), 1456, 1406 (w), 1244 (s), 1175, 1084, (w), 1033, 1021 (m), 
869, 819, 782, 750, 712, 612, 561 (m)  cm.. GC-MS (EI, 70 eV): m/z (%) = 330 ([M, 35Cl,
37Cl]+, 63), 328 ([M, 35Cl, 35Cl]+, 100), 281 (24), 155 (18. HRMS (EI, 70 eV): calcd for 
C18H14Cl2N2 [M, 35Cl, 35Cl]+: 328.5341; found: 328.5341. 
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2,5-Dichloro-4,6-bis(4-methoxyphenyl)pyrimidine (45d). Starting with 45 (217 mg, 1.0 
mmol), Pd(PPh3)2Cl2 (21 mg, 3 mol%), dioxane (5 mL), 
2M K2CO3 (2 mL) and 4-methoxyphenylboronic acid 
(304 mg, 2.0 mmol), 48c was isolated as a  white solid 
(334 mg, 93%). Reaction temperature: 70 °C for 5 h. mp 
= 105-107 °C. 1H NMR (300 MHz, CDCl3):  = 3.84 (s, 
6H, OCH3), 6.95 (d, 4H, J = 9.1 Hz, ArH), 7.85 (d, 4H, J = 9.1 Hz, ArH). 13C NMR (75.5 
MHz, CDCl3):  = 55.4 (OCH3), 113.6 (CH), 124.6, 127.9 (C), 131.5 (CH), 158.0, 161.6, 
166.5 (C). IR (KBr): v = 2878, 2966, 2935, 2826 (w), 1611, 1523, 1513, 1511, 1483, 1468, 
1433, 1333, 1325, 1321, 1274 (m), 1255 (s), 1178, 1117, 1097, 1038, 1018 (m), 961 (w), 866 
(m), 822, 820, 806, 773, 766 (s), 728 (m), 692, 667, 632 (w), 614, 578, 562 (m) cm. GC-MS 
(EI, 70 eV): m/z (%) = 362 ([M, 35Cl, 37Cl]+, 65), 360 ([M, 35Cl, 35Cl]+, 100), 325 (33), 253 
(11), 252 (04), 236 (09), 132 (10). HRMS (EI, 70 eV): calcd for C18H14Cl2N2O2 [M, 35Cl,
35Cl]+: 360.04323; found: 360.04311. 
9.4.4 Synthesis of unsymmetrical 2,4,6-triaryl-5-chloropyrimidines 50 
5-Chloro-2-(3-chlorophenyl)-4,6-dip-tolylpyrimidine (50a). Starting with 49b (82 mg, 0.25 
mmol), Pd(PPh3)2Cl2 (6 mg, 3 mol%), dioxane (3 mL), 2M 
K2CO3 (1 mL) and 3-chlorophenylboronic acid (39 mg, 0.25 
mmol), 50a was isolated as a white solid (91 mg, 90%). 
Reaction temperature: 80 °C for 5 h. Mp = 195-197 °C. 1H 
NMR (250 MHz, CDCl3):  = 2.37 (s, 6H, 2CH3), 7.24-7.35 
(m, 6H, ArH), 7.75 (d, J = 8.1 Hz, 4H, ArH), 8.40 (dt, J = 
1.7, 7.5 Hz, 1H, ArH), 8.40 (t, J = 1.8 Hz, 1H, ArH). 13C NMR (62.9 MHz, CDCl3):   = 13.1 
(2CH3), 124.0 (C), 125.5, 127.4, 127.8, 128.7, 129.7, 129.7 (CH), 133.2, 133.6, 137.6, 139.3, 
159.0, 163.6 (C). IR (KBr): v = 3058, 3034, 2918, 2851, 1613 (w), 1537, 1500, 1364 (s), 
1307, 1261, 1184, 1091, 1074, 1034, 883, 822, 807 (m), 780.1 (s), 741, 735, 722, 703 (m), 
673, 661, 622, 598, 567 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 406 ([M, 35Cl, 37Cl]+, 66), 404 
([M, 35Cl, 35Cl]+, 100), 389 (04), 369 (29), 252 (12), 232 (42). HRMS (ESI+): calcd for 
C24H19Cl2N2 [M+H, 35Cl, 35Cl]+: 405.0920; found: 405.0923, calcd for C24H19Cl2N2 [M+H, 
35Cl, 37Cl]+: 407.0895; found: 407.0897. 
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5-Chloro-2-(4-methoxyphenyl)-4,6-diphenylpyrimidine (50b). Starting with 49a (75 mg, 
0.25 mmol), Pd(PPh3)2Cl2 (6 mg, 3 mol%), dioxane (3 mL), 2M 
K2CO3 (1 mL) and 4-methoxyphenylboronic acid (38 mg, 0.25 mmol), 
50b was isolated as a white solid (80 mg, 86%). Reaction temperature: 
80 °C for 5 h. Mp = 189-191 °C. 1H NMR (250 MHz, CDCl3):  = 
3.81 (s, 3H, OCH3), 6.90 (d, 2H, J = 9.0 Hz, ArH), 7.43-7.50 (m, 6H, 
ArH), 7.82-7.87 (m, 4H, ArH), 8.44 (d, 2H, J = 9.0 Hz, ArH). 13C 
NMR (75.5 MHz, CDCl3):   = 55.4 (OCH3), 113.8 (CH), 123 (C), 128.1 (CH), 129.5 (C), 
129.7, 129.8, 130.2 (CH), 137.3, 162.0, 164.5 (2C). IR (KBr): v = 3059, 3028, 3006, 2954, 
2931, 2835 (w), 1608, 1560, 1534 (m), 1504, 1490 (s), 1468, 1444, 1423, 1385 (m), 1361 (s), 
1302 (m), 1250 (s), 1174, 1106, 1075, 1058, 1037, 1030, 1002 (m), 980, 969, 958, 912, 864 
(w), 838, 797, 787, 771 (m), 757 (s), 729 (m), 687 (s), 632, 615, 540 (m) cm. GC-MS (EI, 70 
eV): m/z (%) = 372 ([M]+, 100), 357 (03), 337 (04), 204 (12), 136 (22). HRMS (EI, 70 eV):
calcd for C23H17ClN2O [M]+: 372.10294; found: 372.10278. 
9.4.5 Synthesis of unsymmetrical 2,4,5,6-tetra-aryl-pyrimidine 51a 
2,5-Bis(4-methoxyphenyl)-4,6-diphenylpyrimidine (51a). Starting with 49a (75 mg, 0.25 
mmol), Pd(PPh3)2Cl2 (6 mg, 3 mol%), dioxane (3 mL), K2CO3 (H2O, 
2 M, 1 mL) and 4-methoxyphenylboronic acid (76 mg, 0.5 mmol), 
51a was isolated as a  white solid (87 mg, 79%). Reaction 
temperature: 100 °C for 5 h. Mp = 175-177 °C. 1H NMR (250 MHz, 
CDCl3):  = 3.77 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 6.87-6.93 (m, 
4H, ArH), 7.42 (d, J = 8.8, 2H, ArH), 7.45-7.47 (m, 6H, ArH), 7.83-
7.87 (m, 4H, ArH), 8.44 (d, J = 8.7, 2H, ArH). 13C NMR (75.5 MHz, 
CDCl3):   = 55.3, 55.4 (OCH3), 113.8, 114.2 (CH), 123.8 (C), 127.7, 
128.1 (CH), 129.5 (C), 129.7, 129.8, 130.2 (CH), 133.5, 137.3, 158.5, 161.3, 162.0, 164.5 (C). 
IR (KBr): v = 3058, 3005, 2955, 2934, 2930, 2835 (w), 1607, 1585, 1534 (m), 1503, 1491 (s), 
1467, 1444, 1385 (w), 1362, 1250, 1174, 1039 (s), 1012, 969, 958, 912 (w), 837, 821, 804, 
797, 772 (m), 687, 615, 541 (s) cm. GC-MS (EI, 70 eV): m/z (%) = 444 ([M]+, 100), 411 
([10), 369 (14), 223 (19). HRMS (ESI+): calcd for C30H24N2O2 [M]+: 444.1837; found: 
444.1830. 
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9.4.6 Synthesis of 4-aryl-2,5,6-trichloropyrimidines 52 
2,4,5-Trichloro-6-p-tolylpyrimidine (52a). Starting with 45 (217 mg, 1.0 mmol), 
Pd(PPh3)2Cl2 (07 mg, 1 mol%), dioxane (5 mL), 2M K2CO3 (2 mL) 
and p-tolylboronic acid (136 mg, 1.0 mmol), 52a was isolated as a  
white solid (238 mg, 87%). Reaction temperature: 60 °C for 2 h. Mp 
= 130 °C. 1H NMR (300 MHz, CDCl3):  = 2.35 (s, 3H, CH3), 7.21 
(d, 2H, J = 8.2 Hz, ArH), 8.20 (d, 2H, J = 8.5 Hz, ArH). 13C NMR 
(62.9 MHz, CDCl3):   = 21.6 (CH3), 125.2 (C), 128.8, 129.6 (CH), 131.5, 143.0, 159.6, 161.9 
(C). IR (KBr): v = 2916, 2854, 2720 (w), 1612, 1530 (m), 1503 (s), 1406 (w), 1358 (s), 1307, 
1297, 1266 (w), 1180 (s), 1032, 1020 (m), 966, 955, 938 (w), 832, 817 (m), 784 (s), 766, 753, 
728, 720, 709, 676, 642, 629, 618, 597 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 278 ([M, 
37Cl3]+, 02), 276 ([M, 35Cl, 37Cl2]+, 25), 274 ([M, 35Cl2, 37Cl]+, 100), 272 ([M, 35Cl3]+, 88), 237 
(42), 116 (24). HRMS (EI, 70 eV): calcd for C11H7Cl3N2 [M, 35Cl3]+: 271.96748; found: 
271.96649. 
2,4,5-Trichloro-6-(4-methoxyphenyl)pyrimidine (52b). Starting with 45 (217 mg, 1.0 
mmol), Pd(PPh3)2Cl2 (21 mg, 3 mol%), dioxane (5 mL), 2M K2CO3
(2 mL) and 4-methoxyphenylboronic acid (152 mg, 1.0 mmol), 52b
was isolated as a  brownish semisolid (275 mg, 95%). Reaction 
temperature: 60 °C for 2 h. Mp = 120-121 °C.  1H NMR (300 MHz, 
CDCl3):  = 3.82 (s, 3H, OCH3), 6.94 (d, 2H, J = 9.0 Hz, ArH), 7.83 (d, 2H, J = 9.0 Hz, ArH). 
13C NMR (75.5 MHz, CDCl3):   = 55.5 (OCH3), 113.8 (CH), 126.8 (C), 131.7 (CH), 156.9, 
161.4, 162.2, 166.0 (C). IR (KBr): v = 2971, 2928, 2836 (w), 1604, 1574, 1530, 1511, 1483, 
1458, 1446, 1372, 1325, 1317, 1309, 1284 (m), 1253 (s), 1177, 1116, 1097, 1038, 1025 (m), 
962 (w), 867 (m), 832, 820, 807, 774, 766 (s), 729 (m), 691, 668, 634 (w), 615, 579, 569, 537 
(m) cm. GC-MS (EI, 70 eV): m/z (%) = 294 ([M, 37Cl3]+, 03), 292 ([M, 35Cl, 37Cl2]+, 26), 290 
([M, 35Cl2, 37Cl]+, 92), 288 ([M, 35Cl3]+, 100), 275 (04), 253 (17), 210 (14), 157 (07). HRMS 
(EI, 70 eV): calcd for C11H7Cl3N2O [M]+: 287.96240; found: 287.96228. 
2,4,5-Trichloro-6-(4-fluorophenyl)pyrimidine (52c). Starting with 45 (217 mg, 1.0 mmol), 
Pd(PPh3)2Cl2 (21 mg, 3 mol%), dioxane (5 mL), 2M K2CO3 (2 mL) 
and 4-fluorophenylboronic acid (140 mg, 1.0 mmol), 52c was isolated 
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as a  white solid (258 mg, 93%). Reaction temperature: 60 °C for 2 h. Mp = 148 °C. 1H NMR 
(300 MHz, CDCl3):  = 7.10-7.16 (m, 2H, ArH), 7.78-7.82 (m, 2H, ArH). NMR (62.9 MHz, 
CDCl3):  = 115.5 (d, JF,C = 21.8 Hz, CH), 125.2 (C), 131.3 (d, JF,C = 3.4 Hz, C), 131.5 (d, 
JF,C = 8.8 Hz, CH), 158.2 (C), 164.2 (d, JF,C = 252.1 Hz, CF), 166.3 (C). IR (KBr): v = 3068, 
2960, 2924, 2853 (w), 1601, 1538 (m), 1502 (s), 1410, 1381, 1359, 1231, 1149, 1099, 1029, 
1014, 989, 955, 871, 845 (m), 834, 794 (s), 740, 731, 673, 636, 625, 613 (w), 564, 528 (w) 
cm. GC-MS (EI, 70 eV): m/z (%) = 292 ([M, 37Cl3]+, 280 ([M, 35Cl, 37Cl2]+, 25), 278 ([M, 
35Cl2, 37Cl]+, 100), 276 ([M, 35Cl3]+, 95), 253 (17), 240 (14), 182 (07). HRMS (EI, 70 eV):
calcd for C10H4Cl3FN2 [M]+: 275.94241; found: 275.94228. 
2,4,5-Trichloro-6-(2-methoxyphenyl)pyrimidine (52d). Starting with 45 (217 mg, 1.0 
mmol), Pd(PPh3)2Cl2 (21 mg, 3 mol%), dioxane (5 mL), 2M K2CO3 (2 
mL) and 2-methoxyphenylboronic acid (152 mg, 1.0 mmol), 52d was 
isolated as a  white solid (281 mg, 97%). Reaction temperature: 60 °C 
for 2 h. Mp = 108 °C.  1H NMR (300 MHz, CDCl3):  = 3.70 (s, 3H, 
OMe), 6.89-6.96 (m, 2H, ArH), 7.15-7.27 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 
55.7 (OMe), 111.1, 120.3 (CH), 127.8 (C), 128.6 (CH), 131.5 (CH), 132.5, 157.0, 167.8 (C). 
IR (KBr): v = 3060, 2971, 2928 (w), 1604, 1530, 1512 (m), 1483 (s), 1458, 1446, 1372, 1317, 
1309, 1284 (m), 1253 (s), 1177, 1116, 1097, 1038, 1025 (m), 867, 832, 820, 807, 773, 766 (s), 
729, 691, 668, 660 (w), 634, 615, 579, 587 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 294 ([M, 
37Cl3]+, 03), 292 ([M, 35Cl, 37Cl2]+, 25), 290 ([M, 35Cl2, 37Cl]+, 90), 288 ([M, 35Cl3]+, 100), 275 
(04), 253 (17), 210 (14), 157 (07). HRMS (ESI+): calcd for C11H8Cl3N2O [M+1]+: 287.9697; 
found: 288.969696, calcd for C11H8Cl237ClN2O [M+1]+: 290.9668; found: 290.9669. 
2,4,5-Trichloro-6-(3-(trifluoromethyl)phenyl)pyrimidine (52e). Starting with 45 (217 mg, 
1.0 mmol), Pd(PPh3)2Cl2 (09 mg, 1.25 mol%), dioxane (5 mL), 2M K2CO3
(2 mL) and 3-(trifluoromethyl)phenylboronic acid (189 mg, 1.0 mmol), 
16e was isolated as a  white solid (297 mg, 91%). Reaction temperature: 
70 °C for 5 h. Mp = 168-169 °C. 1H NMR (300 MHz, CDCl3):  = 7.53-
7.58 (m, 1H, ArH), 7.71-7.74 (m, 1H, ArH), 8.51-8.54 (m, 1H, ArH), 8.60 
(brs, 1H, ArH). 19F NMR (282.4 MHz, CDCl3)  = -62.7. 13C NMR (62.9 MHz, CDCl3):  = 
125.6 (q, JF,C = 4.2 Hz, CH), 126.8 (C), 128.6 (q, JF,C = 3.2 Hz, CH),  128.9 (q, JF,C = 274.7 
Hz, CF3), 129.4, 131.8 (CH), 131.2 (C), 132.0 (q, JF,C = 32.9 Hz, C-CF3), 135.0, 160.0, 160.3 
(C). IR (KBr): v = 3075, 2919, 2851 (w), 1529, 1504, 1485, 1445, 1380 (m), 1318, 1305, 
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1265 (s),1161 (m), 1124, 1101, 1073 (s), 1049 (m), 999, 991, 934 (w), 921 (m), 881, 844 (w), 
816, 773, 696 (s), 652, 554 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 332 ([M, 37Cl3]+, 03), 330 
([M, 35Cl, 37Cl2]+, 28), 328 ([M, 35Cl2, 37Cl]+, 100), 326 ([M, 35Cl3]+, 97), 326 (97), 291 (87), 
230 (10), 170 (11), 152 (14). HRMS (EI, 70 eV): calcd for C11H4Cl3F3N2 [M, 35Cl3]+: 
325.93921; found: 325.9380. 
2,5-Dichloro-4,6-bis(4-chlorophenyl)pyrimidine (52f). Starting with 45 (217 mg, 1.0 
mmol), Pd(PPh3)2Cl2 (09 mg, 1.25 mol%), dioxane (5 mL), 2M 
K2CO3 (2 mL) and 4-chlorophenylboronic acid (156 mg, 1.0 mmol), 
52f was isolated as a  white solid (258 mg, 88%). Reaction 
temperature: 70 °C for 5 h. Mp = 155-156 °C.  1H NMR (300 MHz, 
CDCl3):  = 7.39 (d, 2H, J = 8.8 Hz, ArH), 8.25 (d, 2H, J = 8.86 Hz, 
ArH). 13C NMR (62.9 MHz, CDCl3):  = 126.1 (C), 129.1, 130.1 (CH), 132.7, 138.7, 159.8, 
160.8 (C). IR (KBr): v = 1592, 1575, 1544, 1526 (w), 1486 (s), 1382, 1329, 1286, 1265, 1246, 
1188, 1174, 1091, 1047, 1011 (m), 840, 814, 769 (s), 727, 716, 657, 630, 577 (w) cm. GC-MS 
(EI, 70 eV): m/z (%) = 300 ([M, 37Cl4,]+, 01), 298 ([M, 35Cl, 37Cl3]+, 07), 296 ([M, 35Cl2, 
37Cl2]+, 42), 94 ([M, 35Cl3, 37Cl]+, 100), 292 ([M, 35Cl4]+, 75), 257 (54), 222 (03), 137 (21). 
HRMS (EI, 70 eV 
): calcd for C10H4Cl4N2 [M, 35Cl4]+: 291.9129; found: 291.91288. 
9.4.7 One-pot Synthesis of unsymmetrical 2,4,6-triaryl-5-chloropyrimidine 50c 
5-Chloro-4,6-bis(4-ethylphenyl)-2-(3-(trifluoromethyl)phenyl)pyrimidine (50c). The 
reaction was carried out in a pressure tube. To a dioxane 
suspension (5 mL) of the chlorinated pyrimidine 45, 
Pd(PPh3)2Cl2 (09 mg, 1.25 mol%) and of the 4-
ethylphenylboronic acid (300 mg, 2.0 mmol), was added an 
aqueous solution of K2CO3 (2 M, 2 mL). The mixture was 
heated at the indicated temperature 70 °C under Argon 
atmosphere for 5 h. Reaction was cooled down to room temperature (20 °C) and 3-
(trifluoromethyl)phenylboronic acid (190 mg, 1.0 mmol)  The reaction mixture was diluted 
with water and extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
flash chromatography (silica gel, EtOAc / heptanes) to yield 50c as white solid (428 mg, 92%) 
a reduced by product 9 (13 mg, 03%). Mp = 183 °C. 1H NMR (300 MHz, CDCl3):  = 1.50 (t, 
N N
Cl
CF3
N N
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J = 7.6 Hz, 6H, 2CH3), 2.44 (q, J = 7.6 Hz, 4H, 2CH2), 7.56 (d, J = 8.5 Hz, 4H, ArH), 7.76 (t, 
J = 8.1 Hz, 1H, ArH), 7.90 (brd, J = 8.1 Hz, 1H, ArH), 8.03-7.07 (m, 4H, ArH), 8.62 (brd, J = 
7.93 Hz, 1H, ArH), 8.49 (brs, 1H, ArH). 19F NMR (282.4 MHz, CDCl3)  = -63.1. 13C NMR 
(75.5 MHz, CDCl3):   = 15.3 (2CH3), 28.86 (2CH2), 124.1 (C), 125.3 (q, JF,C = 3.6 Hz, CH), 
127.3 (q, JF,C = 3.8 Hz, CH), 127.7 (CH), 127.8 (q, JF,C = 274.2 Hz, CF3),  128.5 (C), 129.0, 
129.8 (CH), 130.6 (q, JF,C = 32.7 Hz, C-CF3), 131.6 (CH), 134.4, 137.8, 160.0, 164.8 (C). IR 
(KBr): v = 3034, 2968, 2934, 2876 (w), 1610, 1537, 1503, 1488, 1450, 1355 (m), 1319 (s), 
1272, 1162, (m),  1119 (s), 1089, 1074, 1054, 1031 (m), 1017, 1001, 921, 887 (w), 840, 794, 
693 (m), 652, 636, 601, 576, 538 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 466 ([M]+, 100), 
451 (34), 260 (05). HRMS (ESI+): calcd for C27H23ClF3N2 [M+1]+: 467.1496; found: 
467.1502. 
2,4,5-Tris(4-ethylphenyl)pyrimidine (53).Compound 53 was isolated as a white solid by-
product of 50c (12 mg, 3%). Melting point could not be measured due 
to very small yield. 1H NMR (300 MHz, CDCl3):  = 1.09-1.25 (m, 
9H, 3CH3), 2.54-2.70 (m, 6H, 3CH2), 7.06 (d, J = 8.3 Hz, 2H, ArH), 
7.11 (brs, 4H, ArH), 7.26 (d, J = 8.4 Hz, 2H, ArH), 7.43 (d, J = 8.3 
Hz, 2H, ArH), 8.41 (d, J = 8.4, 2H, ArH), 8.66 (s, 1H, ArH). 13C 
NMR (62.9 MHz, CDCl3):   = 15.2, 15.3, 15.4 (CH3), 28.5, 28.7, 
28.8 (CH2), 127.6, 128.1, 128.2, 128.3, 129.2, 130.0 (CH), 130.3, 
134.1, 135.1, 135.4, 143.9, 145.7, 147.1 (C), 158.5 (CH) 162.9, 163.2 
(C). IR (KBr): v = 3020, 2962, 2929, 2870, 1609, 1575, 1523, 1501 
(m), 1417 (s), 1375 (m), 1334, 1320, 1278, 1245, 1223 (w), 1175, 1048, 1017, 999, 964 (m), 
830 , 806 (s), 783, 692, 685, 592, 571, 531 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 392 ([M]+, 
67), 391 ([M-1]+, 100), 373 (08), 204 (01). HRMS (EI, 70 eV): calcd for C28H27N2 [M-1]+: 
391.21688; found: 391.217041. 
9.5 Site-Selective Suzuki-Miyaura Cross-Coupling Reactions of 2,3,4,5-
Tetrabromofuran
  
9.5.1 Synthesis of tetraarylfurans 55 
General procedure A for Suzuki Cross Ccoupling Reactions:  
N N
H
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 The reaction was carried out in a pressure tube. To a dioxane or toluene/dioxane (4:1) 
suspension (2.5 mL) of the brominated furan, Pd(PPh3)4 (2-3 mol%) and of the arylboronic 
acid (1.0 to 1.1 equiv.) was added an aqueous solution of K2CO3 (2 M, 0.5 mL). The mixture 
was heated at the indicated temperature (80 °C) under Argon atmosphere for the indicated 
period of time (3-5 h). The reaction mixture was diluted with water and extracted with CH2Cl2
(3 x 25 mL). The combined organic layers were dried (Na2SO4), filtered and the filtrate was 
concentrated in vacuo. The residue was purified by flash chromatography (silica gel, EtOAc / 
heptanes). 
2,3,4,5-Tetraphenylfuran (55a). Following the General procedure A compound 55a was 
prepared from 54 (96 mg, 0.25 mmol), Pd(PPh3)4 (09 mg, 3 mol%), 
1,4-dioxane (2.5 mL), 2M K2CO3 (0.5 mL) and phenylboronic acid 
(132 mg, 1.10 mmol) as a white crystalline solid (86 mg, 92%). The 
synthesis of 55a has been previously reported.85 Mp = 171 °C (lit.84, 
171 °C). 1H NMR (250 MHz, CDCl3): δ  = 7.05-7.10 (m, 4H, ArH), 7.13-7.22 (m, 8H, ArH), 
7.41-7.46 (m, 4H, ArH). 13C NMR (62.9 MHz, CDCl3) : δ = 125.1 (C), 125.9, 127.2, 127.3, 
128.3, 128.4, 130.4 (CH), 130.9, 133.2, 147.7 (C). IR (KBr): v = 3082, 3047, 2918, 2852 (w), 
1482, 1443 (m), 1387, 1315, 1249, 1152 (w), 1071, 1024, 946, 917, 908, 793, 765, 756, 739, 
704 (m), 689, 679 (s), 657, 648, 618 (m), 580, 536 (w) cm; GC-MS (EI, 70 eV): m/z (%) = 72 
([M]+, 100), 267 (23), 165 (05). HRMS (EI, 70 eV): calcd for C28H20O [M]+ :  372.15087 
found 472.150596. 
2,3,4,5-Tetrakis(3-chlorophenyl)furan (55d). Following the General procedure A
compound 55d was prepared from 54 (96 mg, 0.25 mmol), 
Pd(PPh3)4 (09 mg, 3 mol%), 1,4-dioxane (2.5 mL), 2M K2CO3
(0.5 mL) and 3-chlorophenylboronic acid (171 mg, 1.10 mmol) as 
a  white crystalline solid (101 mg, 80%). Mp = 118-119 °C. 1H 
NMR (300 MHz, CDCl3): δ  = 6.93-7.00 (m, 2H, ArH), 7.06-7.23 
(m, 12H, ArH), 7.47-7.48 (m, 2H, ArH). 13C NMR (75.5 MHz, CDCl3) : δ = 124.0 (CH), 
124.5 (C), 125.8, 128.0, 128.1, 128.4, 129.8, 130.0, 130.1 (CH), 131.6, 133.9, 134.5, 134.7, 
147.2(C).  IR (KBr): v = 1598, 1569, 1470 (m), 1426, 1321, 1300, 1257, 1136 (w), 1111, 
1100, 1090, 878, 789 (m), 780, 755, 681 (s), 665, 616, 550 (w) cm. GC-MS (EI, 70 eV): m/z
(%) = 516 ([M, 37Cl4]+, 02), 514 ([M, 35Cl, 37Cl3]+, 19), 512 ([M, 35Cl2, 37Cl2]+, 52),   510 ([M, 
O
O
Cl Cl
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35Cl3, 37Cl]+, 100),  508 ([M, 35Cl4]+, 19),  369 (14), 263 (15). HRMS (EI, 70 eV): calcd for 
C28H16 Cl4O [M, 35Cl4]+ :507.9955 found 507.99534. 
2,3,4,5-Tetrakis(3-(trifluoromethyl)phenyl)furan (55f). Following the General procedure 
A compound 55f was prepared from 54 (96 mg, 0.25 mmol), 
Pd(PPh3)4 (09 mg, 3 mol%), 1,4-dioxane (2.5 mL), 2M K2CO3
(0.5 mL) and 3-(trifluoromethyl)phenylboronic acid (208 mg, 
1.10 mmol) as a  white crystalline solid (132 mg, 82%). Mp = 
125-126 °C. 1H NMR (300 MHz, CDCl3): δ  = 7.23-7.27 (m, 
2H, ArH), 7.32-7.39 (m, 6H, ArH), 7.45-7.58 (m, 6H, ArH), 7.67 (brs, 2H, ArH). 19F NMR 
(282.4 MHz, CDCl3): δ  = -63.11, -63.20. 13C NMR (75.5 MHz, CDCl3): δ = 122.7 (q, JF,C = 
4.1 Hz, CH), 123.8 (q, JF,C = 272.2 Hz, CF3), 123.9 (q, JF,C = 273.3 Hz, CF3), 124.5 (C), 
124.7 (q, JF,C = 3.9 Hz, CH),  124.8 (q, JF,C = 3.9 Hz, CH), 122.7 (q, JF,C = 3.6 Hz, CH), 
128.9, 129.2, 129.4 (CH), 130.4 (C), 131.3 (q, JF,C = 36.7 Hz, C-CF3), 131.4 (q, JF,C = 36.7 
Hz, C-CF3), 132.5 (C), 133.4 (CH), 147.7 (C). IR (KBr): v = 1617, 1611, 1492, 1476, 1462, 
1439, 1354 (w), 1324 (s), 1294, 1284, 1205 (m), 1160, 1113, 1097, 1068 (s), 1000, 967, 897, 
850 (m), 800 (s), 739 (w), 707, 700, (s), 652 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 644 
([M]+, 100), 555 (11), 411 (12), 325 (10). HR-MS (EI, 70 eV): m/z= 644.10095;, calcd. for 
C32H16F12O (M+) found: 644.099515.
2,3,4,5-Tetrakis(4-methoxyphenyl)furan (55g). Following the General procedure A
compound 55g was prepared from 54 (96 mg, 0.25 
mmol), Pd(PPh3)4 (09 mg, 3 mol%), 1,4-dioxane (2.5 
mL), 2M K2CO3 (0.5 mL) and 4-methoxyphenylboronic 
acid (167 mg, 1.10 mmol) as a  white crystalline solid 
(120 mg, 98%). The synthesis of 55g has been 
previously reported.85  Mp = 206-207 °C (lit.85, 206-208 °C). 1H NMR (300 MHz, CDCl3): δ  
= 3.70 (s, 12H, 4OCH3), 6.67-6.98 (m, 8H, ArH), 6.96 (d, 4H, J = 8.3 Hz, ArH), 7.34 (d, 4H, 
J = 8.9 Hz, ArH).  13C NMR (75.5 MHz, CDCl3) : δ = 55.1, 55.2 (OCH3), 113.8, 113.9 (CH), 
123.3, 124.1, 125.8 (C), 127.2, 131.6 (CH), 147.2, 158.5, 158.7 (C).  IR (KBr): v = 3433 (w), 
3020, 3001, 2953, 2922, 2839, 1603 (m), 1501, 1492, 1283, 1172, 1029, 831 (s), 788 (m) cm; 
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GC-MS (EI, 70 eV): m/z (%) = 492 ([M]+, 100), 377 (15), 357 (09), 246 (05), 246 (22). 
HRMS (EI, 70 eV): calcd for C32H28 O5 [M]+ : 492.19313 found 492.193346. 
2,3,4,5-Tetrakis(4-ethylphenyl)furan (55b). Following the General procedure A compound 
55b was prepared from 54 (96 mg, 0.25 mmol), Pd(PPh3)4
(09 mg, 3 mol%), 1,4-dioxane (2.5 mL), 2M K2CO3 (0.5 
mL) and 4-ethylphenylboronic acid (165 mg, 1.10 mmol) 
as a  white solid (111 mg, 92%). Mp = 167-168 °C. 1H 
NMR (300 MHz, CDCl3): δ  = 1.15 (t, 6H, J = 7.6 Hz, 
2CH3), 1.16 (t, 6H, J = 7.6 Hz, 2CH3), 2.51-2.58 (m, 8H, 4CH2), 6.89-7.03 (m, 12H, ArCH), 
7.35 (d, 4H, J = 8.2 Hz, ArH). 13C NMR (75.5 MHz, CDCl3) : δ = 15.1, 15.3 (2CH3), 28.5, 
28.6 (2CH2), 124.4 (C), 125.8, 127.7, 127.8 (CH), 128.7 (C), 130.3 (CH), 130.6, 142.7, 143.2, 
147.5 (C).  IR (KBr): v = 3023 (w), 2964, 2929, 2869, 2859, 1518, 1454, 1372 (m), 1317, 
1298, 1261, 1242, 1185 (w), 1184, 1114, 1104, 1062, 1045, 1018, 966, 944 (m), 832 (s), 795, 
782, 747 (w), 686, 647, 637, 628 (m), 595, 587, 551 (w) cm; GC-MS (EI, 70 eV): m/z (%) = 
484 ([M]+, 100), 469 (15), 351 (09). HRMS (EI, 70 eV): calcd for C36H36O [M]+: 484.27607 
found 484.275860.
2,3,4,5-Tetrakis(4-tert-butylphenyl)furan (55c). Following the General procedure A
compound 55c was prepared from 54 (96 mg, 0.25 mmol), 
Pd(PPh3)4 (09 mg, 3 mol%), 1,4-dioxane (2.5 mL), 2M 
K2CO3 (0.5 mL) and 4-tert-butylphenylboronic acid (195 
mg, 1.10 mmol) as a  white solid (137 mg, 92%). Mp = 
163 °C. 1H NMR (300 MHz, CDCl3): δ  = 1.22 (s, 18H, 
6CH3), 1.23 (t, 18H, 6CH3), 7.00 (d, 4H, J = 8.7 Hz, ArH), 
7.16 (d, 4H, J = 8.9 Hz, ArH), 7.20 (d, 4H, J = 8.7 Hz, ArH), 7.4 0 (d, 4H, J = 8.7 Hz, ArH).
13C NMR (75.5 MHz, CDCl3) : δ = 131.3, 31.4 (6CH3), 34.5, 34.6, 124.7 (C), 125.0, 125.2, 
125.3 (CH), 128.5 (C), 130.0 (CH), 130.4, 147.3, 149.7, 149.9 (C). IR (KBr): v = 2960 (s), 
2904, 2867 (m), 1789, 1766 (w)  1681, 1674, 1604, 1475, 1462, 1407, 1362, 1298 (m), 1267 
(s), 1182, 1108, 1012 (m), 974, 942, 926, 887, 856 (w), 828 (s), 784, 770, 702, 687, 649, 626, 
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575, 545 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 484 ([M]+, 100), 469 (15), 351 (09). HRMS 
(EI, 70 eV): calcd for C44H52 O [M ]+ :  596.40182 found 596.40177. 
2,3,4,5-Tetrakis(4-fluorophenyl)furan (55e). Following the General procedure A compound 
55e was prepared from 54 (96 mg, 0.25 mmol), Pd(PPh3)4 (09 
mg, 3 mol%), 1,4-dioxane (2.5 mL), 2M K2CO3 (0.5 mL) and 
4-fluorophenylboronic acid (154 mg, 1.10 mmol) as a  white 
solid (94 mg, 80%). The synthesis of 55e has been previously 
reported. 85 Mp = 122-123 °C. 1H NMR (300 MHz, CDCl3): δ  
= 6.86-6.85 (m, 8H, ArH), 6.98-7.04 (m, 4H, ArH), 7.31-7.41 (m, 4H, ArH). 19F NMR (282 
MHz, CDCl3): δ  = -113.35, -111.25 .  13C NMR (75.5 MHz, CDCl3) : δ = 115.6 (d,  JF,C = 
21.9 Hz, CH), 115.7 (d,  JF,C = 21.3 Hz, CH), 123.5 (C), 126.6 (d,  JF,C = 3.3 Hz, C),  127.6 
(d,  JF,C = 8.2 Hz, CH), 128.6 (d,  JF,C = 3.5 Hz, C), 131.9 (d,  JF,C = 8.0 Hz, CH), 147.1, (C), 
127.6 (d,  JF,C = 248.5 Hz, 2CF). IR (KBr): v = 3054, 2920, 2851 (w), 1738, 1732, 1589, 1475 
(w), 1434 (m), 1393, 1378, 1307, 1260 (w), 1192, 1117 (s), 1089, 1068, 1025, 996 (m), 747, 
743, 718, 691, 537 (s) cm. GC-MS (EI, 70 eV): m/z (%) = 444 ([M]+, 100),  321 (30), 201 
(05). HRMS (EI, 70 eV): calcd for C28H16 O4 [M ]+ : 444.11318 found 444.11267. 
2,3,4,5-Tetrakis(3,5-dimethylphenyl)furan (55h). Following the General procedure A
compound 55h was prepared from 54 (96 mg, 0.25 mmol), 
Pd(PPh3)4 (09 mg, 3 mol%), 1,4-dioxane (2.5 mL), 2M K2CO3
(0.5 mL) and 3,5-dimethylphenylboronic acid (165 mg, 1.10 
mmol) as a  white crystalline solid (91 mg, 76%). Mp = 156 °C.
1H NMR (300 MHz, CDCl3): δ  = 2.11 (s, 12H, 4CH3), 2.15 (s, 
12H, 4CH3), 6.71 (s, 2H, ArH), 6.72 (s, 2H, ArH), 6.76 (s, 4H, 
ArH), 7.08 (s, 4H, ArH). 13C NMR (75.5 MHz, CDCl3) : δ = 21.1, 21.4, 123.6 (CH), 125.2 
(C), 128.3, 128.5, 128.8 (CH), 131.1, 133.2, 137.3, 137.6, 147.5 (C).  IR (KBr): v = 3003, 
2915, 2860 (w), 1618, 1599, 1462, 1444, 1377, 1299, 1213, 1198, 1176, 1148, 1036, 913, 894 
(m), 848 (s), 801, 729, 702, 692, 675 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 484 ([M]+, 100), 
351 (33), 321 (05), 242 (06). HRMS (EI, 70 eV): calcd for C36H36 O [M ]+ :  484.27607 found 
484.27587.
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9.5.2 Synthesis of 2,5-diaryl-3,4-dibromofurans 56 
3,4-Dibromo-2,5-bis(4-fluorophenyl)furan (56b). Following the General procedure A
compound 56b was prepared from 54 (96 mg, 0.25 mmol), 
Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 mL), 
2M K2CO3 (0.5 mL) and 4-fluorophenylboronic acid (70 mg, 
0.50 mmol) as a  white solid (90 mg, 87%). Mp = 83-84 °C. 1H NMR (300 MHz, CDCl3): δ  = 
7.05-7.17 (m, 4H, ArH), 7.91-7.96 (m, 4H, ArH). 19F NMR (282 MHz, CDCl3): δ  = -111.4. 
13C NMR (62.9 MHz, CDCl3): δ = 102.1 (C), 115.6, 116.0 (CH), 125.2 (d, JC,F = 3.6 Hz, C), 
127.6, 127.8 (CH), 147.4, 162.3 (d, JC,F  = 251.9 Hz, CF).  IR (KBr): v = 1786, 1760, 1605, 
1497, 1523, 1492 (m), 1410, 1298, 1275 (w), 1233, 1159 (s), 1072, 996, 943, 829 (m), 729, 
641, 632, 597, 587 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 416 ([M, 81Br,81Br]+, 50), 414 ([M, 
79Br,81Br]+, 100), 412 ([M, 79Br,79Br]+, 50), 305 (18), 225 (18), 207 (10).  HR-MS (EI, 70 eV): 
m/z= 411.89100, calcd. for C16H8OBr2F2 (M+, [79Br,79Br])  found: 411.890019; 413.88840, 
calcd. for (M+, [79Br,81Br]) found 413.888075; 415.88635, calcd. for (M+, [81Br,81Br]) found 
415.886165. 
3,4-Dibromo-2,5-bis(3-chlorophenyl)furan (56a). Following the General procedure A
compound 56a was prepared from 54 (96 mg, 0.25 mmol), 
Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 mL), 2M 
K2CO3 (0.5 mL) and 3-chlorophenylboronic acid (78 mg, 0.50 
mmol) as a  white solid (87 mg, 85%). Mp = 91-92 °C. 1H NMR 
(300 MHz, CDCl3): δ  = 7.26-7.33 (m, 4H, ArH), 7.83 (dt, J = 1.6, 7.4 Hz, 2H, ArH), 7.89-
7.91 (m, 2H, ArH). 13C NMR (75.7 MHz, CDCl3): δ = 103.7 (C), 123.7, 125.5, 128.2, 130.0 
(CH), 130.4, 134.8, 147.1 (C).  IR (KBr): v = 1596, 1567, 1471, 1461 (m), 1426, 1401, 1321, 
1302, 1258, 1241, 1136 (w), 1112, 1102, 1092, 1074, 991, 958, 878, 789 (m), 779, 754, 681 
(s), 664, 615, 549, 529 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 446 ([M, 79Br, 81Br, 35Cl, 35Cl]
+ or [M, 79Br, 79Br, 35Cl, 37Cl]+, 100), 444 ([M, 79Br, 79Br, 35Cl, 35Cl]+, 36), 450 ([81Br, 81Br, 
37Cl, 37Cl]+, 31), 339 (10), 223 (14). HR-MS (EI, 70 eV): m/z= 443.83135, calcd. for 
C16H8OBr2Cl2 (M+, [79Br,  79Br, 35Cl, 35Cl])  found: 443.832061. 
3,4-Dibromo-2,5-bis(3-(trifluoromethyl)phenyl)furan (56c). Following the General 
procedure A compound 56c was prepared from 54 (96 mg, 0.25 
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mmol), Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 mL), 2M K2CO3 (0.5 mL) and 
3-(trifluoromethyl)phenylboronic acid (95 mg, 0.50 mmol) as a  white solid (109 mg, 85%). 
Mp = 103-104 °C. 1H NMR (300 MHz, CDCl3): δ  = 7.50-7.59 (m, 4H, ArH), 8.12-8.15 (m, 
2H, ArH), 8.21 (brs, 2H, ArH). 19F NMR (282 MHz, CDCl3): δ  = 62.87. 13C NMR (62.9 
MHz, CDCl3): δ = 104.0 (C), 122.4 (q, JF,C = 4.0 Hz, CH), 124.23 (q, JF,C = 272.6 Hz, CF3),  
125.4 (q, JF,C = 3.7 Hz, CH), 128.7, 129.3 (CH), 129.4 (C), 131.3 (q, JF,C = 32.7 Hz, C-CF3), 
147.4 (C).  IR (KBr): v = 3028 , 2922, 2867, 1746, 1692, 1610, 1511, 1445, 1428 (w), 1327, 
1307, 1147 (m), 1122, 1071 (s), 1052, 961, 946, 902, 845 (w), 801 (m), 750, 740, 715 (w), 
693 (s), 664, 655, 573 (w) cm. GC-MS (EI, 70 eV): m/z (%) = 514 ([M, 79Br,79Br]+, 52), 514 
([M, 81Br,81Br]+, 100), 516 ([M, 81Br,81Br]+, 49),  495 (07), 407 (12), 326 (07), 257 (15), 173 
(37). HR-MS (EI, 70 eV): m/z= 511.88406, calcd. for C18H8Br2OF6 (M+, [79Br, 79Br])  found: 
511.884645; 513.88201, calcd. for (M+, [81Br,79Br]) found 513.882475; 515.87997, calcd. for 
(M+, [81Br, 81Br]) found 515.880736
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Appendix  
10 Crystallographic Data  
10.1 Crystal data and structure refinement for Diethyl 9-methyl-9H-carbazole-2,3-
dicarboxylate (19a) 
Identification code  mh96-3 
Empirical formula  C19H19NO4
Formula weight  325.35  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1   
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.135 (4) Å  = 71.282°. 
b = 9.673 (5) Å  = 79.208°. 
c = 12.548 (7) Å  = 78.97°. 
Volume 794.7 (8) Å3
Z 2 
Density (calculated) 1.360 Mg/m3
Absorption coefficient 0.096 mm-1
F(000) 344 
Crystal size 0.32 x 0.15 x 0.08 mm3
Θ range for data collection 7.891 to 59.925°. 
Index ranges -10h10, -13k13, -17l15 
Reflections collected 4557 
Independent reflections 2986 [R(int) = 0.032] 
Absorption correction multi-scan 
Max. and min. transmission 0.9924 and 0.9700 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.080 
Final R indices [I>2σ(I)] R1 = 0.0477, wR2 = 0.1157 
R indices (all data) R1 = 0.0879, wR2 = 0.1271 
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10.2 Crystal data and structure refinement for 2-(2-cyanoethyl)-9-methyl-9H-carbazole-3-
carbonitrile(20) 
Identification code  mh95a 
Empirical formula  C17H13N3
Formula weight  259.3  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1   
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.512 (11) Å  = 67.65°. 
b = 9.495 (13) Å  = 88.51°. 
c = 10.261 (13) Å  = 71.31°. 
Volume 637.4 (15) Å3
Z 2 
Density (calculated) 1.351 Mg/m3
Absorption coefficient 0.082 mm-1
F(000) 272 
Θ range for data collection 4.910 to 40.817°. 
Index ranges -7h9,  -12k12,  -13l13 
Reflections collected 2424 
Independent reflections 2524 [R(int) = 0.026] 
Absorption correction multi-scan 
Max. and min. transmission 0.9975 and 0.9127 
104
104
10.3 Crystal data and structure refinement for Isobutyl 6-oxo-6H-benzo[c]chromene-8-
carboxylate (42) 
Identification code  mh15 
Empirical formula  C18H16O4
Formula weight  296.31  
Temperature  173(2) K 
Wavelength  0.71073 Å
Crystal system  Orthorhombic 
Space group (H.-M.)  P n m a  
Space group (Hall)  -P 2ac 2n 
Unit cell dimensions a = 11.943 (5) Å  = 90°. 
b = 6.772 (5) Å  = 90°. 
c = 17.526 (5) Å  = 90°. 
Volume 417.5 (13) Å3
Z 4 
Density (calculated) 1.388 Mg/m3
Absorption coefficient 0.098 mm-1
F(000) 624 
Crystal size 0.63 x 0.04 x 0.04 mm3
Θ range for data collection 6.450 to 50.167°. 
Index ranges -15h15, -8k-8, -22l22 
Reflections collected 1747 
Independent reflections 864 [R(int) = 0.109] 
Absorption correction multi-scan 
Max. and min. transmission 0.9961 and 0.9409 
Refinement method Full-matrix  
Goodness-of-fit on F2 0.894 
Final R indices [I>2σ(I)] R1 = 0.0525, wR2 = 0.0946 
R indices (all data) R1 = 0.1463, wR2 = 0.1138 
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10.4 Table 6. Crystal data and structure refinement for 2,4,5,6-Tetraphenylpyrimidine
47a
Identification code  mh201 
Empirical formula  C28H20N2
Formula weight  384.47  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  F d  d 2   
Space group (Hall)  F 2 -2d 
Unit cell dimensions a = 23.815 (5) Å  = 90°. 
b = 57.776 (9) Å  = 90°. 
c = 5.814 (5) Å  = 90°. 
Volume 8000 (7) Å3
Z 16 
Density (calculated) 1.277 Mg/m3
Absorption coefficient 0.075 mm-1
F(000) 3232 
Crystal size 0.51 x 0.06 x 0.06 mm3
Θ range for data collection 4.81 to 25.55°. 
Index ranges -28h26, -67k70, -7l6 
Reflections collected 13820 
Independent reflections 2590 [R(int) = 0.066] 
Absorption correction multi-scan 
Max. and min. transmission 0.9955 and 0.9626 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.005 
Final R indices [I>2σ(I)] R1 = 0.0452, wR2 = 0.0747 
R indices (all data) R1 = 0.0834, wR2 = 0.0833 
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10.5 Table 12.  Crystal data and structure refinement for 2,3,4,5-tetraphenylfuran (55a) 
Identification code  mh350 
Empirical formula  C28H20O 
Formula weight  372.44  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  C  2/C  
Space group (Hall)  -C 2yc 
Unit cell dimensions a = 25.6061 (11) Å  = 90.00°. 
b = 8.0159 (3) Å  = 117.206°. 
c = 21.5847 (8) Å  = 90.00°. 
Volume 3940.2 (3) Å3
Z 8 
Density (calculated) 1.256 Mg/m3
Absorption coefficient 0.075 mm-1
F(000) 1568 
Crystal size 0.37 x 0.29 x 0.10 mm3
Θ range for data collection 4.114 to 59.926°. 
Index ranges -36h36,  -10k11,  -30l30 
Reflections collected 5745 
Independent reflections 3872 [R(int) = 0.040] 
Absorption correction multi-scan 
Max. and min. transmission 0.9926 and 0.9730 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.037 
Final R indices [I>2σ(I)] R1 = 0.0476, wR2 = 0.1192 
R indices (all data) R1 = 0.0819, wR2 = 0.1294 
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10.6 Table 12.  Crystal data and structure refinement for 2,3,4,5-tetrakis(4-
methoxyphenyl)furan (55g) 
Identification code  mh236 
Empirical formula  C32H28O5
Formula weight  492.54  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P  1 
Unit cell dimensions a = 9.9197 (2) Å  = 87.7670°. 
b = 11.0554 (3) Å  = 81.3120°. 
c = 24.3304 (6) Å  = 78.6210°. 
Volume 2585.65 (11) Å3
Z 4 
Density (calculated) 1.265 Mg/m3
Absorption coefficient 0.085 mm-1
F(000) 1040 
Crystal size 0.48 x 0.26 x 0.20 mm3
Θ range for data collection 4.785 to 59.182°. 
Index ranges -13h13, -15k15, -34l34 
Reflections collected 15043 
Independent reflections 10035 [R(int) = 0.035] 
Absorption correction multi-scan 
Max. and min. transmission 0.9832 and 0.9604 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.060 
Final R indices [I>2σ(I)] R1 = 0.0469, wR2 = 0.1084 
R indices (all data) R1 = 0.817, wR2 = 0.1189 
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Abbreviations  
Ac  Acetyl  
Anal.  Elemental Analysis  
bp.  Boiling point  
calcd  Calculated  
CI  Chemical Ionization  
COSY  Correlated Spectroscopy  
DEPT  Distortionless Enhancement by Polarization Transfer  
dr  Diastereomeric ratio  
ee  Enantiomeric excess  
EI  Electron Impact   
Et2O  Diethyl ether  
EtOH  Ethanol  
GC  Gas Chromatography  
GP  General Procedure  
HMBC Heteronuclear Multiple Bond Correlation  
HPLC  High Performance Liquid Chromatography  
HRMS  High Resolution Mass Spectrometry  
IR  Infrared Spectroscopy  
MS  Mass Spectrometry  
mp  Melting point  
NaOEt  Sodium ethanolate  
nBuLi  n-Butyllithium  
NEt3  Triethylamine  
NMR  Nuclear Magnetic Resonance  
NOESY Nuclear Overhauser and Exchange Spectroscopy 
ORTEP Oak Ridge Thermal Ellipsoid Plot   
OTf  Triflate  
Ph  Phenyl  
ppm  Parts per million  
Rf  Retention factor  
Tf2O  Trifluoromethanesulfonic anhydride (triflic anhydride) 
TFA  Trifluoroacetic acid  
THF  Tetrahydrofuran  
TLC  Thin Layer Chromatography  
TMS   Tetramethylsilane  
Tol  Tolyl (p-MeC6H4)  
Tos  Tosyl (p-MeC6H4SO2
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